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Preface: Aim of the Research 
 Mitochondria, besides their well-known role of “powerhouses” of the cell, is a 
central organelle in many others cellular processes as aging and apoptosis. An 
extensive interplay occurs between nuclear and mitochondrial genome, and allows cells 
to integrate mitochondrial metabolism in the cellular network. All the processes that 
concur to proper mitochondrial functionality and integration are collectively known as 
“mitochondrial biogenesis”. The yeast S. cerevisiae has been one of the most used 
model organism for mitochondrial research and many approaches have been used to 
identify nuclear genes involved in mitochondrial metabolism and in the last few years 
genome-scale approaches became very popular. However, the yeast mitochondrial 
proteome is still not totally covered. 
 In Chapter 1 of this dissertation is described a genome-wide screening focused 
on identification of nuclear genes involved in mitochondrial biogenesis, performed at 
University of Parma, Department of Genetics in collaboration with Department of 
Biochemistry and Molecular Biology. Knowing that certain genes express mitochondrial 
phenotypes only in stressful conditions we carried out a genome-wide screening at 37˚C 
postulating that previous published results, obtained in experiments at 30˚C, could have 
underestimated the number of nuclear genes involved in such processes. Using 
complete ethanol media and analysing growth at 37˚C and 30˚C we identified 488 genes 
whose deletion led to a defect. 
Through data mining and experimental confirmation we generated a list of 177 nuclear 
genes that were previously not linked to mitochondrial biogenesis or with a mitochondrial 
role still poorly understood. For the majority of those the mitochondrial phenotype was 
expressed only at 37˚C. Furthermore we gave a first characterization of the OXPHOS 
defect analysing cytochromes content and oxygen consumption, creating 4 phenotypical 
classes to depict the different impairments observed. 
Interestingly several histone modifiers, transcriptional factor and cellular pathways were 
specifically enriched in our dataset at 37˚. Cytoplasmic tRNAs chemical modification, N-
terminal protein acetylation and alkaline pH sensing were among the pathways 
identified. A functional importance of such processes in mitochondrial biogenesis under 
stress is for the first time discussed. 
 In Chapter 2 particular attention has been given to one of the pathways identified 
in the described screening. Indeed enrichment in the pathway of chemical modification in 
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wobble bases of cytoplasmic tRNAs was very interesting since a relation between this 
process and mitochondrial biogenesis was never shown. We explored the possibility that 
tRNAs modified in this pathway could be essential for mitochondrial protein synthesis at 
37˚C studying in particular the effects of three deletions in genes representative of the 
three different steps of the pathway. We were able to demonstrate clearly that under 
stress the mitochondrial protein synthesis is regulated by cytoplasmic tRNAs chemical 
modification, although the molecular mechanisms underlying are still uncertain. 
 In Chapter 3 is described a single gene analysis carried out under the 
supervision of Prof. Antoni Barrientos at University of Miami Miller School of Medicine 
(Department of Neurology). We characterized functionally YIR024C, identified in the 
aforementioned screening as gene whose deletion caused OXPHOS defects at 37˚C. It 
codes for a mitochondrial protein of unknown function, a hypothetical interactor of 
Adrenodoxin Reductase (Arh1p). 
Through extensive biochemical characterization a yir024c null mutant was found to have 
several mitochondrial respiratory chain defects. Mitochondrial encoded subunits of 
complex IV (Cox1p, Cox2p and Cox3p) and Cyt b were markedly decreased at 37˚C, 
along with corresponding enzymatic activities. Also mitochondrial heme profile showed 
impairments in the same conditions. 
We obtained a strain expressing an epitope-tagged version of the protein, used to 
determine the mitochondrial localization, topology and the native size. These analyses 
confirmed that Yir024c is a mitochondrial protein, integral to the inner membrane and 
exposing a globular domain of 152 amino acids in the inter membrane space. The 
protein revealed a native size of about 250Kda, indicating that it resides in a complex. 
We failed in confirming the predicted physical interaction with Arh1p as this protein was 
not part of the same complex of Yir024cp and was not found to co-precipitate in affinity 
purification studies. To identify Yir024cp functional partners the 250Kda complex was 
purified and mass spectrometry analyses are in progress.  
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1.1 Introduction 
1.1.1 Mitochondria 
Mitochondria are essential eukaryotic organelles evolved through an ancestral 
endosymbiotic event (Margulis 1975; Margulis et al. 1985). The most addressed 
mitochondrial role is to be “the powerhouse” of the cell being pivotal sites of fatty acids 
metabolism, tri-carboxylic cycle (TCA, Krebs Cycle) and oxidative phosphorylation. 
Nevertheless mitochondria play recognized roles in many other essential cellular 
processes such as calcium homeostasis, apoptosis, ageing and are major production 
sites of oxygen reactive species (ROS). With their metabolic capabilities mitochondria 
take part also in Fe/S cluster assembly, heme biosynthesis, metabolism of amino acids 
and nucleotides. These organelles are integrated in the cellular network in a very 
complex fashion and many aspects of this relationship are still partially unknown. 
Furthermore malfunction in mitochondria have been extensively associated with 
numerous neurodegenerative disorders in Homo sapiens (Wallace 2001; DiMauro et al. 
2003; Diaz et al. 2008; Duffy et al. 2011) and many other pathological conditions (Kamp 
et al. 2011). Indeed mitochondrial malfunctions with consequent energy failure target 
moreover tissues where energy demand is high, such as brain, nervous tissue and 
muscles. 
Mitochondria are elliptic organelles with a variable diameter of 0.2-1µm and length of 3-
4µm. From structural point of view are quite complex organelles, with a double system of 
lipid membranes (outer and inner) that creates two distinct compartments: the soluble 
core matrix and the inter-membrane space (IMS). The outer membrane is lipid rich and 
contains high number of β-barrel proteins forming pore complexes that regulates 
permeability in a size-dependent manner. Outer membrane is also the site were nuclear 
encoded mitochondrial proteins are recognized and imported in mitochondria. 
The inner membrane is much more complex and contains the highest protein content 
among the biological membranes (Herrmann 2011). It is folded in the matrix in several 
invaginations (cristae) that allow the extension of inner membrane length, site of all 
respiratory complexes used in the oxidative phosphorylation and ATP synthesis. Each 
crista is connected to external portions of the inner membrane, the “inner membrane 
boundaries”. The junctions between cristae and boundaries are called “contact sites”, 
dynamic protein rich structures with crucial role in the mitochondrial inner organization 
(Harner et al. 2011; Hoppins et al. 2011; Alkhaja et al. 2012). The IM boundaries, being 
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close to the outer membrane, are site of metabolite transporters and protein import and 
insertion systems for the matrix and the inner membrane. 
 
 
Mitochondria are not single cytoplasmic units but highly dynamic organelles heavily 
interconnected and forming a reticulum. This structure is continuously regulated in 
response to cellular environment in a complex process known as “mitochondrial 
dynamic” with distinct and coordinated processes of fusion and fission (Dimmer 2002; 
McBride et al. 2006). 
As pointed out before mitochondria are principal site of energy production. Principal 
energy sources for the cells are sugars and fatty acids. Sugars are catabolized through 
glycolysis, which occurs in cytosol, allowing production of 2 ATP, 2 NADH and 2 
pyruvate molecules for each glucose molecule processed. In anaerobiosis pyruvate is 
converted to lactate during lactic fermentation or, in yeasts, also to ethanol in alcoholic 
fermentation. These processes, which again occur in the cytosol, recycle NADH back to 
NAD+ to allow glycolysis to continue. In presence of oxygen pyruvate can be totally 
oxidized with higher net ATP production in a process called cellular respiration. 
 
 
 
FIG 1.2: General overview of cellular respiration. Reducing equivalents produced in glycolysis, 
pyruvate processing and Krebs cycle are used in mitochondria during oxidative phosphorylation. 
Copyright Pearson Education Inc.   
FIG 1.1: Mitochondria ultrastructure (electronic microscopy). 
Copyright Pearson Education Inc.   
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Pyruvate is imported in mitochondria and converted by pyruvate dehydrogenase in 
acetyl-CoA that is in turn shuttled in Krebs cycle. Also fatty acids are totally converted in 
mitochondria in acetyl-CoA units in a process known as β-oxidation. In S. cerevisiae 
(and in yeast in general) this process takes place in peroxisomes producing acetyl-CoA 
units later imported in mitochondria through an acetyl-carnitine carrier. 
Krebs cycle (tri-carboxylic acids cycle, TCA cycle), a set of eight reactions occurring in 
the mitochondrial matrix, converts acetyl-CoA in CO2 with production of reductive 
equivalents in form of NADH and FADH2. Stoichiometrically 1 molecule of acetyl-CoA is 
converted in 2 CO2 with production of 3 NADH, 1 FADH2 and an additional high energy 
GTP molecule. The final product of the cycle, oxaloacetate, is used in the first reaction, a 
condensation with acetyl-CoA catalyzed by citrate synthase. Krebs cycle is also a pivotal 
amphibolic pathway; indeed intermediates such as α-ketoglutarate and oxaloacetate are 
common precursors for biosynthesis of aminoacids, nucleotides and other molecules. All 
the enzymes of Krebs cycle are soluble proteins of mitochondrial matrix with the only 
exception of succinate dehydrogenase, which is anchored to inner membrane via two 
integral membrane subunits (Sdh3p and Sdh4p in yeast) while the catalytic core (Sdh1p 
and Sdh2p in yeast) is facing the matrix. This enzyme represents a physical connection 
between Krebs cycle and oxidative phosphorylation. Indeed SDH complex is also the 
second respiratory complex (complex II) of mitochondrial respiratory chain (MRC). 
 
 
 
FIG 1.3: Eight steps of Krebs cycle (TCA cycle). 
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MRC is the latest metabolic step that uses the reductive equivalents produced in the 
other metabolic pathways to generate an electron flow along the mitochondrial inner 
membrane. This flow is used to reduce oxygen in H2O and is coupled to proton pumping 
from matrix to IMS generating an electrochemical gradient across the inner membrane. 
Four enzymatic complexes across the inner membrane compose MRC and use different 
electron transport centers that are cyclically reduced and oxidized: Fe/S clusters, heme 
centers, heme binding proteins (cytochromes) and the soluble factor coenzyme Q10. 
Complex I is the biggest respiratory complex of the chain. It shuttles electrons from 
NADH to coenzyme Q10 via flavin mononucleotide center (FMN) and several Fe/S 
clusters. The process is coupled to the expulsion of 4H+ in the IMS. S. cerevisiae is one 
of the few eukaryotes lacking complex I even if the same reaction is performed by NADH 
dehydrogenase (Nde1p/Nde2p and Ndi1) without proton pumping. 
Complex II is the aforementioned Krebs cycle enzyme that couples oxidation of 
succinate to fumarate with the reduction of coenzyme Q10. The same complex can also 
oxidize FADH2 and shuttle the electrons in the respiratory chain. Two catalytic subunits 
(Sdh1p and Sdh2p in yeast) transfer electrons from succinate to a flavin adenine 
dinucleotide cofactor (FAD) and sequentially to three Fe/S cluster before reducing a 
covalently bound heme b moiety found in the membrane domain of the complex (Sdh3p 
and Sdh4p in yeast). Electrons are finally flow to coenzyme Q10. No proton pumping is 
associated to this respiratory complex. 
Complex III (cytochrome bc1 complex) is an integral membrane complex that faces both 
mitochondrial matrix and IMS. Electrons flow from reduced Q10 to cytochrome b, an 
embedded protein with a covalently bound heme b moiety. This in turn shuttles the 
electrons to a Fe/S protein (Rieske protein) and eventually to cytochrome c1 on the IMS 
side. The process is completed with the oxidation of cytochrome c1 and reduction of 
soluble IMS protein cytochrome c. Complex III couples the electron flow to pumping of 
two protons. 
Complex IV is the last respiratory complex and is deputed to the oxidation of soluble 
cytochrome c and final reduction of oxygen to H2O concomitantly to expulsion of four H
+. 
The complex COX structure contains two cytochromes (a and a3) and copper centers for 
electron transport. 
A last non-respiratory complex is involved in energy production in mitochondria: ATPase 
or complex V. This enzymatic complex dissipates the electrochemical proton gradient 
produced across inner membrane to synthetize ATP starting from ADP and inorganic 
phosphate. It is formed by two discrete units: F0 and F1. The first consists of a proton 
 8 
channel in the inner membrane where 3H+ flow back inside the matrix. The second unit 
(F1) is connected to the first one generating a rotary motor that perform a 120˚ rotation 
every imported proton. With a rotational catalysis mechanism ADP and Pi are bound 
together with ATP release. Produced ATP that is needed in the cytosol is exported via 
ATP/ADP carrier that concomitantly imports ADP in the matrix to be recycled. 
 
FIG 1.4: MRC complexes across the inner membrane. Image taken from KEGG pathways 
database. Yeast S. cerevisiae lacks complex I. 
 
S. cerevisiae is a facultative aerobe/anaerobe that harbors some peculiarities from 
metabolic point of view. Metabolic life is regulated in accordance to oxygen availability 
and carbon source provided. Indeed when glucose is provided in aerobic environment 
and respiratory metabolism would be the most convenient, S. cerevisiae relies its energy 
production exclusively on glycolysis and fermentation. When glucose is provided in 
limiting amounts or in batch cultures when glucose levels are decreasing, respiratory 
metabolism is de-repressed. Yeast has the capability to use also alternative carbon 
sources then glucose. Disaccharides like maltose, sucrose and melibiose can be broken 
in monosaccharides like glucose and fructose, and then normally used. Galactose is an 
epimer of glucose that is directly phosphorylated by galactokinase and converted to 
galactose-1-phosphate. This product is in turn converted to glucose-1-phosphate by 
galactose-1p-urydiltransferase. In this reaction galactose is shuffled with the glucose 
bound in UDP-glucose with resulting glucose-1-phosphate and UDP-galactose. Glucose-
1-phospate is used in normal glycolysis whilst UDP-galactose is converted to UDP-
glucose by an epimerase. Galactose has the particularity to be a sugar totally processed 
in glycolysis without any glucose-repressing effects on mitochondrial function. 
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Yeast can also use other carbon sources that are not fermentable (oxidative) like 
glycerol, ethanol, acetate and lactate. All these metabolites require a proper 
mitochondrial functionality to be used as sole carbon sources and are commonly used in 
mitochondria-related research to highlight mitochondrial dysfunctions. 
The use of yeast like S. cerevisiae in this research field comes from the ability to survive 
with respiratory deficient mitochondria if a fermentable carbon source is available, 
showing a growth defect only in presence of respiratory carbon sources. Impairments in 
each of the processes that directly or indirectly affect mitochondrial metabolic function 
(collectively called “mitochondrial biogenesis”) will therefore be highlighted in presence 
of oxidative carbon sources, but not in presence of fermentable ones. However some 
mitochondrial functions are essential for life regardless of the carbon source, such as 
Fe/S cluster biosynthesis. This exceptional ability, unique among eukaryotes and 
restricted to only some yeast genus (Bulder 1964), made S. cerevisiae one of the most 
used model organisms in mitochondrial research. 
 
  
 10 
1.1.2 Mitochondrial Biogenesis: an Overview 
Mitochondrial biogenesis is a complex event that comprises a great variety of different 
cellular processes. Every single aspect of cellular life that can influence and regulate 
mitochondrial function can be mentioned in “mitochondrial biogenesis processes”. These 
events can be directly or indirectly connected to mitochondria. For instance every 
process that takes place in mitochondria, played by the members of mitochondrial 
proteome, is concurring directly to a correct functionality of the organelle. Processes 
physically residing in mitochondria can range from respiratory functions, assembly of 
protein complexes, organization of mitochondrial ultrastructure or mitochondrial DNA 
expression and maintenance. On the other hand to ensure a correct mitochondrial 
biogenesis is necessary to integrate mitochondria in the cellular network and to regulate 
mitochondria function in response to environment and external stimuli, process that 
requires also other cellular compartments. Thus giving a proper definition of 
“mitochondrial biogenesis” is quite challenging. 
Mitochondria possess the peculiarity of having a mitochondrial genome (mtDNA) with a 
size of 68Kb (in short strains) or 86Kb (in long strains). This genome is the product of 
more than a billion years of evolution in which an original independent genome (after the 
endosymbiosis event) was extensively reduced in a mechanism known as Müller ratchet 
(Muller H. J. 1964). This size reducing was coupled with either loss or transfer of genes 
to the nuclear DNA. The coding capacities of mitochondrial genome are thus limited to 
seven essential protein components of mitochondrial respiratory complexes (Cox1p, 
Cox2p, Cox3p, Cyt b, Atp6, Atp8 and Atp9) and a protein of the small subunit of 
mitochondrial ribosome, Var1p. S. cerevisiae mtDNA also encodes for a complete set of 
24 tRNAs and 2 rRNAs. Up to 13 introns are present in 3 genes (COX1, COB and 
21sRNA) and different intronic ORFs have been characterized. These ORFs code for 
maturases that assist splicing, endonucleases, reverse transcriptases and additional 
unknown/putative proteins (Foury et al. 1998). 
Although the coding potential is limited compared to the total mitochondrial proteome, 
these mtDNA encoded proteins are essential in mitochondrial biogenesis. Furthermore 
mitochondria need active processes of packaging, replication, transcription and 
translation essential for proper mitochondrial DNA expression. All the proteins necessary 
for these processes are nuclear encoded and thus participate to mitochondrial 
biogenesis. For instance more then 22 proteins were found to be part of the nucleoids, 
dynamic nucleo-protein structures anchored to inner membrane organizing more then 10 
mtDNA molecules each (Chen et al. 2005; Kucej et al. 2008). Other 77 proteins (76 
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nuclear encoded) are part of the mito-ribosomes with additional initiation, elongation and 
termination factors (Mieszczak et al. 1988). Very interesting is to consider how 
expensive is to maintain such systems active. For a total 8 essential proteins, more then 
200 nuclear encoded proteins are produced and imported in mitochondria only to allow a 
correct DNA metabolism and expression (Contamine et al. 2000; Lipinski et al. 2010). 
Many other proteins are used also to regulate the expression of these proteins, mainly 
residing on post-transcriptional events. For instance Cox1p, Cox2p and Cox3p 
translation is tightly regulated by assembly state of COX complex, environmental 
conditions such as oxygen availability or mitochondrial functionality (Soto et al. 2009; 
Soto et al. 2011). Just to mention, up to date six nuclear encoded translational activators 
are known to directly drive translation of COX1 (Pet309p and Mss51p), COX2 (Pet111p) 
and COX3 (Pet54p, Pet122p and Pet494p) mRNAs and a total of 25 different nuclear 
encoded proteins are known to work as trans-activating factors during mitochondrial 
genome translation. 
Mitochondrial proteome is believed to count about 1000 (yeast) to 1500 (human) distinct 
members (Sickmann et al. 2003; Perocchi et al. 2006; Pagliarini et al. 2008). Being only 
8 essential proteins encoded in mitochondrial DNA appears clear that one of the most 
important processes directly involved in mitochondrial biogenesis is the import of 
cytoplasmic translated proteins into mitochondria and their subsequent sorting to the 
correct site. Yeast evolved a complex machinery to recognize, process, import and sort 
proteins destined to mitochondria.  
 
 
Fig 1.5: Mitochondrial protein 
biogenesis and (B) mitochondrial 
machinery for protein import. Image 
taken from Chacinska et al. 2009. 
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Firstly an outer membrane holocomplex representing a general entry gate recognizes 
cytosolic synthetized proteins that have to be imported. This complex, named TOM 
(Translocase Outer Membrane), forms a channel in the outer membrane, composed by 
the β-barrel protein Tom40p and other structural components (Tom5p, Tom6p and 
Tom7p). Associated receptors (Tom20p, Tom22p and Tom70p) are responsible of 
protein recognition and import. From here the fate of each protein depends on the 
mitochondrial sub-localization (Diaz et al. 2008; Chacinska et al. 2009). Matrix proteins 
are imported through a translocase of the inner membrane complex, TIM23, built of a 
structural and a motor component. In an ATP-dependent manner this complex import 
proteins from IMS to the matrix where they will be finally processed and folded. Common 
inner membrane proteins are imported in the matrix through TOM-TIM23 complexes and 
then inserted by Oxa1p, a mitochondrial matrix protein. Proteins with only one 
membrane helix are instead inserted laterally in the membrane directly by TIM23. Finally 
proteins with high hydrophobicity or even number of transmembrane helices are directly 
blocked in the IMS, recognized by small TIM proteins (Tim9p, Tim10p and Tim12p) and 
transferred to a different translocase of the inner membrane, the TIM22 complex, to be 
finally inserted. Outer membrane proteins usually contain a β-barrel domain and are 
imported through the classical TOM complex. Once in the IMS a set of small Tim 
proteins recognizes the polypeptide and drives it to an addition outer membrane 
translocase complex, called TOB/SAM. This complex finally mediates the insertion. A 
final essential component of protein import machinery has been evolved for IMS proteins 
that share particular disulfide bonds in their structure. The so called “disulfide relay 
system” based mainly on two essential IMS proteins, Erv1p and Mia40p, recognizes 
proteins with particular cysteine patterns (for instance twin C-X9-C motifs) and directly 
drive an oxidative folding process creating the necessary disulfide bonds (Deponte et al. 
2009). 
Encoding organellar proteins in two different genomes require also a highly coordinated 
expression between the two compartments that relies on both nuclear-mitochondrial and 
mitochondrial-nuclear signaling. These pathways are known as anterograde and 
retrograde regulation and allow concomitantly to maintain mitochondria informed about 
cellular environment and to send to the nucleus signals about respiratory functions (Liu 
Z. et al. 2006; Woodson et al. 2008; Lipinski et al. 2010). 
An excellent and extensively characterized signaling cascade is the one based on Rtg 
factors (Liu Z. et al. 2006). Rtg1p and Rtg3p are two helix-loop-helix leucine zippers 
transcriptional factors that form a heterodimer to bind promoter regions. Two positive 
 13 
regulators (Rtg2p and Grr1p) and four negative regulators (Mks1p, Lst8p, Bmh1p and 
Bmh2p) create a signaling network that affects nuclear translocation of Rtg1/Rtg3 
heterodimer. Many signals contribute to negative or positive Rtg regulation integrating 
mitochondrial function in the dynamic cellular environment. As yet not complete example 
Rtg1/Rtg3 is able to induce peroxisomes proliferation, β-oxidation and other anaplerotic 
pathways upon mitochondrial dysfunction in order to reconfigure cellular metabolic 
programs and ensure a correct supply of α-ketoglutarate (lacking in TCA defective 
mitochondria) used in biosynthesis of compounds like glutamate. On the other hand, 
when glutamate/glutamine levels are high due to mitochondria activity or environmental 
conditions a negative feedback signal downregulates Rtg1/Rtg3 nuclear translocation. 
 
  
Mitochondrial biogenesis can be to this point considered as the sum of all functions that 
directly participate in generating a functional organelle, allowing expression of its 
genome, import of nuclear encoded proteins and assembly of all the mitochondrial 
complexes required for proper functionality. These direct processes are regulated 
through a coordinated expression of two distinct genomes that can also be target of 
environmental signals like ones sensed through Rtg pathway. However in the last years 
a great interest has been given to the highly dynamic behavior of these organelles in the 
cellular network. Since the first observation that mitochondria are not single units but 
rather form a complex network (Bereiter-Hahn 1990)  three main processes have been 
characterize that contribute equally to mitochondrial dynamics: fusion, fission and 
selective degradation (mitophagy). These processes rather than contribute directly to 
Fig 1.6: Mechanism and signals that Rtg retrograde 
pathway senses to integrate mitochondria in cellular 
network. Image taken from Liu and Butow 2006. 
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mitochondrial functions (such as TCA cycle or OXPHOS process) are involved in shape 
dynamics of mitochondrial network in response to environmental clues and mitochondrial 
functionality and recently they might mediate relationships between mitochondria and 
other organelles as ER and peroxisomes. 
Two major GTPase complexes are associated with mitochondrial fusion: Fzo1p and 
Mgm1p complexes. This process allows mitochondria to fuse in a single structure, 
sharing then all the components and genomes. The GTPase Dnm1p as well as Fis1p 
and Mdv1p catalyze fission. Although molecular mechanisms of fission and fusion are 
quite understood, their regulation and biological functions are still poorly characterized. 
They are believed to control mitochondrial quality, on one hand allowing mitochondrial 
content mixing during fusion and thereby contribute to integrity and homogeneity. On the 
other hand fission could be used to isolate damaged mitochondria from the network, 
targeting them to clearance (Tatsuta et al. 2008). Interestingly mitochondrial dynamics 
and morphology were recently connected to bioenergetics state of mitochondria. Fusion 
complex Mgm1 is indeed influenced by reduced levels of ATP with consequent 
mitochondria fragmentation (Herlan et al. 2004). The same event was observed in upper 
eukaryotes, where OPA1 (human ortholog of Mgm1p) proteolysis was stimulated upon 
membrane potential dissipation with subsequently mitochondrial fragmentation (Duvezin-
Caubet et al. 2006; Ishihara et al. 2006). Mitochondrial dynamics could indeed act as a 
mitochondrial modulator in order to adequate cellular response to physiological 
conditions (Westermann 2010).  
A third process completes this scenario: the selective degradation of mitochondria. 
Autophagy is a specialized cellular process involving lysosomal/vacuolar clearance of 
long-lived proteins and organelles (Bhatia-Kissova et al. 2010). This non-selective 
process can be regulated and directed to specific purposes, like turnover of 
dysfunctional and damaged mitochondria. Such process is known as “mitophagy”. A key 
gene of the process was found to be ATG32, proposed to act as mitochondrial receptor 
interacting with the autophagy cascade member coded by ATG11. Atg32p thus is 
required to promote mitophagy recruiting to mitochondria the aspecific autophagy 
machinery (Kanki et al. 2009; Okamoto et al. 2009). In the last years became evident 
how mitophagy is not only a simple turnover mechanism but could be induced 
specifically in response to cellular environment. In this way cells would strictly regulate 
the quality and the quantity of mitochondria, eluding an accumulation of unproductive 
and harmful mitochondria (Kurihara et al. 2011). This process has therefore to integrate 
stimuli of different nature from nutrient availability and growth phase to redox imbalance, 
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ROS production and aging process (Bhatia-Kissova et al. 2010). Although molecular 
mechanisms nowadays are partially known, how this process is regulated and which are 
the molecular signals and the pathways involved remain unclear. Some indications exist, 
like role of independent regulators Uth1p and Aup1p and more recently the stress sensor 
Whi2p. The latter seems to link in yeast the general stress response that is activated 
reaching the stationary growth phase and the nutrient limitation to the activation of 
mitophagy and autophagy processes (Muller M. et al. 2011). 
Concluding, also mitophagy process along with mitochondrial dynamics play an 
important role in integrating in the cellular environment the mitochondrial network, 
properly shaping it through fusion, fission and degradation processes. These three 
events could therefore be interconnected and together indirectly influence the 
mitochondrial function and thus mitochondrial biogenesis. Crucial importance of these 
processes is proven by the several pathologies related to impairments in such 
processes. For instance Parkinson’s disease or autosomal optic atrophy type I are 
indeed severe neurodegenerative disorders associated to dysfunctions in both 
mitophagy and mitochondrial dynamics respectively (Schafer et al. 2009; Narendra et al. 
2010). 
Many experimental approaches can be used to assess and explore new roles and new 
members of mitochondrial biogenesis. Especially at this status of mitochondrial 
knowledge, when the scientific community is not so far from completion of mitochondrial 
proteome, a researcher should adopt a wider perspective when interpreting results and 
hypotheses, embracing also the “systems biology” point of view. Mitochondrial 
biogenesis definitely does not reside only in specific functions played by mitochondrial 
proteome but also on processes apparently unrelated that could act integrating 
mitochondria in the cellular network, event essential for proper mitochondrial 
functionality/cellular life. 
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1.1.3 High-Throughput Approaches to Study Mitochondrial 
Biogenesis in S. cerevisiae 
More then 50 years of research on genetics and molecular biology of S. cerevisiae 
provided an exceptional set of research tools that can be used to dissect any aspect of 
cellular life. For sure in the last decades a great amount of data was obtained by high-
throughput techniques that allowed analyses of thousands of different mutants, crossed 
strains or tagged proteins at the same time in any condition of interest. Mitochondria, 
given its pivotal role in eukaryotes life, made no exception. For sure one of the first high-
throughput approach to study mitochondrial biogenesis worth of mentioning was the one 
described by Tzagoloff A. and Dieckmann C.L. (Tzagoloff et al. 1990). Authors divided 
all the nuclear mutants known by previous studies to harbor defects in mitochondrial 
function and hundreds of new ones obtained by mutagenesis in more then 200 
complementation groups, thus creating a numerous collection. Mutants, identified by 
defects in oxidative growth, were organized in phenotypical classes on the base of 
mitochondrial phenotypes, such as defects in mitochondrial encoded cytochromes, in 
ATPase complex, or in other processes not involving MRC (TCA mutants for instance). 
For the first time was also precisely defined the term “pet mutant”, used to distinguish 
cytoplasmic petite mutants (harboring cytoplasmically inherited mutations) and mutants 
in nuclear genes with compromised mitochondrial function. Nowadays this term is still 
used to identify any nuclear mutant with a carbon-source dependent mitochondrial defect 
that could be also additionally affected by other environmental factors (as temperature). 
Although the aforementioned collection contained several mutants, after the completion 
of S. cerevisiae genome sequencing a new powerful tool was introduced: the “knock-out” 
mutant collection. Several kinds of knock out collections are now available commercially 
and consist of thousand of yeast haploid or diploid strains carrying one single deletion in 
each non essential nuclear gene. Growth analyses using these collections were carried 
out in several conditions in order to study many different processes. These could range 
from nuclear DNA repair, virus replication, tolerance to salt and nutrient availability, 
tolerance to oxidative, heavy-metals, temperature and ethanol stresses (Winzeler et al. 
1999; Giaever et al. 2002; Jazayeri et al. 2002; Scherens et al. 2004; Panavas et al. 
2005; Ruotolo et al. 2008; Auesukaree et al. 2009; Teixeira et al. 2009; Yoshikawa et al. 
2009). 
Mitochondrial function was also extensively studied with high-throughput growth analysis 
of knock-out collections (Dimmer 2002; Steinmetz et al. 2002; Luban et al. 2005; Hess et 
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al. 2009; Merz et al. 2009). Some of these analyses produced extensive data reporting 
growth defects for hundreds of nuclear pet mutants, and are worth of further description. 
Dimmer K.S. and colleagues described in 2002 a genome-wide screening performed on 
4794 S. cerevisiae diploid strains carrying homozygous deletion in non essential genes. 
A first screening evaluated the growth performances of the entire collection on complete 
media supplied with oxidative carbon source glycerol at 30˚C. A total of 341 deletions 
caused a specific growth defect absent in the control condition (rich media with glucose). 
For the knowledge of that moment, more then half of the identified pet genes encoded 
known mitochondrial proteins. The remaining genes were relative to non-mitochondrial 
proteins with a total of 58 genes of unknown function. A second screening instead 
evaluated the mitochondrial morphology and distribution (MDM) looking for mdm 
mutants. If mdm mutant never displayed any wild-type mitochondria during analysis was 
defined as class I mutant and the corresponding gene was considered essential for 
mitochondrial morphology. A subset of mdm mutants was respiratory competent in the 
first screening and were referred as class II mutants. A last class was created, class III, 
relative to mdm mutants that instead showed also pet phenotype (Dimmer 2002). 
In 2005 Cornelia Luban and colleagues presented a genome-wide screening focused on 
splicing metabolism of group II introns in mtDNA. A first screening was performed on 
complete media with glycerol at 30˚C using a complete knock out collection of 4878 
viable haploid S. cerevisiae strains. A total of 355 mutants showed a pet phenotype on 
glycerol media. Authors compared results with those described by Dimmer in 2002 and 
found an overlap of 67.6%. A particular focus was given in nuclear genes possibly 
involved in splicing metabolism of group II introns of mtDNA. To this purpose in the 
preselected 355 strains loss of mtDNA was induced, replaced then by a rho+ genome 
without group two introns and looking for complementation of foreseen pet phenotype. In 
this case phenotypes of 109 pet mutants were complemented by introduction of 
intronless mtDNA (Luban et al. 2005). 
Merz S. and Westermann B. performed an interesting and exhaustive genome-wide 
screening, published in 2009. Analyzing a knock out collection of haploid strains for 
defects in growth on glycerol media at 30˚C, a total of 319 pet mutants were identified. 
The phenotype observed was checked also on different oxidative carbon sources, to 
confirm a general OXPHOS impairment rather then glycerol metabolism defects. A 
complex experimental flowchart (depicted in Figure 1.7) based on mitochondrial DNA 
maintenance analysis, cytoduction experiments to replenish mutants with fresh 
undamaged mtDNA, DAPI staining and mitochondrial translation analysis were used to 
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characterize the origin of pet phenotype. This allowed the identification of 88 genes 
required for mitochondrial translation, 10 genes for expression of specific mitochondrial 
products and 16 for mtDNA maintenance (Merz et al. 2009). 
 
 
 
A last interesting dataset was produced by Hess D.C. and colleagues in 2009. In this 
case an algorithm was used to predict nuclear genes involved in mitochondrial 
biogenesis, rather than a direct phenotypical test on oxidative carbon sources. An 
ensemble of three different prediction algorithms, namely bioPIXIE, MEFIT and SPELL, 
was trained with data from numerous sources (expression profiling, sequencing, 
interactions ect.) and 106 genes curated by Saccharomyces Genome Database (Myers 
et al. 2005; Huttenhower et al. 2006; Hibbs et al. 2007; Myers et al. 2007). This 
ensemble ranked all genes from most likely to be involved in mitochondrial biogenesis to 
least likely. From the first round prediction 183 most confident genes were selected and 
in only 42 a relationship with mitochondrial function was already known. Prediction was 
then confirmed on experimental basis assaying petite mutants frequency, oxidative 
growth and mitochondrial morphology. The training set used for the first ensemble 
prediction was augmented with the experimentally confirmed prediction and a second 
iteration was performed. Additional 52 predictions were obtained, later confirmed 
experimentally. From a total of 193 total candidates authors demonstrated a functional 
role in mitochondrial biogenesis for 109 candidates. Among the confirmed genes only 42 
FIG 1.7: Experimental flowchart followed for 
functional characterization of 319 pet mutants 
identified on complete glycerol media at 30˚C. 
Image taken from Merz S. and Westermann B. 
2009. 
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were already known to be involved in mitochondrial biogenesis (Hess et al. 2009). These 
results demonstrated that also well trained computational predictions can be very 
effective in predict genes function, direct experimental approaches and extend 
knowledge about biological processes, with acceleration in the discovery rates (Hibbs et 
al. 2009). 
 
In the present dissertation is presented a genome-wide screening focused on 
mitochondrial biogenesis, based on growth analysis of a S. cerevisiae knock out 
collection. Results and strategies will be described in the next section and compared 
with actual knowledge about mitochondrial biogenesis. 
  
 20 
1.2 Results and discussion 
1.2.1 A Genome Wide Screening Focused on Mitochondrial 
Biogenesis Identifies 488 Strains 
In order to identify new nuclear genes possibly involved in mitochondrial biogenesis and 
metabolism, a genome-wide screening using S. cerevisiae null mutants collection was 
performed. A classical strategy to identify a respiratory dysfunction is a growth test in the 
presence of an oxidative carbon source. Optimal growth temperature for S. cerevisiae is 
30˚C and deletions in genes essential for mitochondrial function show a strong 
phenotype already in this condition. However many references report for null mutants in 
genes involved in mitochondrial function a growth defect at temperatures above or below 
the optimal one (Phillips et al. 1993; Yang et al. 1994; Grandin et al. 1999; Shi et al. 
2005; Medina-Silva et al. 2006; Polevoda et al. 2006; Spinazzola et al. 2006; Dallabona 
et al. 2010). Most likely 37˚C is a suitable condition to reveal phenotypes that would be 
subtle at 30˚C and possibly lost in high-throughput analysis. Interestingly, high 
temperature combined with oxidative carbon source could also be indicative for genes 
related to mitochondrial response in stress conditions. For these reasons the screening 
was performed at 37˚C, postulating that previous results, obtained in experiments at 
30˚C, could have underestimated the number of nuclear genes involved in such 
processes.  
S. cerevisiae knock out collection in BY4742 genetic contest was purchased at Open 
Biosystems and converted into 384-well plate format, for a total of 13 plates (see section 
4.1.1 for details). A total of 4688 strains, not including 90 strains that failed quality control 
and 48 slow-growth strains (Yeast Deletion Mutant Database). Collection in this format 
was already used in a similar screening focused on metal tolerance (Ruotolo et al. 
2008). The primary high-throughput screening was performed as described in section 
4.2.1 at 37˚C in presence of ethanol 2% as sole carbon source. Mutant growth was then 
compared to performance in the same carbon source at 30˚C to check a possible 
temperature dependence of the phenotype. Media containing glucose at 30˚C and 37˚C 
were used as reference. 
The strategy implemented was first of all validated using a control 384-plate. This 
dedicated plate contained strains known to be defective in the conditions of interest. 
Every strain selected was present four times in the plate and each condition was tested 
in four independent experiments (data not shown). Results reflected quite well the 
published data thus validating the strategy. 
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Each plate of the collection was then analyzed 4 times in each condition. To give semi-
quantitative scores to the growth two controls were included in the analysis of each 
plate: a wild-type BY4742 strain as positive control and BY4742 ρ0 (carrying no 
mitochondrial DNA, i.e. respiratory deficient) as negative one.  
 
 
FIG 1.8: Image representative of strains growth in primary and secondary screening. HS (high 
sensitive), MS (medium sensitive) or LS (low sensitive) were used for defective growth, 
accordingly to phenotype’s severity. BY4742 ρ
0
 and wild type strains were included as control. In 
the secondary screening 4µl of 10-fold dilutions ranging from 10e7 to 10e3 cells/ml were spotted 
in an ordered fashion. 
 
In order to consider reliable the data obtained in primary screening, a secondary 
screening was performed as described in section 4.2.2. This allowed to confirm or refute 
primary results and to choose the cut-off value for phenotypes observed. Phenotype 
could indeed be observed in 4/4, 3/4, 2/4 or 1/4 replicates. The concordance rate is 
defined as percentage of phenotypes observed in primary screening later confirmed. 
Concordance was calculated considering phenotypes registered 3 times and 4 times or 
2, 3 and 4 times out of 4 independent replicates. Already applying a cut-off to 2 out of 4 
the concordance rate was 79% at 30˚C and 82% at 37˚C. These values were considered 
optimal. Also the false-negative rate analysis was also calculated on a subset of 
deletants with positive growth in primary screening. Strains are considered false-
negatives when showing no defects in primary screening but being sensitive in the 
subsequent analyses. In the present screening false-negative rate was also good with 
14% and 24% at 30 and 37˚C respectively. 
HS 
LS 
MS 
10E4 10E3 10E2 10E1 10E0 
wt 
ρ
0
 
primary s. secondary s.            YPE secondary s.              YPD 
cells 4x 10E4 10E3 10E2 10E1 10E0 
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A final list of strains that showed a specific defect in primary screening for ethanol 
utilization at both temperatures was obtained from comparison between YPD and YPE 
conditions. Excluding 42 thermo-sensitive strains (deficient at YPD37˚C) a total of 488 
strains resulted defective in the tested conditions (Appendix 1.1). Phenotypes could be 
temperature specific (37˚C or 30˚C) or not, as shown in figure 1.9. In support of the 
chosen working hypothesis a specific defective growth at high temperature was identified 
in 133 strains (27%). Among 348 strains that displayed phenotype at both temperatures 
19 showed a severe worsening at 37˚C compared to 30˚C and 67 a slight worsening. In 
these mutants could be reasoned that temperature gives an important contribution to the 
deficiency. Remaining 262 strains displayed the same phenotype regardless 
temperature. 
 
 
FIG 1.9: Chart-pie showing results of the screening. A total of 488 strains represented in the left 
pie were defective in the tested conditions. Among those 348 were defective at both temperature 
and are organized in the right pie. 
 
An index for the quality of the screening is the analysis of functional categories 
represented in the dataset. GO consortium created a controlled hierarchical vocabulary 
of terms that allow description of biological functions, processes and localizations to 
characterize genes and coded proteins (Ashburner et al. 2000). Different tools to analyze 
datasets are available through the Saccharomyces Genome Database, as GO Term 
Finder. This tool analyzes an input dataset returning a list of GO terms that are 
significantly enriched. The final list of 488 defective strains was analyzed with GO Term 
Finder tool for cellular component and biological process terms. As expected, majority of 
the enriched terms are directly connected with mitochondria (Table 1.1). We can 
therefore identify proteins essential for each process of mitochondrial biogenesis like 
mitochondrial organization, maintenance and expression of mitochondrial genome, 
mitochondrial respiratory chain assembly and ATP synthesis. The same biological 
262 
67 
19 
348 133 
7 
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processes are reflected in the subcellular enriched localizations: i.e. mitochondrial 
ribosomes, nucleoid and respiratory complexes.  
 
TABLE 1.1: GO Term Finder restricted results applied to the 488 genes list. Complete results are 
available in Appendix 4.  
GO TERM BIOLOGICAL PROCESS P-value Genes 
GO:0007005 mitochondrion organization 6.45E-75 146 
GO:0032543 mitochondrial translation 1.84E-56 83 
GO:0097034 mitochondrial respiratory chain complex IV biogenesis 1.71E-16 18 
GO:0045333 cellular respiration 7.58E-15 38 
GO:0033108 mitochondrial respiratory chain complex assembly 8.80E-15 19 
GO:0000959 mitochondrial RNA metabolic process 2.27E-13 17 
GO:0000002 mitochondrial genome maintenance 1.10E-11 19 
GO:0033617 mitochondrial respiratory chain complex IV assembly 3.82E-10 11 
GO:0015980 energy derivation by oxidation of organic compounds 6.04E-10 39 
GO:0042773 ATP synthesis coupled electron transport 7.98E-10 15 
GO:0042775 mitochondrial ATP synthesis coupled electron transport 7.98E-10 15 
GO:0006119 oxidative phosphorylation 1.53E-09 15 
GO:0070127 tRNA aminoacylation for mitochondrial protein translation 3.65E-09 10 
GO:0008535 respiratory chain complex IV assembly 3.92E-09 11 
GO:0022904 respiratory electron transport chain 5.05E-09 15 
GO:0009060 aerobic respiration 5.81E-09 26 
GO:0017004 cytochrome complex assembly 9.11E-08 8 
GO:0097033 mitochondrial respiratory chain complex III biogenesis 2.72E-06 7 
GO:0006122 mitochondrial electron transport, ubiquinol to cytochrome c 6.95E-06 7 
 
GO TERM CELLULAR COMPONENT p-value genes 
GO:0044429 mitochondrial part 4.21E-78 191 
GO:0005739 mitochondrion 2.78E-58 242 
GO:0005759 mitochondrial matrix 2.64E-57 102 
GO:0005761 mitochondrial ribosome 3.35E-44 58 
GO:0005743 mitochondrial inner membrane 4.43E-32 80 
GO:0005740 mitochondrial envelope 1.61E-28 102 
GO:0005762 mitochondrial large ribosomal subunit 4.27E-26 32 
GO:0031966 mitochondrial membrane 1.73E-24 92 
GO:0005763 mitochondrial small ribosomal subunit 1.75E-17 23 
GO:0044455 mitochondrial membrane part 4.84E-16 46 
GO:0005746 mitochondrial respiratory chain 1.63E-11 16 
GO:0070469 respiratory chain 4.10E-11 17 
GO:0016469 proton-transporting two-sector ATPase complex 1.10E-06 13 
GO:0005758 mitochondrial intermembrane space 1.28E-06 15 
GO:0005750 mitochondrial respiratory chain complex III 2.19E-06 7 
GO:0042645 mitochondrial nucleoid 6.26E-05 9 
 
 
 
Enrichment of these GO terms in the dataset is index of high quality and reliability. 
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A comparison of quality among different genome-wide screenings was also performed. 
Sensibility and specificity of results were calculated for our dataset as described 
elsewhere (Elstner et al. 2009). The same parameters were also calculated for three 
comparable genome-wide screenings (Dimmer 2002; Luban et al. 2005; Merz et al. 
2009). A list of 336 mitochondrial proteins was used as reference set for the calculations. 
This was obtained subtracting mitochondrial encoded proteins and genes coding for 
essential proteins from MitoP2 database (Elstner et al. 2008). Sensibility is defined as 
portion of a reference set covered by an input list. The present screening, along with the 
one performed by Dimmer KS et al., showed the highest sensibility (40%), as reported in 
Table 1.2. Specificity, defined as the portion percentage of a dataset being part of the 
reference, scored instead the lowest value: 28% against a mean of 36%. This was quite 
expected as reference set is composed only of mitochondrial proteins playing 
presumably essential roles. The working hypothesis of 37˚C of course shifts to a certain 
extent the dataset to mitochondrial related functions, essential under stress condition. 
Those functions could be played also in the cytoplasm. If dataset is enriched in such 
functions a lower specificity in covering a mitochondrial proteome is justifiable. 
Nevertheless to have a complete quality comparison specificity was calculated also with 
the portion of our dataset comprising deletions with phenotype already at 30°C. Notably 
our dataset scored again the highest value along with Dimmer et al. one. 
 
Screening identified SENSIBILITY identified SPECIFICITY 
our screening (tot.) 135 out of 336 40% 135 out of 488 28% 
Merz et al. 111 out of 336 33% 111 out of 319 35% 
Luban et al. 121 out of 336 36% 121 out of 357 34% 
Dimmer et al. 134 out of 336 40% 134 out of 341 39% 
     
our screening (30°C) 109 out of 336 32% 109 out of 276 39% 
 
TABLE 1.2: Specificity and sensibility values for comparable genome-wide screenings. 
Parameters were calculated as described in Elstner et al. 2009 using a restricted MitoP2 
database as reference set (see text for details).  
 
The parameters used for this ranking, showed again the high quality of the screening 
performed. The list of 488 deletions was thus considered reliable and used for 
subsequent analysis in order to define the number of genes connected for the first time 
to mitochondrial biogenesis. 
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1.2.2 Data Filtering Allows Selection of 177 Genes  
Aim of the performed screening was to identify nuclear genes with a role in mitochondrial 
biogenesis under stress condition. To this purpose from the original dataset obtained 
(488 genes) both nuclear genes with a mitochondrial role previously not shown and 
genes whose function is still poorly understood/unknown were considered suitable 
candidates. To select candidates both data mining and experimental confirmations were 
implemented, allowing selection of 177 genes. A flowchart of the process is given in 
figure 1.10. 
 
 
 
 
FIG 1.10: Flowchart of the selection process. 
 
 
 
 
 
 
488 genes (Appendix 1) 
 
343 genes 
filtering 
OXPHOS analysis 
 
10 genes 
17 (Appendix 1 “pet only”) 
326 (Appendix 1 “genome”) 
42 (Appendix 2 “genome”) 
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candidates 
EtOH specific 
(Appendix 3) 
(Appendix 2) 
135 genes (Appendix 2 “new”) 
145 (Appendix 1 “new”) 
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The final list of 488 deletions was compared to the available data in the SGD and to four 
different genome-wide screenings aimed to the study of mitochondrial biogenesis 
(Dimmer 2002; Luban et al. 2005; Hess et al. 2009; Merz et al. 2009). As mentioned 
previously the screening performed by Hess DC et al. was not relied on phenotypic test 
firstly but rather on a bioinformatical prediction later confirmed by experimental tests. For 
the different approach used by Hess DC those results were not included in quality 
analysis but used in the data filtering. 
This tight filter excluded 343 identified (70%) and only genes never related to 
mitochondrial function in single gene or high-throughput analysis were retained 
representing the 30% of the entire dataset. This is index of high concordance among 
present screening and literature. A total of 326 out of 343 were already related to 
mitochondrial biogenesis in at least one other genome-wide screening (reported in 
Appendix 1 with the signature “genome”). In details: 20 were identified four times, 126 
three times, and the remaining 180 only in one or two other screenings. As postulated in 
Merz et al. 2009 the number of times that a nuclear gene was identified could be related 
to the penetrancy (i.e. severity) of associated pet phenotype. On the other hand it could 
be reasoned that lack of essential functions, played by mitochondrial proteins, underlies 
highly penetrant phenotypes. In accordance with this the proportion of genes coding for 
mitochondrial proteins increases constantly in those sets, ranging from 33% for proteins 
identified in only one other screening, to 90% in ones identified four times. A total of 37 
out of 326 genes, yet identified at 30˚C, displayed pet phenotype only at 37°C in our 
screening. Interestingly 27 of those were identified only one other time. In some cases 
the discrepancy could be due to the different genetic contest used. Indeed only Merz S. 
and colleagues analyzed mutants in BY4742 contest while Dimmer K.S. and Luban C. 
worked with BY4741 and BY4743. Different genetics contest could cause a sort of 
phenotypic plasticity. The remaining 17 genes out of 343 had already clear mitochondrial 
roles described in the SGD entry and were thus excluded (reported in Appendix 1 with 
“pet only” signature). Interestingly enough those genes were never identified with high-
throughput techniques so the applied strategy here described was successful. Eventually 
a list of 145 genes was obtained (reported in Appendix 2 with “new” signature). Among 
those 31 reported a “decreased rate of respiratory growth” phenotype in Saccharomyces 
Genome Database and were retained.  
An OXPHOS negative phenotype is usually related to mutants unable to perform 
oxidative growth regardless the carbon source provided. The screening performed used 
in first instance ethanol as sole carbon source, in combination or not with a temperature 
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stress. The observed phenotype could be due to a general OXPHOS impairment or 
defects in ethanol utilization or tolerance. Concerning this last possibility it has to be 
noted that ethanol is a well-known stressing agent. A concentration of 2%, chosen for 
the analysis, does not represent a stressing condition at 37˚C for S. cerevisiae wild type 
strain. Nevertheless it cannot be excluded that such condition might be toxic in mutants 
for proteins with a protective role. To rule out these possibilities the 145 strains were 
individually verified at least two times by spotting serial dilutions onto rich medium plates 
with lactate, acetate or glycerol as carbon sources. A total of 135 strains resulted 
defective in at least two different respiratory carbon sources suggesting a general 
OXPHOS impairment. Conversely 10 strains showed a growth defect only on ethanol-
containing medium (Appendix 3). Based on data from Saccharomyces Genome 
Database we suggest for the large part of these genes an involvement at high 
temperature in ethanol tolerance. Although only one gene (CIK1) has a demonstrated 
direct role in resistance to ethanol some others are involved in cell wall and plasma 
membrane organization (SSD1, ACK1, SER1), a process known to be involved in 
ethanol tolerance (Teixeira et al. 2009). Additionally 4 genes (YGR127W, UTR1, MAL31, 
YPL066W) encode for proteins with roles in response to external stimuli as thermal 
stress, process that exhibits an extensive similarity and functional overlap with ethanol 
stress response (Piper 1995).   
The 135 deletants corresponding to the identified OXPHOS genes were considered for 
further analyses and are represented in figure 1.11. A total of 83 genes (61%) displayed 
a specific phenotype only at 37˚C. Among 50 genes with a phenotype at both 
temperatures, 25 displayed a worsening at higher temperature. The majority of deletions 
in the identified genes caused a defect only at high temperature thus underlining the 
efficiency of the present screening. 
 
 
 
Nevertheless, in order to increase the knowledge about mitochondrial biogenesis or 
related processes, 42 additional deletants were considered for a total of 177 genes 
(Appendix 1.3). These additional candidates were selected from the filtered genes 
 
 
2 
50 83 
30˚C 
37˚C 
FIG 1.11: Phenotypes distribution of 135 genes 
related to mitochondrial biogenesis for the first 
time. 
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because functional roles, at the moment of the screening, were totally unknown or still 
poorly understood. The OXPHOS nature was in this case guaranteed by the 
independent discovery in at least one other screening (in all cases performed in a carbon 
source different from ethanol). This dataset of 177 genes can be organized again 
according to the phenotypes displayed and represented in a Venn diagram (figure 1.12). 
A total of 88 genes displayed a specific phenotype at 37˚C and 86 at both temperatures. 
Three deletants showed a growth defect only at 30˚C. Among the 86 deletants with 
phenotype in both conditions 31 scored a worsening at high temperature that was severe 
in five cases. It can be reasoned that for about the 67% of the selected deletions the 
temperature played a key role in phenotype generation.  
 
 
 
 
How is composed this set of candidates? Among the 177 candidates, 24 genes (13%) 
code for mitochondrial proteins and 4 additional for proteins with probable mitochondrial 
localization. Nevertheless 15 other proteins still have a subcellular localization yet to be 
defined. Thus most of identified genes code for proteins localized in a compartment 
different from mitochondria. 
Gene Ontology analysis for “biological process unknown” term revealed the presence of 
34 gene products with totally uncharacterized function. Among those 15 have a 
mitochondrial location and could therefore play new yet uncharacterized mitochondrial 
roles. 
Moreover a total of 75 proteins (42%) have a homolog in Homo sapiens. This allows 
potential discovery of new genes involved in mitochondrial biogenesis in higher 
eukaryotes and Homo sapiens that could also be related to the onset of human 
mitochondrial pathologies. Yeast represented a valuable tool as model organism in such 
disorders (Di Fonzo et al. 2009; Tuppen et al. 2010). 
  
3 
86 88 
37˚C 
30˚C 
 
 
FIG 1.12: Phenotypes distribution of 177 new candidates. 
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1.2.3 Functional Characterization of 177 Candidates  
In order to characterize selected mutants and achieve insights into connection to 
mitochondrial biogenesis, classic tools were used. 
The intactness of mitochondrial respiratory chain (MRC) was assessed registering the 
cytochrome spectra absorption profiles as described in section 4.2.3. This analysis 
evaluates the absorption of cytochrome c (550nm), cytochrome b (570nm) and 
cytochrome aa3 (complex IV, 603nm); cytochrome content is an index of structural 
integrity of MRC.  
Basing on the cytochrome spectra profile, the 177 candidates were organized in four 
different phenotypic classes: A, B, C and D. Each class reflected the status of MRC 
cytochromes compared to the wild type in the same conditions (wild type was present in 
each experiment). Strains were assigned to class A when strong defects were observed 
in the cytochromes profiles. Class D was chosen when profiles were perfectly 
comparable to a wild type. Class C and B represent middle classes with major variability. 
Class C resembles strains with cytochrome defects mostly quantitative (i.e. all 
cytochromes are present in a lower content). Instead class B, besides evident 
quantitative defects, could also share qualitative impairments in specific cytochromes 
(mainly COX or cytochrome b). As shown in figure 1.13 and related table, 88% of the 
dataset was distributed among classes A, B and C. For these genes MRC impairment 
could be the reason underlying the observed respiratory growth deficiency. Supporting 
this hypothesis high accordance between classes and primary screening phenotypes 
exist. Considering 37˚C condition, the highest number of HS strains is indeed in class A 
and the lowest in class C. Viceversa LS strains are mostly represented in class C whilst 
only 8 were scored in class A. 
An evaluation of real functionality was at the same time achieved recording oxygen 
consuming on whole cells, as described in section 4.2.4. Absolute values (expressed in 
nmol O2/minute*weight) were converted in respiratory efficiencies as percentage of the 
wild type, included in each analysis. Median values of efficiency were then associated to 
each phenotypic class, as reported in figure 1.13. 
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FIG 1.13: A B C D classes (a) Cytochrome spectra profile of a wild-type strain and of four 
representative deletants, chosen to depict each class. Classes range from less (D) to most 
severe (A). (b) Number of deletants scored in each class with associated respiratory efficiency 
(median) expressed as percentage of wild-type. (c) Distribution of deletants among classes 
represented in pie-chart.  
 
A good correlation between spectra and respiratory rates was present. Class A scored 
the lowest median value of 4%. Class B and Class C scored 32% and 57% respectively. 
As expected class D was the less affected with a median respiratory efficiency value of 
85%. Concluding, an explanation for the observed OXPHOS negative phenotype can be 
postulated for 88% of the dataset and could be related to impairments in MRC. 
For some class D mutants showing a LS or MS growth defect cannot be excluded the 
hypothesis that the mild respiratory impairment could be the cause of the observed 
phenotype. Nevertheless this is not possible for the 8 mutants showing an HS 
phenotype, which could harbor defects in other processes affecting mitochondrial 
function, rather then respiration. To this concern further investigations are required. 
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The unexpected behavior of vam10Δ mutant is still to elucidate. This strain showed a MS 
OXPHOS phenotype at 37˚C but higher cytochrome content and at the same time 
oxygen consumption almost three times higher that wild type (figure 1.14).  
 
 FIG 1.14: Phenotype of the vam10Δ strain.  (a) Cytochromes profile and oxygen consumption. (b) 
Growth phenotype in complete ethanol media at 37˚C. 
 
VAM10 is part of a cluster of genes involved in membrane trafficking, and its deletion 
causes vacuole fragmentation. Vacuoles and mitochondria are known to be functionally 
related and this also influence processes such as mitophagy and apoptosis, essential for 
proper mitochondrial function (Kanki et al. 2009; Li et al. 2009; Bhatia-Kissova et al. 
2010; Johansson et al. 2010; Repnik et al. 2010; Sousa et al. 2011). 
Many vacuole mutants have been identified in screenings for pet mutants and also in the 
present one. To our knowledge a vacuolar mutant is for the first time associated with 
increased cytochrome content and oxygen consumption. If these phenotypes are due to 
a reduced turnover of mitochondria remain to be demonstrated and similarly it is unclear 
how cells with an apparently functional respiratory apparatus can be defective in 
oxidative growth. One possible explanation, yet to be confirmed, is an accumulation of 
defective mitochondria with abnormal membrane potential, tied-up in futile respiratory 
cycles uncoupled to ATP production. If true this observation could be also related to two 
other phenotypes reported at SGD for vam10Δ mutant: “nutrient utilization increased” 
and “decreased fitness”.  
wild type 
vam10Δ 
cyt c 
cyt b 
cyt aa
3
 
570  nm 603 550 
wild type 
vam10Δ 
37˚C 
a 
b 
10E4 10E3 10E2 10E1 10E0 cells 4x 
O
2
 cons. 
263% 
100% 
 32 
1.2.4 Gene Ontology Analysis and Comments about Identified 
Functions 
As mentioned previously GO analyses can be used to analyze datasets looking for 
functional classes significantly enriched or to have an overview on all the processes 
represented. Analysis of present dataset could allow identification of new proteins or new 
pathways possibly involved in mitochondrial biogenesis or in mitochondrial stress 
response. 
Slim Mapper tool is used to map each gene of a list to a GO term that can represent 
either a biological process, a subcellular localization or a molecular function. The list of 
177 candidates was analyzed and the terms associated are shown in Figure 1.15. 
 
FIG 1.15: Go Slim Mapper tool applied to 177 candidates. Output is represented in a bar chart 
with functional categories and number of genes per GO term. Total results shown in Appendix 5. 
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Some observations can already be made from this first general list. Genes were mapped 
to many different functional categories, ranging from “transcription from RNA polymerase 
II promoter” to “cell cycle regulation” and “endosome transport”. Therefore majority of 
these genes doesn’t code for mitochondrial proteins leading to the observation that 
mitochondrial stress response could heavily rely on integration of mitochondria in other 
cellular processes. Interestingly a number of genes were mapped to “biological process 
unknown” that as pointed out previously represents a challenging research focus as they 
could represent new mitochondrial functions. 
An additional interesting aspect is that at least 24 of genes in the 177 dataset could be 
mapped to mitochondria cellular component and moreover all these proteins did not 
have a characterized function at the moment of the screening. For some of those, as 
Mzm1p, the role in mitochondrial biogenesis was uncovered during last steps of data 
analysis(Atkinson et al. 2011). 
In Chapter 3 of this dissertation is described a functional characterization of YIR024C 
gene product, considered interesting for different aspects later mentioned.  
Using GO Term Finder an input list is analyzed in a way similar to Slim Mapper but 
results highlight only classes that are significantly enriched in comparison to the normal 
genome frequency. Term Finder analysis of 177 candidates list was carried out using 
Holm-Bonferroni multiple test hypothesis correction and p-value <0.05, algorithm 
implemented among YeastMine online resources (results are shown in table 1.3). As can 
be seen some biological processes and cellular components are significantly enriched in 
the input dataset and must represent important functions related to mitochondrial 
biogenesis. 
The most significant enriched terms are the biological processes “tRNA wobble base 
modification”, “tRNA wobble uridine modification” and the cellular component “elongator 
holoenzyme complex” that represent one of the catalytic cores of this process. Strikingly 
the same terms are identified also if Term Finder algorithm is applied to the list of 88 
genes with specific phenotype at 37˚C and moreover also “protein urmylation” term, 
relative to an ubiquitin-related protein modification with a role in tRNA modification, 
became significantly enriched (see table 1.4). These results underline an important role 
importance of this pathway in mitochondrial biogenesis under stress conditions and this 
interesting process was object of additional analyses, described in the Chapter 2 of this 
dissertation. 
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TABLE 1.3: Results of Go Term Finder tool applied to total list of 177 candidates.  
GO TERM BIOLOGICAL PROCESS p-value genes 
GO:0002097 tRNA wobble base modification 1.47E-08 9 
GO:0002098 tRNA wobble uridine modification 1.47E-08 9 
GO:0006357 regulation of transcription from RNA polymerase II promoter 1.07E-06 26 
GO:0043162 ubiquitin-dependent protein catabolic process via the MVB pathway 1.24E-06 7 
GO:0006473 protein acetylation 2.59E-06 10 
GO:0040007 growth 5.91E-06 15 
GO:0043543 protein acylation 1.02E-05 10 
    GO TERM CELLULAR COMPONENT p-value genes 
GO:0033588 Elongator holoenzyme complex 9.79E-08 5 
GO:0044440 endosomal part 5.34E-06 12 
GO:0005768 endosome 2.88E-05 14 
GO:0031248 protein acetyltransferase complex 3.89E-05 4 
GO:0031414 N-terminal protein acetyltransferase complex 3.89E-05 4 
 
TABLE 1.4: Term Finder tool was used to analyze a list of 88 deletions with phenotype at 37˚C. 
GO TERM BIOLOGICAL PROCESS p-value genes 
GO:0002097 tRNA wobble base modification 5.02E-11 9 
GO:0002098 tRNA wobble uridine modification 5.02E-11 9 
GO:0006400 tRNA modification 5.48E-07 9 
GO:0032447 protein urmylation 1.45E-06 4 
GO:0045324 late endosome to vacuole transport 1.12E-05 6 
GO:0015031 protein transport 1.17E-05 21 
    GO TERM CELLULAR COMPONENT p-value genes 
GO:0033588 Elongator holoenzyme complex 3.00E-09 5 
GO:0034518 RNA cap binding complex 2.69E-05 3 
GO:0044440 endosomal part 2.95E-05 8 
 
 
Nevertheless other terms significantly represented in the 177 genes dataset were 
noteworthy; a brief description and comment will be made on the following: N-terminal 
acetylation of cytoplasmic proteins, histones acetylation, gene expression regulation, 
and cellular response to alkaline pH. A total of 45 genes are described in the following 
dissertations and mitochondrial phenotypes observed are reported in table 1.5. 
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N-terminal acetylation: acetylation of protein N-terminus is one of the most common 
post-translational modifications, occurring in the vast majority of eukaryotic proteins. 
Corresponding GO term was identified with high frequency in GO Slim Mapper tool and 
the corresponding enzymatic process was statistically enriched in the 177 dataset 
(“protein acylation”, “protein acetylation”, “N-terminal protein acetyltransferase complex”). 
Three principal N-terminal acetyltransferase complexes are known in yeast: NatA, NatB 
and NatC (Polevoda et al. 2003; Polevoda et al. 2003). Those complexes physically 
interact with ribosomes to modify proteins during translation (Gautschi et al. 2003; 
Polevoda et al. 2008). These complexes are formed by a catalytic subunit and ancillatory 
subunits. All the three catalytic subunits of NatA, NatB and NatC (respectively Ard1p, 
Nat3p and Mak3p) were identified. Additionally for NatB also the other component 
(Mdm20p) was identified thus completing the complex, and for NatC one of the two 
ancillary subunits (Mak31p) was identified too. Notably only Nat3p/Mdm20p complex 
was reported to have some mitochondrial phenotypes via acetylation of Tpm1p (also 
identified in the present screening), component of the actine cytoskeleton (Singer et al. 
2003). The data obtained in the present screening show a role for all three complexes in 
mitochondrial biogenesis under thermal stress. 
Two considerations are worth mentioning. First, Ard1p dysregulation is involved in 
tumorigenesis and neurodegenerative disorders in humans and could be a novel target 
for cancer drugs (Arnesen et al. 2008; Kuo et al. 2010). Second, as mentioned 
previously Nat complexes interact physically with ribosomes to modify proteins during 
translation process and we also identified several genes whose product is involved in 
40S and 60S ribosomes formation or assembly (MTG2, RPL13B, RPL14A, RPL23B, 
RPL39, RPL43A, RPS27B, REI1, YVH1). Thus it could be postulated that these subunits 
could modulate translation and concomitant post-translational modification under stress 
conditions. However only RPL43A deletion showed a specific phenotype at 37˚C while 
RPL14A and RPL23B deletions showed a pejorative phenotype with increased 
temperature. 
 
Histones Acetylation: Histone tails modification is a well-known process essential for 
modulation of gene expression. GO terms representative of this class are the same of N-
terminal acetylation as the chemical addition is basically the same. Principal kinds of 
regulatory modifications are acetylation, de-acetylation and methylation in the H3 and H4 
histone subunits. The most common description of this phenomenon is that acetylation is 
a positive regulation event while methylation is negative (Lewin 2004). However many 
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modifiers are nowadays known to introduce modifications that can also be combined to 
achieve a real fine-tuning of gene expression, event described by the “histone code” 
theory.  
SAGA complex is a big HAT complex (histone tail acetylation complex) that works as co-
activator of gene expression acetylating lysine residues on histone H3 tail, but retains 
also repressing functions (Baker et al. 2007). Three subunits of SAGA complex were 
included in 177 genes list: Sgf29p, Spt8p and Spt7p. Looking back in the total list of 488 
identified also Ngg1p and Gcn5p can be found, also if they have not been considered as 
yet identified in other screenings. GCN5 codes for a catalytic subunit of the SAGA 
complex and mediates mitochondrial retrograde response (Grant et al. 1997; Kim S. et 
al. 2004). The scored phenotype of gcn5Δ strain was MS on ethanol at 37˚C. It can be 
postulated that this activity might be involved in mitochondrial stress response 
modulated by other subunits of the SAGA complex that could act as modulators of target 
specificity. Two other proteins with an HAT role were also identified and included in the 
177 list: Eaf7p and Rtt109p. 
Although not involved in acetylation and thus not included in this functional class, also 
identification of Bre2p is really noteworthy. Deletion in BRE2 caused a specific 
phenotype at 37˚C and was never related to mitochondrial biogenesis. This protein is 
part of the highly conserved COMPASS complex involved in tri-methylation of Lys4 on 
histone H3 and contributes to generate a domain essential for a proper catalytic activity 
(South et al. 2010; Takahashi et al. 2011). This kind of modification conversely to other 
methylations induces gene expression from a subset of genes and is involved in a 
number of cellular processes (Dehe et al. 2006; Shilatifard 2008). Strikingly this 
modification seems to occur and regulate H3Lys4 acetylation on active promoters, which 
is introduced by the aforementioned identified Gcn5p and Rtt109p modifiers (Guillemette 
et al. 2011). Very suggestive would be the hypothesis of a combined regulation of genes 
involved in mitochondrial stress response by this kind of modifications. Indeed Bre2p is 
an ancillary subunit that could modulate activity of COMPASS complex at 37˚C in order 
to positively regulate histone modifications by Gcn5p and Rtt109p and in turn to activate 
genes essential for mitochondrial stress response. 
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TABLE 1.5: 45 genes representing interesting functional categories identified in the present 
screening. Mitochondrial phenotypes observed are reported. YPE30˚C and YPE37˚C columns 
refer to the phenotype in primary screening.  
GENE YPE30°C YPE37°C List OXPHOS CLASS R. EFF% Process 
ARD1 0 LS 177 yes A 4 NatA complex 
MDM20 0 HS 488 
   
NatB complex 
NAT3 LS LS 177 yes A 11 NatB complex 
TPM1 0 MS 488 
   
NatB target 
MAK31 LS LS 177 yes C 38 NatC complex 
MAK3 LS MS 177 yes B 24 NatC complex 
SPT7 MS MS 177 yes C 57 SAGA complex 
SGF29 HS HS 177 yes A 2 SAGA complex 
GCN5 0 MS 488 
   
SAGA complex 
SPT8 LS LS 177 yes A 27 SAGA complex 
RTT109 LS MS 177 yes B 31 Rtt109 complex 
EAF7 0 HS 177 yes B 8 Nua4 complex 
BRE2 0 MS 177 yes D 65 COMPASS 
CCR4 LS LS 177 yes C 79 Trascription 
GCR2 LS MS 177 yes A 41 Trascript. Factor 
SWI6 LS MS 177 yes B 38 Trascript. Factor 
SMI1 0 HS 177 yes C 59 Trascript. Factor 
MAF1 0 HS 177 yes B 46 Trascript. Factor 
UME6 MS HS 177 yes B 21 Trascript. Factor 
MSS11 0 HS 177 yes B 56 Trascript. Factor 
RIM101 0 HS 177 yes B 19 Trascript. Factor 
RIM8 0 MS 177 yes C 51 Rim101 pathway 
RIM9 MS HS 177 yes B 27 Rim101 pathway 
RIM13 0 LS 177 yes C 68 Rim101 pathway 
DFG16 0 MS 177 yes B 41 Rim101 pathway 
RIM20 0 HS 177 yes A 14 Rim101 pathway 
STP22 0 HS 177 yes B 67 ESCRT-complex I 
SRN2 LS HS 177 yes D 87 ESCRT-complex I 
VPS28 0 HS 177 yes B 41 ESCRT-complex I 
VPS25 LS HS 488 
   
ESCRT-complex II 
VPS36 LS HS 177 yes C 46 ESCRT-complex II 
SNF8 0 HS 177 yes C 49 ESCRT-complex II 
DID4 MS HS 177 yes B 74 ESCRT-complex III 
SNF7 LS HS 488 
   
ESCRT-complex III 
VPS20 HS HS 488 
   
ESCRT-complex III 
DOA4 0 HS 488 
   
MVB pathway 
BRO1 0 HS 177 yes B 23 MVB pathway 
SAC6 0 HS 488 
   
Rim101p regulated 
PEP7 MS HS 488 
   
Rim101p regulated 
DIT1 0 MS 177 yes C 70 Rim101p regulated 
CCM1 HS HS 488 
   
Rim101p regulated 
COX7 HS HS 488 
   
Rim101p regulated 
MDH2 0 LS 177 yes D 83 Rim101p regulated 
ELP3 0 MS 177 yes C 50 Rim101p regulated 
POS5 MS HS 488 
   
Rim101p regulated 
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Gene expression regulation: among the non-mitochondrial proteins identified one 
expected functional class was of course the transcription regulation by transcriptional 
factors. These proteins can indeed regulate several genes at the same time representing 
an essential strategy to adapt cellular responses to environmental stimuli. In this case 
regulation of gene expression could be used to integrate correctly mitochondria and 
mitochondrial stress response in the cellular network. Among the 177 candidates 
different genes coding for transcriptional factors were identified: UME6, MAF1, MSS11, 
GCR2, SMI1, RIM101 and the cofactor coded by SWI6. 
For some of those transcriptional factors (Maf1p, Smi1p, Mss11p, Rim101p) a role in 
mitochondrial biogenesis under heat stress can be postulated. Indeed phenotypes for 
the corresponding deletion strains were identified specifically at 37˚C. The role of 
Rim101p transcriptional factor, involved in environmental pH sensing, will be later 
described. 
Maf1p was proposed to negatively regulate tRNAs transcription in response to nutrient 
availability and stress. Under non favorable conditions it become dephosporylated and is 
translocated to the nucleus down regulating RNA Pol III (Ciesla et al. 2008). Remarkably 
one specific defect observed in maf1 mutant strains is a dysregulation of Mod5p protein, 
enzyme involved in the biosynthesis of isopentenyladenosine in cytoplasmic and 
mitochondrial tRNAs (Murawski et al. 1994). However MOD5 deletion was not identified 
in the present screening. 
Smi1p is a transcriptional factor involved in cell cycle regulation and cell wall integrity 
(Martin et al. 1999; Martin-Yken et al. 2002; Martin-Yken et al. 2003; Basmaji et al. 
2006). Interestingly cell wall integrity was recently related to mitochondria in C. albicans. 
Indeed ccr4 mutants (an mRNA de-adenylase) showed defects in cell wall integrity, 
mitochondrial function and phospholipids trafficking (Dagley et al. 2011). In the same 
work authors identified several mitochondrial known mutants (as components of outer 
membrane complex Sam) as defective in cell wall integrity and phospholipids trafficking 
between ER and mitochondria. Notably in the present screening also CCR4 (ortholog in 
S. cerevisiae) was identified as new gene involved in mitochondrial biogenesis. 
Interestingly Caf4p, a protein involved in mitochondrial dynamics (i.e. fusion and fission) 
recruiting Dnm1p to mitochondria, was shown to be physically associated to the CCR4 
complex in S. cerevisiae interacting with several components (Liu H. Y. et al. 2001; 
Griffin et al. 2005). 
Mss11p is implicated in invasive growth, pseudohyphal differentiation and starch 
utilization (Gagiano et al. 1999; Gagiano et al. 2003). 
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Deletion in SWI6, UME6 and GCR2 caused a phenotype at both temperatures tested. In 
these cases a more general role in mitochondrial biogenesis can be postulated. SWI6 
codes for a transcriptional cofactor that forms a complex with Swi4p involved in cell-cycle 
regulation and also involved in cell wall integrity sensing (Dirick et al. 1992; Leem et al. 
1998; Kim K. Y. et al. 2010). Interestingly a Swi6p role as oxidative-stress sensor was 
recently characterized: cysteine 404 residue was found to regulate the activity of 
Swi6/Swi4 complex causing a delay in the cell cycle upon induction of oxidative stresses 
(Fong et al. 2008; Chiu et al. 2011). Ume6p is involved in coupling metabolic sensing 
with mitosis, repressing or up-regulating early mitosis genes during the late step of the 
process (SGD). Gcr2p instead interact with Gcr1p regulating glycolytic genes (Uemura et 
al. 1992). 
 
Alkaline pH response: Although a unique “Alkaline pH response” term doesn’t exist and 
thus this pathway wasn’t statistically enriched, its implication in mitochondrial biogenesis 
and mitochondrial stress response has to be pointed out. Indeed a high coverage of this 
pathway was achieved in the present screening and probably lack of statistically 
significance could be due to the high dispersion among different GO terms. Nevertheless 
in Term Finder output the categories “ubiquitin-dependent protein catabolic process via 
the multivesicular body sorting pathway”, “endosomal part” and “late endosome to 
vacuole transport” were statistically enriched. As mentioned above these classes take 
part in alkaline pH response. 
Yeast grows far better in acidic or neutral condition whilst also a slight alkaline pH 
represent a stress that the cell has to manage. This response is essential in many yeast 
species moreover on some commensal/pathogens like Candida albicans that colonizes 
mucoses with a pH range from 2 to 10 (Davis 2003). At least three important pathways 
are implicated in the alkaline pH response: Rim101 pathway, the calcium activated 
calcineurin pathway, Wnt1/Slt2/Pkc1 MAP kinases and also the recently associated PKA 
kinase pathway (Arino 2010; Casado et al. 2011). 
Rim101 pathway is a complex signal transducing chain that ends with the proteolytic 
activation of Rim101p. Free of its C-terminus it translocates to the nucleus and works as 
zinc finger transcription factor, acting both as repressor and activator (Su et al. 1993; 
Lamb et al. 2003). The final proteolytic event is catalyzed by the caspase Rim13p. 
Rim13p cleaves Rim101p when alkaline pH is sensed at level of plasma membrane. The 
sensing is performed by at least three proteins integral to the plasma membrane: Rim9p, 
Rim21p and Dfg16p. Finally Rim8p and Rim20p are also necessary for a correct 
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Rim101p processing. That’s more: the Multi Vescicular Body pathway was recently 
connected to the alkaline pH sensing. Indeed all the three ESCRT complexes (I, II and 
III) and Bro1p were shown to be essential for a correct Rim101p activation (Boysen 
2005; Hayashi et al. 2005; Boysen et al. 2010). A molecular model for the whole process 
has only been postulated: Rim9p and Rim21p sense the pH in association with Dfg16p, 
or help its biogenesis. Bro1p is involved in the MVB pathway and is recruited to the 
endosomes via ESCRT complexes proteins where its proposed role is to be a scaffold 
for the subsequent steps of MVB pathway. Interestingly Bro1p is very similar to Rim20p: 
they share the same endosome localization and probably the same scaffold role. Based 
on experimental evidences Rim20p could replace Bro1p when the alkaline pH is sensed 
at plasma membrane. The mechanism proposed is therefore a recruiting of Rim8p to the 
membrane via Dfg16p that is internalized in membrane vesicles, step that requires an 
intact endosome-trafficking system (i.e. ESCRT complexes). The presence of Dfg16p 
would allow dissociation of Bro1p and recruiting of Rim20p that could act as scaffold for 
Rim13p and Rim101p that is eventually processed. 
The RIM101 pathway was almost completely covered in the performed genomic wide 
screening and included in the 177 candidates list. Namely RIM8, RIM9, RIM13, RIM20, 
RIM101, DFG16 and BRO1 were identified, with the only exception of RIM21. 
Additionally ESCRT-complex I (MVB12, SRN2, STP22, VPS28), ESCRT-complex II 
(SNF8, VPS25, VPS36) and ESCRT-complex III (DID4, SNF7, VPS20, VPS24) were 
totally covered with the only exception of MVB12 and VPS24. Additionally DOA4 was 
also identified, coding for a member of MVB pathway implicated in Bro1p dependent de-
ubiquitination of cargoes destined for endosome import (Luhtala et al. 2004). 
Several observations however pointed out that Rim101p has a broader role than simply 
promote alkaline pH inducible responses regulating also a number of cellular processes 
as meiosis, ions tolerance, cell differentiation, adaptive response to weakly acids (Su et 
al. 1993; Lamb et al. 2003; Mira et al. 2009). Basing on the results of the present 
screening a new role in regulation of mitochondrial biogenesis in thermal stress 
conditions is strongly suggested. The OXPHOS high sensitive phenotype of rim101Δ 
mutant is indeed displayed exclusively at 37˚C while growth is totally comparable to a 
wild type at 30˚C. This was observed also in almost every identified gene involved in the 
Rim101 signaling cascade. 
However lacking an experimental confirmation, it cannot be excluded that conditions 
used in the screening could have caused an alkalization of the environment and effects 
on mitochondrial biogenesis have been only a secondary effect. Indeed relationships 
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between alkaline conditions and mitochondria are known. For instance in yeast Yarrowia 
lypolitica respiratory metabolism is very high at alkaline pH (Zvyagilskaya et al. 2004). In 
S. cerevisiae iron and copper uptake, whose function in mitochondrial biogenesis is well 
established, were identified as limiting factors in growth under alkaline stress (Serrano et 
al. 2004). In murine cell lines alkaline pH can induce oxidative stress stabilizing oxygen 
reactive species (ROS) produced by either complex III or I (Selivanov et al. 2008). 
Furthermore an alkaline dependent ROS production with consequent mtDNA 
fragmentation leading to alkaline-induced cell death was observed in murine lines, 
phenotypes rescued by overexpression of MnSOD (Majima et al. 1998). However, the 
present screening failed in identifying any of the other three pathways previously 
mentioned and generally induced by alkaline pH (only exception is one single protein, 
Slt2p). This suggests that Rim101p could act in mitochondrial biogenesis regardless its 
role in alkaline pH sensing, i.e. alkaline pH and other stimuli faced with Rim101p might 
require the same adaptations that a proper mitochondrial stress response does. 
A list of documented Rim101p targets was obtained from YEASTRACT database 
(http://www.yeastract.com) and analyzed. Supporting the aforementioned hypothesis the 
list contained several genes already known to be involved in mitochondrial biogenesis 
(SGD): namely CAF4, CCM1, COX7, NFU1, POS5, SHE9, UTH1 and YFR045W. 
CCM1, COX7 and POS5 were identified in the present screening and included in the 488 
genes. Noteworthy the present screening identified six other genes regulated by 
Rim101p: PRM7, SAC6, PEP7, DIT1, MDH2, ELP3. Possibly mis-regulation of one or 
more of these genes could be the direct or indirect cause of mitochondrial biogenesis 
defect observed in mutants of Rim101 pathway. Strikingly Elp3p, catalytic core of the 
Elongator complex yet involved in cytoplasmic tRNA modification, is among Rim101 
targets. A demonstration for the role of this complex in mitochondrial biogenesis under 
stress condition will be given in the next chapter of this dissertation. 
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2.1 Introduction 
2.1.1 Cytoplasmic Transfer RNAs (tRNAs) 
Transfer RNAs are the essential bricks of translation being adaptors between the 
messenger RNA language and protein one. Those adaptors are small molecules of 
74-95 nucleotides that, despite sequence divergences, are folded in universal 
secondary and tertiary structures. The predominant 3D structure of a tRNA is 
commonly defined as an L shape, as shown in figure 2.1. A better understanding of 
the functional domains is given by a look in the typical cloverleaf representation of 
secondary structure, organized in stems, arms and loops. We can universally 
distinguish (fig 2.1 lower right panel): 
 Acceptor stem (violet): it is formed from pairing of first and last bases and is 
substrate for the addition of a terminal 5’-CCA-3’ triplet used to conjugate 
covalently the corresponding amino acid.  
 TΨC arm (green): the name comes from the corresponding triplet with a modified 
base pseudouridine (Ψ) 
 D arm (red): contains the modified base dihydrouridine 
 Variable loop (orange): is located between the TΨC arm and anticodon one. Its 
length is variable (3-21 bases) 
 Anticodon arm (blue): is the one containing the deciphering triplet (usually 34 35 
36, in grey). 
 
 
 
FIG 2.1: tRNA
Phe
 3D structure modeled from 
crystal diffraction analysis. Both tertiary and 
secondary structures are reported (Shi et al. 
2000). 
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The double helices represented in the secondary structure are maintained in the 3D 
folding but their disposition creates two main double helices disposed with a 90˚ 
angle, giving rise to the L shape. One terminus contains the aminoacylated arm, in 
the other we find the anticodon loop with the decoding triplet (Lewin 2004). 
Every tRNA, being loaded with a specific amino acid and harboring a precise 
anticodon, has the potential to translate the genetic code in an aminoacidic 
sequence. A faithful translation depends on the correct matching between tRNA and 
amino acids. Specific enzymes, called aminoacyl-tRNA synthetases (aaRS), catalyze 
the aminoacylation reaction (charging), which consists of two steps. The first step is 
the attack of ATP to the α-phosphate of the amino acid that is now activated in the 
form of aminoacyl-adenylate. In the second step the amino acid moiety is transferred 
to the 3'-terminal ribose (the adenine of the 5’-CCA-3’ triplet) of a cognate tRNA, 
yielding an aminoacyl-tRNA and AMP (Arnez et al. 1997). Two classes of aaRS exist, 
differentiated by their folding and the site in which the amino acid moiety is 
transferred. Class I uses the 2’OH of terminal adenine and class II instead the 3’-OH. 
The only exception is PheRS that attaches the phenylalanine to the 2’OH of tRNAPhe 
(Arnez et al. 1997). 
Protein synthesis is a fast process with an incorporation rate of 10-20 amino acids 
per second and an observed fidelity of 1 error in 103-104 polymerized amino acids 
(Andersson et al. 1982; Cochella et al. 2005). The fidelity of the reaction is based on 
two processes: first every tRNA must be recognized by the correct aaRS; second the 
aaRS must select the right amino acid for the cognate tRNA. Transfer RNAs are big 
and complicated molecules that harbor enough determinants to be correctly 
distinguished, but more difficult could be the discrimination of amino acids that 
sometimes are quite similar (i.e. threonine and the isosteric valine, or serine that 
shares the same γ-hydroxyl group). This is explained by the existence in the aaRS of 
two catalytic sites: the site of activation and the proofreading site. This led to the 
proposal of a “double-sieve” model of fidelity assurance. The first sieve is the 
activation site that can discriminate amino acids on the base of big differences in the 
side chain properties (dimension for instance). Although errors can be made at this 
step, the second site is smaller and more accurate and can discriminate also minor 
differences, leading to the high accuracy of the overall process (Cochella et al. 2005). 
A third layer of accuracy is given by the subsequently recognizing of the right aa-
tRNA in the entry site of ribosomes (A site) where the major role is played by the 
pairing between codon and anticodon. 
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One common and important aspect of tRNA biology is that these small molecules are 
heavily modified. After transcription and maturation (i.e. 3’ and 5’ end processing and 
splicing) they are subject to chemical modification in several bases, with a great 
diversity of added groups and interested position. Effects of this editing range from 
structural properties to decoding capacities whether the affected bases are in the 
anticodon loop or in the remaining parts. Significance of chemical modification will be 
briefly discussed in the next sections. 
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2.1.2 tRNAs Chemical Modifications 
A total of 107 different chemically modified nucleosides have been identified in RNA 
molecules, with the greatest variety in tRNAs: 92 in total with 81 specific (RNA 
modification database, http://rna-mdb.cas.albany.edu/RNAmods/). Effects of a 
modified base in a tRNA can be very different, depending on the base and moreover 
on the position involved. It is helpful to distinguish between modifications that affect 
codon-anticodon interaction and thus decoding capacities from those that act on the 
tRNA structure, shaping and fine-tuning it for peak performance (Motorin et al. 2010). 
The identity of such modifications can be a simple methylation in one of the esocyclic 
or endocyclic nitrogens, substitution of an oxygen with a thiol group, or addition in 
different steps of complicate chemical groups like 5-methylaminomethil (mnm5), 2-
methylthio-N6-threonylcarbamoyl (ms2t6) and 5-methoxycarbonylmethyl-2-thio 
(mcm5s2). 
In the group of structural modifications three major effects (extensively reviewed in 
2010 by Yuri Motorin and Mark Helm) can be reported: 
 Nanoscale rearrangements: these modifications can alter the normal pattern of 
hydrogen bonds formed in the double helices thus affecting the sugar, the 
Hoogsteen or the Watson-Crick edge of a base. In some cases the modification 
(or the lack of) can alter the thermodynamic equilibrium between different 3D 
structures leading to the significant appearance of alternative structures, often 
biologically inactive. 
 Subtle effects on the angstrom scale: this kind of modification can favor one of 
the two alternative conformations of the sugar pucker: the 2’-endo or 3’-endo. 
The second one is implicated in the formation of alpha helices, like DNA, and 
thus a modification that shift the equilibrium toward the 3’-endo is favoring the 
formation of double helices. This is known for modification like methylation in the 
sugar 2’OH or thiolation of pyrimidine O2 atom. 
 Thermostability: the key parameter for this property is the melting temperature 
(Tm). An increase of the Tm is usually indicative of a structural stabilization. From 
a biological point of view, a structural stabilization can be related to resistance 
against unspecific degradation by general bases or nucleases, whose 
mechanism involves a nucleophilic attack on the sugar 2’-OH. This terminal is 
more exposed in a not organized geometry (in-line); modifications favoring a helix 
conformation (see above) can thus improve the stability. In some extreme cases 
the thermostability is a physiological necessity, like in genus Thermus 
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thermopilus, a prokaryote that lives in near boiling water. Different strategies are 
implemented to resist in these conditions, like high GC content or imposing of 
particular chemical modifications in nucleic acids. 
One general characteristic of these modifications is that usually the lack of only one 
doesn’t have a strong phenotypic effect. This is in accordance with the concept of 
thermodynamic equilibrium that these modifications can alter, without an “all or 
nothing” effect. Nevertheless stronger defects are common when more than one 
modification lack, remarking the importance of a correct chemical editing for the 
structural fine tuning of these molecules. 
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2.1.3 Modifications in the Anticodon Loop Bases 
Modifications in the anticodon loop bases have a different biological relevance. A 
pronounced hot spot can be found at positions 34 and 37 (Motorin et al. 2010). The 
significance of these modifications is relevant, directly affecting the decoding 
capacities of anticodon and being the fundament of modern genetic code evolution. 
Francis Crick gave the first interpretation on how the genetic code works in 1966 
(Crick 1966). It was clear that cells limited the number of tRNA in comparison to the 
number of possible codons of three letters. To read 61 possible codons (64 minus 
three stop codons) only 40 tRNA were evolved thus implicating that some anticodons 
had to recognize more than one codon (Agris et al. 2007). Crick explored this 
possibility with the proposal of the “Wobble Hypothesis”. Briefly, the first two bases of 
the codon were read with a rigid canonical Watson-Crick base pairing, but in the third 
one the reading could be wobbling. The first base of the anticodon (named wobble 
position) could thus pair with different bases. The only modified base implemented by 
Crick was the Inosine in position 34, that was proposed to read U, C or A in the third 
position of the codon. 
First published report of modified bases in a tRNA sequence was in 1968 (Goodman 
et al. 1968), and from that moment, in large parte, the science of Susumu Nishimura 
and colleagues was essential to improve the knowledge about chemical 
modifications in tRNA and their functional roles (Nishimura et al. 2006; Agris et al. 
2007). The study of these modifications led to the expansion of original Crick 
hypothesis with the 1991 “Modified Wobble Hypothesis” that gave a first 
interpretation about chemical editing of anticodon bases. Nowadays the knowledge 
about chemical modification of anticodon loop bases is greatly improved and a lot of 
modifications have been studied and the roles cleared. Looking at the codon usage 
table is evident how some amino acids are encoded with six and four-fold degenerate 
codons while others are only one or two fold degenerate. This creates mixed and not 
mixed boxes, as shown in figure 2.2. The proposed and largely demonstrated role of 
chemical modifications in wobble base is to pre-structure the anticodon to allow 
recognizing of anticodon with wobbling rules, different for amino acids of mixed 
boxes and not. For instance cmo5U34 modification is present only in tRNAs that read 
4-fold degenerate codons and the modification would only stabilize the codon-
anticodon pairing also with wobbling at third position, regardless the identity of the 
third codon base. The modification per se is not needed to recognize the cognate 
codon, but only to expand the decoding capacities. This is the case of tRNAValUAC that 
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harbors a cmo5U34 modification and tRNA
Ala
UGC, tRNA
Ser
UGA and tRNA
Pro
UGG, all 
coding for single amino acid codon boxes, able to pair the cognate codon although 
recognition was achieved with different affinities (Yarian 2002).  
 
 
 
Different roles have been proven for ubiquitous xm5s2U34 (tabella con modificazioni 
U34!) modifications of tRNA
Lys
UUU tRNA
Glu
UUC and tRNA
Gln
UUG (Kruger et al. 1998; 
Yarian 2002). The modified bases in this case are necessary to enable U-A pairing 
with U-G wobbling, but U-U and U-C pairing would be excluded due to the more rigid 
conformation given by the 2-thiol group, regardless identity of 5’-terminus group.  
Summarizing it seems that some U34 modifications expand the wobble rules and 
others restricts, at least in the prokaryotic systems largely used at that time (mostly 
E. coli). In eukaryotes anticodons ending with C34 are more common, observation that 
initially convinced about the absence of U-G wobbling. Using S. cerevisiae as model 
system, rules of eukaryotic wobbling were recently tested in vivo, studying the 
contribution of single modifications to the decoding process (Johansson et al. 2008). 
Given that thiolation and addition of 5’ groups are independent processes, usage of 
mutants in both pathways was useful to dissect roles of ncm5, mcm5 and s2 
modifications. This analysis led to the conclusion that ncm5 and mcm5 groups 
promote reading of G ending codons, while concomitant mcm5 and s2 enhance 
decoding of both A and G ending codons (a table of yeast cytosolic tRNAs object of 
modification in wobble base is provided in the next section). This conclusion also 
challenges the notion of an absent U-G wobbling in eukaryotes. 
In the anticodon loop one other base is almost ubiquitously modified, in combination 
with U34, to enable wobbling: the purine 37. This base is the 3’ adjacent to the 
anticodon and doesn’t contact directly the codon bases but its importance is crucial, 
FIG 2.2: Codon Usage table with 
color distinction for mixed boxes 
(grey). Image taken from Yarian C. 
et al 2002. 
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especially when the first codon base is A. This extends the concept of codon 
recognition beyond that of the three bases pairing, leading to the final “Extended 
Anticodon Hypothesis”. This modification is important in combination with ones in U34 
to enable a codon-anticodon interaction stable enough to be accepted in the 
ribosome also with wobbling at third position (Agris et al. 2007). Indeed in Crick’s 
original hypothesis a lot of emphasis was given to the geometry of the pairing in A 
site of ribosomes. The first two bases follow a Watson-Crick interaction, forming a 
canonical minihelix with the codon that can be distorted by the third base, if wobbling 
or mispaired. The geometry of the minihelix is assessed at A site by 16s rRNA, with a 
total of eight hydrogen bonds between three rRNA residues (namely A1492, A1493 
and G530) and the minor groove of the minihelix. Fewer hydrogen bonds would be 
formed with a mismatched tRNA or an unmodified tRNA that “tries” a wobble pairing. 
This is completely true and unmodified in the recent hypothesis but complemented 
with the role of modified bases. Pur37 modifications, in combination with U34 ones, 
pre-structure the anticodon to a geometry that enables a stable pairing with the 
codon in the A site, also if the third base doesn’t follow a canonical geometry.  
These modifications are thus essential for wobbling with rules that change in a 
modification dependent manner.  
Very interesting is the integration of chemical modifications roles in the evolution of 
genetic code and its tRNA adaptors. Crick proposed that the first  “primitive code” 
was based on triplets but the number of amino acids was small and were all coded 
by unmodified tRNAs. A second phase was reached with an “intermediate code” 
were evolution pushed to use all the 64 codons trying to reduce the number of non-
sense codons. The amino acids were still few and in this phase modifications such as 
cmo5U34 could be critical to expand the decoding capacities enabling wobbling and 
decoding of four-fold degenerate codon boxes. This process could involve the 
simpler amino acids, and possibly earliest, with a simple side chain (i.e. Ala, Leu, Val, 
Ser and Thr) (Agris et al. 2007). The final step of evolution was the introduction of 
new amino acids that needed free decoding potential. In this case modifications like 
xm5s2U34 could have played a pivotal role in order to split four-fold degenerate boxes 
in mixed ones. 
The importance of tRNA chemical editing in the wobble base is otherwise 
demonstrated by different dysfunctions of mutants in the biogenesis of such 
modifications (Slaugenhaupt et al. 2002; Kirino et al. 2005; Simpson et al. 2008; 
Chen et al. 2009; Wang Xinjian et al. 2009; Wang Xinjian et al. 2010). Moreover, 
mutations in genes coding for human mitochondrial tRNALysUUU
 and tRNALeuUAA are 
 56 
cause of mitochondrial myoclonus epilepsy with ragged-red fibers (MERRF) and 
myopathy encephalopathy lactic acidosis and stroke-like episodes (MELAS) 
disorders (Goto et al. 1990; Kobayashi et al. 1990; Shoffner et al. 1990; Goto et al. 
1991). These mitochondrial tRNAs were found to harbor two new kinds of taurine 
modified uridines: 5-taurinemethyluridine (τm5U34) and 5-taurinemethyl-2-thiouridine 
(τm5s2U34) (Suzuki et al. 2002), known today to be a common modification in 
mammalian mitochondrial tRNAs. These particular modifications were lacking in the 
same mt-tRNAs from cell lines of MERRF and MELAS patients and the molecular 
pathogenesis of these disorders was subsequently explained. Presence of the 
modified group allow tRNALysUUU
 and tRNALeuUUR to recognize efficiently their codons, 
respectively AAA AAG and UUA UUG, introducing the above mentioned wobbling 
rules. Lack of this modification impairs deciphering of both lysine codons with a 
whole translational defect, and leucine UUG codon with a consequent defect in UUG 
rich genes, leading to mitochondrial deficiencies (fig 2.3). A common symptom of 
MELAS patients is a complex I deficiency, nicely explained by a translational defect 
of ND6 gene, coding for a complex I subunit (Kirino et al. 2005; Suzuki et al. 2011). 
Notably almost every pathogenic mutation doesn’t fall into anticodon bases, as 
shown in figure 2.3. This implies that other positions in the tRNA sequence influence 
the modification of wobble base. These mutations could influence the folding 
properties of the molecule impairing the modification by specific mitochondrial 
enzymes like Mtu1p. 
 
 
 
Other examples underlining the importance of chemical modification in wobble bases 
come from the work in model organisms, like S. cerevisiae. For illustrative, yet 
incomplete purposes, can be cited the work on mitochondrial tRNALys, tRNAGlu and 
FIG 2.3: Schematic representation of 
pathogenic MELAS and MERRF 
mutations with consequence on 
mitochondrial translation. Image taken 
from Suzuki T. et al 2011. 
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tRNAGln. These tRNAs harbor a 5-carboxymethylaminomethyl-2-thiouridine 
(cmnm5s2U34) in position 34. Enzymes responsible for biosynthesis of this group are 
essentially three: Mto2p (alias Mtu1p, homolog of human Mtu1p), Mto1p and Mss1p. 
The first catalyzes the thiolation step while Mto1p and Mss1p are involved in the 5’ 
modification. Indirect defects in mitochondrial RNA metabolism were already proven 
in mto1 null mutant combined with a particular mutation in 15s rRNA (Wang Xinjian et 
al. 2009). Much stronger mitochondrial phenotypes were observed in mto2 null 
mutant and in double mutant mto1mss1, probably due to the defects in mitochondrial 
translation caused by the absence of a correct U34 modification (Umeda et al. 2005). 
A complete dissection of this heavily related hub of genes was achieved with a 
complete analysis of double and triple mutants, confirming that combination of the 
loss in the two independent steps of U34 modification was causing a strong 
mitochondrial defect, based on the lack of a correct codon decoding during 
mitochondrial translation (Wang Xinjian et al. 2010). 
As to be pointed out that very recently a defect in Mto1p in human cell lines was 
shown to have no effects on mitochondrial translation (Sasarman et al. 2011). 
Nevertheless all this results taken together demonstrate again the importance of a 
correct wobble base chemical modification: a highly conserved process in all the 
steps of evolution, that maybe implements the same general rules with genus 
specific exceptions. 
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2.1.4 Biogenesis of Cytosolic tRNAs Wobble Modifications 
Cytsolic tRNAs undergo chemical modification in U34. As in other fields of interest, 
work in the model system S. cerevisiae was essential to uncover enzymatic steps 
and the protein involved, a list yet to be completed. In yeast eleven cytosolic tRNAs 
are modified in 5’ terminus of the nucleobase: a carbamoylmethyl group (ncm) or a 
methoxycarbonylmethyl (mcm) are added. Four have an additional substituent in the 
2’ in combination with the 5’ modification. Three are thiol groups (mcm5s2U34 in 
tRNALys, tRNAGlu and tRNAGln) and one is an additional methyl (ncm5U34m in tRNA
Leu). 
An exhaustive list is shown in figure 2.4, and structures are given in figure 2.5. 
 
 
 
FIG 2.4: Table showing cytosolic tRNAs subject of U34 modification. Eleven anticodons are 
interested. Seven tRNAs harbor a modification only in 5’, three (namely tRNA
Lys
,
 
tRNA
Gln
 and
 
tRNA
Glu
) also a thiolation in 2’. tRNA
Leu
 has instead a methylation in 2’. Image taken from 
Johansson MJO et al. 2008. 
 
Studies on the mechanisms involved in biosynthesis of such modifications are as old 
as the identification of modified nucleosides themselves, with first experimental 
evidences on intermediates of these reactions in 1970 (Tumaitis et al. 1970). Today 
is known that the 5’ modification follows a sequential reaction and involves several 
gene products (at least 13), and most recent findings propose two alternative 
mechanisms. To this part the function of Elongator complex and Trm9/Trm112. 
Thiolation in 2’ terminus requires at least other 8 genes and is a complex process 
partially residing on mitochondrial Fe/S clusters assembly, but independent from 5’ 
modification enzymes. A brief overview on the mechanism will now be given. 
 
Modification in 5’: Elongator: One of the major contribution to the analysis of wobble 
base chemical modification pathways comes from the existence of a particular yeast 
toxin: γ-toxin or zymocin. Zymocin is a plasmid encoded toxin produced by killer 
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strains of Kluyveromyces lactis, made of three subunits (αβγ). Α and β serves as 
docking factors and facilitator of γ subunit into target cells. Studies on the toxicity 
induced mechanism of γ subunit revealed its role of nuclease, with particular 
specificity in modified wobble base of tRNAs. Zymocin can digest tRNAs only if they 
harbor specific modifications in uridine 34 and thus all the null mutants in genes for 
biosynthesis of such modifications became resistant to the toxic effects. Gamma-
toxin can be endogenously produced in S. cerevisiae strains with appropriate 
expression plasmids. This provides an excellent genetic strategy for the identification 
of genes involved in wobble bases chemical modification, excluding all the mutants 
resistant to exogenous toxin for different reasons (i.e. cell wall, permeability). 
Elongator complex is an highly conserved multitasking enzyme (Svejstrup 2007; 
Versées et al. 2010). Its roles range from assisting RNApolII in the elongation phase 
and chromatin remodeling (H3 H4 histones acetylation, HAT) to exocytosis, all 
experimentally proven. Deficiencies in Elongator are commonly associated to the 
rare genetic disorder Familial Dysautonomia (Slaugenhaupt et al. 2002) while 
particular variants to motor neuron degeneration (SLA) (Simpson et al. 2008). The 
complex is formed of two discrete subcomplexes for a total of six subunits: Elp1-
Elp2-Elp3 and Elp4-Elp5-Elp6 (Winkler 2001). The only essential gene is Elp5, even 
if Elp3p is probably considered the most important subunit and the center of catalytic 
activities. It harbors a potential acetyl-CoA binding site and a region of homology to 
the Radical SAM superfamily, an enzymatic class that use Fe/S clusters and methyl 
donor S-adenosylmethionine to perform radical reactions. Elp3p was recently proven 
to contain a functionally important Fe/S cluster whom proposed role is to structure 
the Elp3p domain and assist in a function unrelated to the HAT one 
(Paraskevopoulou et al. 2006; Greenwood et al. 2008). 
FIG 2.5: Structure of modified uridines, R stands for 
ribose. Image taken from Huang B. et al 2005. 
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All elp null mutants were shown to be resistant to zymocin (Butler et al. 1991; Butler 
et al. 1994; Frohloff et al. 2001), suggesting a role in the resistance to this toxin. This 
was initially related to the well known functions of Elongator complex (Jablonowski et 
al. 2001). In 2005 a connection between Elongator complex (all Elp subunits) plus 
three other toxin resistance genes (KTI11 KT12 KTI13) and loss of modified uridines 
was found. Moreover the molecular mechanism of γ-toxin was explained: a nuclease 
that targets and cleaves specifically tRNAs modified in U34 with an ncm
5, mcm5 and 
mcm5s2 (Huang et al. 2005; Lu 2005). The yet proposed role of Elongator in the early 
step of U34 modification was further demonstrated by HPLC on purified tRNAs 
showing a complete loss of ncm5 and mcm5 modifications, but not s2 that was still 
observed in tRNAs with naturally occurring mcm5s2 modification. Moreover a physical 
interaction between Elp1p and Elp3p with tRNAGluUUC was shown, concomitantly with 
a functional importance of the potential acetyl-CoA binding site (Huang et al. 2005). 
As general comment should be noted how Elongator role is complex and pleiotropic 
and could be very difficult to dissect each function with relatives cause-effects 
relationships. Interestingly an almost total suppression of elp- phenotypes was 
recently achieved by overexpression of two tRNA (Esberg et al. 2006). This would 
push to a central role of Elongator complex in tRNA modification. The proposed 
molecular role of Elongator complex will be further discussed. 
Modification in 5’: Trm9/Trm112: Last theoretical step in the biosynthesis of mcm5 
and ncm5 groups is the esterification of cm5 to ncm5 or mcm5. Although the 
enzyme(s) responsible for the former has yet to be discovered, the biosynthesis of 
mcm5 and the subsequent thiolation to mcm5s2 are more characterized processes. 
YML014W gene codes for a methyltransferase, later named Trm9 (Kalhor et al. 
2003). This enzyme is part of a big family of yeast transferases involved in the 
methylation of different tRNA positions. For instance Trm5 forms 1-methylguanosine 
(m1G37) at position 37 of tRNA (Bjork et al. 2001). Trm9p was clearly demonstrated 
to be essential in the biosynthesis of mcm5 substituents using S-adenosylmethionine 
(SAM) as methyl donor. This was directly shown via HPLC analysis of defective 
products, identified as tRNAArgUCU and tRNA
Glu
UUC lacking their mcm
5 modification. In 
total accordance to chemical data, a trm9 null mutant shows resistance to zymocin 
(Lu 2005). Trm9p was found to interact with Trm112p, a 15Kda protein with a zinc 
finger domain (Gavin et al. 2002). Initial results on Trm9p were indicating that it could 
work by itself, as trace of mcm5 could be detected complementing a trm9 null mutant 
with E. coli Trm9p homolog (Kalhor et al. 2003). Conversely it was recently shown 
that the physical partner Trm112p was essential for methylase activity in yeast 
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(Studte et al. 2008; Mazauric et al. 2010). Trm112p seems to work as a sort of 
activator for a number of yeast methylases, with at least 6 physically proven 
interactor (Fig 2.6). All of them share a Rossman fold, typical of enzymes that use 
SAM as cofactor. Only Lys9p is not a methylase and is the only one lacking a 
complete Rossman fold (Mazauric et al. 2010). Trm11p is a tRNA methylase, 
catalyzing the formation of m2G at position 10 (Purushothaman et al. 2005). Mtq2p is 
involved in the methylation of the class I terminator factor eRF1. The structure of 
Mtq2/Trm112 complex was recently determined and the proposed role for Trm112p 
is to improve binding of SAM and activate the Mtq2p catalytic site (Liger et al. 2011). 
Based on bioinformatics analysis and predictions, was postulated that the 
mechanism by which Trm112p works would be conserved also with other physical 
partners as the aforementioned Trm9p. 
Noteworthy, as Elongator complex, also Trm9p is highly conserved in evolution. 
 
 
 
Modification in 5’: proposed mechanisms: All the biochemical and genetical results 
can be fitted in one linear mechanism, shown in Figure 2.7a. Elongator complex and 
potential regulators perform a first step of modification that might comprise an acetyl-
CoA intermediate. This leads to a cm5U34. A yet unidentified enzyme may know use 
this intermediate to a final trans-esterification to ncm5U34. Conversely, the well-
characterized Trm9/Trm112 complex uses the cm5U34 for the final production of 
mcm5U34 with a SAM based methylation. A line of evidence recently obtained 
strongly challenges this mechanism, leading to the proposal of an alternative path 
(Chen et al. 2011). The exhaustive HPLC analysis on tRNAs extracted from trm9 and 
trm112 null mutants wasn’t successful in isolating the cm5U34 intermediate, but rather 
shown an accumulation of ncm5(s2)U34. This was fitted to a model in which Elongator 
FIG 2.6: Physical partners shared by the 
“hub” protein Trm112p. Image taken from 
Mazauric MH et al. 2010.  
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complex produces an ncm5 modification immediately thiolated to ncm5s2U34 or used 
by Trm9/Trm112 as substrate. In this case an unknown factor, or Trm9/Trm112 itself 
would convert ncm5 to cm5 and then catalyze the characterized reaction to mcm5. 
This model is represented in figure 2.7b.  
In order to expand the list of genes directly involved in wobble modification resistance 
to γ-toxin was a strategy widely used, as mentioned above. Of remarkable interest is 
the implementation of such phenotype in genome-wide screenings. From an analysis 
of 4826 homozygous diploid S. cerevisiae mutants, 63 were scored as resistant to γ-
toxin, expanding the knowledge about this pathway and supporting other 
concomitants experimental findings (Huang et al. 2008).  
 
 
FIG 2.7: (left) original mechanism proposed on experimental evidences until identification in 
trm9 null mutants of ncm
2
U34 accumulation. (right) Alternative mechanism. Images taken 
from Chen C et al 2011. 
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Modification in 2’: substitution of 2’-O with a thiol group 
Largest contribution to the study of U34 thiolation has been given by Suzuki T. 
research group. Using an approach called “ribonucleome analysis” (a genome-wide 
reverse genetic technique combined with mass spectrometry) a total of 767 S. 
cerevisiae null mutants were analyzed, looking for defects U34 thiol derivatives (Noma 
et al. 2008). This led to the identification of four genes previously not known with 
specific defects in thiolation: YHR111w (UBA4), YNL119w (NCS2), YGL211w 
(NCS6) and YOR251c (named TUM1). These have to be added to the already 
identified NFS1 (Nakai et al. 2007). Nfs1p is a cysteine desulfurase that receive a 
sulfur atom in the form of persulfide, used to catalyze other reactions. The sulfur is 
indeed transferred in the mitochondria to intermediate acceptors during Fe/S 
assembly, or shuttled to tRNA thiolation via other proteins. In E. coli a series of 
factors (TusA, TusB, TusC, TusD and TusE) transfer sequentially the persulfide to 
the final MnmA acceptor and eventually to the tRNA (Ikeuchi et al. 2006; Numata et 
al. 2006). S. cerevisiae uses a similar flow in the first steps, but a different chemistry 
for the last ones, involving a sulfur transfer with an ubiquitin-related process. 
Besides the identification of the five genes involved, a hint into molecular mechanism 
has been given by in vitro analysis. Tum1p is protein containing a rhodanese-like 
domain in its C-terminus, with catalytic center in the Cys residue 259. This activates 
Nfs1p and receives a persulfide that is then shuttled in the same way to Uba4p on 
Cys397. Urm1p is an ubiquitin-related modifier, and its conjugation to a target 
(urmylation) depends on Uba4p, an E1-like activating enzyme (Furukawa et al. 
2000). Urm1p forms a thioester link with Uba4p and in this activated form receive the 
sulfur atom on a C-terminal glycine, in thiocarboxylated form. Eventually the 
Ncs2/Ncs6 complex transfers the thiocarboxyl group to a tRNA (Nakai et al. 2008; 
Noma et al. 2008).  
This process relies on at least five other genes, already known. These comprise 
three genes coding for proteins of the cytoplasmic Fe/S assembly machinery (CIA), 
namely Cfd1p Nbp35p and Cia1p. The role of these proteins could be only related; 
giving that at least one protein of the pathway (Elp3p) requires a Fe/S cluster for its 
activity, although not in the thiolation step. More intriguingly is the role of Isu1p and 
Isu2p. Those proteins are scaffold for the mitochondrial Fe/S clusters assembly. 
Their presence is necessary for cytoplasmic tRNA modification, but not for 
mitochondrial ones. A possible explanation is related to the Nfs1p localization: clearly 
mitochondrial, also if recently was localized to the nucleus too (Naamati et al. 2009). 
Nfs1p desulfurase activity in Fe/S is then performed in mitochondria, with the help of 
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Isu1p and Isu2p. Tum1p was shown to be both mitochondrial and cytoplasmatic and 
it could work as a shuttle protein between mitochondria and cytosol, receiving a 
persulfide in the former and delivering to Uba4p in the latter. Nfs1p would be used in 
both processes on the scaffold built of Isu1p and Isu2p, donating a persulfide to 
Isd11p or to Tum1p. 
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2.1.5 tRNA Import into Mitochondria 
Being essential for life every organism has of course a complete set of tRNA genes, 
transcribed by RNA polymerase III. The number of genes varies greatly among 
different organism, from few hundreds (299 in S. cerevisiae) to thousands. Also 
organelles have sets of tRNA genes, but in this case many particularities can be 
found. Besides human and yeast mitochondrial genomes, that code for a complete 
set of tRNAs, many species are known to have incomplete sets of mitochondrially 
encoded tRNAs. As mitochondrial translation is a fundamental process, this lead to 
the conclusion that nuclear encoded tRNAs have to be imported in mitochondria. For 
instance kinetoplastids as Leishmania and Trypanosoma totally lack mitochondrial 
tRNAs and have to import the whole set (Rubio Mary Anne T. et al. 2011). 
Organisms like Trypanosoma bruceii are known to have a free procyclic stage, in 
which they parasitizes a vector like flies, and a bloodstream stage in a vertebrate 
host. Their metabolic necessities change in dependence to the stage and 
mitochondria can be completely transformed from a cristae-absent to cristae-rich 
organelles. Such an extensive remodeling process might be faster under a complete 
control of the nucleus thus justifying a complete migration of these genes from 
mitochondrial to nuclear DNA (Alfonzo et al. 2011). The first experimental proof of 
nuclear encoded tRNA import into mitochondria was given in 1967 in Tetrahymena 
pyriformis (Suyama 1967). To date tRNA import into mitochondria has been proven 
in a wide range of organisms, and recently also in mammals (Rubio M. A. et al. 
2008). In organisms where a complete set of tRNAs is present in mitochondrial 
genome, the role of the imported ones is still in controversial. Only in last years some 
cases have been clarified, showing a functional importance of this process under 
particular stress conditions. This will be further discussed. 
After proving the mitochondrial tRNA import, the next step has been to focus on the 
mechanism involved and on aspects like targeting, selectivity and regulation of the 
process. These processes are still largely unknown and with great variety from 
organism to organism, underlining a sort of evolutionary convergence of different 
mechanisms to a common essential event (Salinas et al. 2008). 
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Last review from Rubio MAT and colleagues, separated in two broadly classes the 
import mechanisms: type A and type B (Rubio Mary Anne T. et al. 2011). Type A is 
based on the canonical protein import system (i.e. TOM/TIM complexes) and 
requires ATP, membrane potential and cytosolic factors (Tarassov et al. 1995). This 
class is based on the only known example: the yeast tRNALysCUU. S. cerevisae 
harbors three different Lys tRNAs named tRK1 (tRNALysCUU), tRK2 (tRNA
Lys
UUU) and 
tRK3 (tRNALysUUU). tRK1 and tRK3 are nuclear encoded and tRK2 mitochondrial. 
tRK3 is exclusively cytoplasmic while tRK1 can be partially imported. The mechanism 
by which tRK1 is imported is quite fascinating. After aminoacylation in the cytosol, 
tRK1 is specifically recognized by one of the two isoforms of glycolytic enzyme 
enolase (Eno2p). Eno2p is known to be part of a macro complex of the mitochondrial 
outer membrane thus working also as a specific targeting system for tRK1 (Brandina 
et al. 2006). On the mitochondrial outer membrane tRK1 is associated to the pre-mito 
LysRS (preMSK1p), enzyme responsible for the aminoacylation of tRK3 in the 
mitochondria. The complex is now translocated in the mitochondrial matrix via 
TOM/TIM translocases (Tarassov et al. 1995; Entelis N. S. et al. 1998; Entelis N. et 
al. 2006). Regulation of the process is interestingly associated with ubiquitin/26s 
proteasome system. Genetic analysis indeed identified three proteins interacting with 
tRK1 or preMSK1p: Rpn13p, Rpn8p and Doa1p. Inhibition of the proteasome cellular 
activity decreases tRNA import of tRK1 while deletion of either RPN13 or DOA1 
stimulates it (Brandina et al. 2007). 
Type B (figure 2.9) is referred to all the other mechanisms that work independently 
from TOM/TIM canonical complexes. This class is still the most controversial, in 
which experimental proofs are present, but the real mechanism still poorly 
FIG 2.8: Critical steps in mitochondrial 
tRNA import process. Image taken from 
Salinas T et al. 2008. 
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understood. In mammals, tRNAGlnCUG and tRNA
Gln
UUG are imported in mitochondria. 
This requires ATP but not the mitochondrial membrane potential. In plants the anion 
channel VDAC is necessary and in kinetoplastids a complicated system in the inner 
membrane (RIC) was identified, relying also on the Complex III Rieske protein RIC6 
(in Leishmania tropica but not in Tripanosoma bruceii). An outer membrane complex 
for tRNA import of kinetoplastids is still lacking. See Rubio MAT et al. 2011 and 
Salinas T et al. 2008 for review. 
To date S. cerevisiae is the only organism in which both A and B types of tRNA 
import are proven to coexist. tRNAGlnCUG and tRNA
Gln
UUG are imported in a type B 
fashion. Rinehart and coworkers demonstrated the import of two tRNAGln isoforms 
with specific RT-PCR on purified mitochondrial tRNA. Again the import was observed 
in vitro on purified mitochondria, process relying on ATP but not on other cytosolic 
factors. 
Although experimental proofs of the import exist, understanding biological 
significance of these events is still a great challenge. Why organisms like S. 
cerevisiae and Homo sapiens still import tRNAs from cytosol to mitochondria when 
harboring a complete mitochondrial set? The only case totally understood is 
tRNALysCUU in yeast and involves wobbling rules at anticodon base U34. As previously 
described S. cerevisiae has three tRNALys genes: tRK1 (tRNALysCUU, cytosolic and 
mitochondrial), tRK2 (tRNALysUUU, cytosolic) and tRK3 (tRNA
Lys
UUU, mitochondrial). 
tRK3, exclusively mitochondrial, harbors a UUU anticodon with an mnm5s2U34 
modification thus being able to decode AAA lysine codon and wobbling to AAG. At 
37˚C tRK3 is not correctly modified provoking a translational deficit in mitochondrial 
proteins with AAG codons (Var1p and Cox2p). Become clear the essential role of 
tRK1 import at 37˚C that complements the decoding deficiencies of hypomodified 
tRK3 allowing the correct translation of Var1p and Cox2p (Kamenski et al. 2007). 
Conversely is not clear which role tRNAGlnCUG and tRNA
Gln
UUG isoforms have in yeast 
and mammals mitochondria after import. At least in yeast was demonstrated that 
tRNAGlnCUG is used in mitochondrial protein synthesis. Creating a nuclear suppressor 
tRNAGlnCUA a mitochondrial cox2-114
UAG allele (harboring a non sense mutation) was 
suppressed. Presence of translated protein was confirmed by western blot but 
strangely no complementation of RD phenotype was observed (Rinehart 2005).  
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FIG 2.9: Type A and Type B of tRNA mitochondrial import. Image taken from Rubio MAT et al. 
2011. 
 
 
 
 
Of remarkable interest in tRNA import mechanism is how selectivity and targeting are 
achieved. In these cases probably we have the most variability among different 
species. Among different examples, excellently reviewed in Salinas et al. 2008, very 
intriguingly is tRNAGluUUC and tRNA
Gln
UUG in Leishmania tarantolae. The selectivity 
here is based again on the chemical modification of wobble base U34. Specific tRNAs 
from cytosol and mitochondria were isolated and characterized using mass 
spectrometry. The only difference that could be detected was the total absence of 
thiolation in U34 in the mitochondrial imported isoforms. In this specific genus the 2’-
thiolation could therefore play an inhibitory role on tRNA import (Kaneko et al. 2003). 
On the other side, in the related kinetoplastids Tripanosoma bruceii it was shown that 
thiolated tRNAs are efficiently imported in mitochondria and dethiolated afterward 
(Bruske et al. 2009). 
All these rules and examples show again how tRNA chemical modification is an 
important process, used not only for the expansion of decoding capacities but also to 
target and select tRNAs. This chemical targeting is very specific and variable among 
the evolution. One of the most intriguing aspects is how the process could be 
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regulated and integrated in the cellular network. Recent findings strongly suggest that 
tRNA chemical modification can be an essential response to extracellular and 
intracellular stresses. Modification could be reprogrammed during stresses, fine-
tuning the performance of translation via tRNAs structure, decoding capacity or 
subcellular localization. A recent high-throughput analysis of S. cerevisiae tRNAs 
chemical modification under four different stresses (MMS, H2O2, NaAsO2 and NaOCl) 
strongly support this idea (Chan et al. 2010). 
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2.2 Results and Discussion 
2.2.1 Cytoplasmic tRNAs Chemical Modification is Essential for 
Mitochondrial Function at 37˚C 
A genome wide screening focused on mitochondrial biogenesis at 37˚C was 
performed and results are described in Chapter 1 of this dissertation. Briefly 4688 S. 
cerevisiae haploid strains were tested for growth on non-fermentable carbon source 
ethanol, at 30 and 37˚C. A total of 488 strains resulted defective and 177 were 
selected as new candidates. Those genes were never related to mitochondrial 
biogenesis or their function at the moment of the screening was yet poorly 
understood. Their OXPHOS phenotype was later confirmed on different carbon 
sources. Cytochrome spectra profiles and respiratory rates were analyzed at 37˚C 
and used as parameters to organize deletants in phenotypic classes. Four classes 
were created accordingly to phenotype severity, ranging from A (very severe 
phenotype) to D (no evident defects). 
Gene Ontology analysis on the mentioned datasets allowed identifying enriched 
functional classes. Strikingly among 88 new candidates (from 177 list) with a specific 
phenotype at 37˚C functional classes “tRNA wobble uridine modification” (child term 
of “tRNA chemical modification” and “tRNA wobble base modification”) and “protein 
urmylation” were significantly enriched (Table 2.1). 
As described in section 2.1.3 wobble uridine (U34) in the anticodon of eleven 
cytoplasmic tRNAs is chemically modified. Carbamoylmethyl group (ncm) or a 
methoxycarbonylmethyl (mcm) are added in 5’ position of U34. tRNA
Lys, tRNAGlu and 
tRNAGln are additionally modified with a thiol group in position 2’ giving rise to the 
modified base mcm5s2U34. Introduction of methyl and thiol groups was demonstrated 
to be necessary to modulate decoding capacities and fine-tuning tRNA performance. 
In some cases modification was essential in physiological conditions but different 
evidences associated this kind of modification to cellular stresses as DNA damage or 
oxidative stress (Begley et al. 2007; Chan et al. 2010). 
Up to three steps are required for a complete modification: a first methylation 
catalyzed by Elongator complex, a second methylation by Trm9p/Trm112p and a 
final thiolation starting with cysteine desulfurase Nfs1p and concluding with functional 
pair Ncs2/Ncs6 that transfer the thio group to the final tRNA acceptor. At least 26 
genes, reported in table 2.2, are clearly involved in the three steps. A detailed 
description of the mechanisms and reactions involved is provided in section 2.1.3. 
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TABLE 2.1: Biological Processes significantly enriched at 37˚C. For details see text in section 
1.2.4 of this dissertation.  
GO TERM BIOLOGICAL PROCESS p-value genes 
GO:0002097 tRNA wobble base modification 5.02E-11 9 
GO:0002098 tRNA wobble uridine modification 5.02E-11 9 
GO:0006400 tRNA modification 5.48E-07 9 
GO:0032447 protein urmylation 1.45E-06 4 
GO:0045324 late endosome to vacuole transport 1.12E-05 6 
GO:0015031 protein transport 1.17E-05 21 
 
 
TABLE 2.2: 26 genes involved in wobble base modification of cytoplasmic tRNAs. See 2.1.3 
for details. 
GENE Note YPE30˚C YPE37˚C LIST OXPHOS CLASS R. EFF% 
ELP1 Elongator Complex 0 HS 177 yes C 36 
ELP2 Elongator Complex 0 HS 177 yes B 30 
ELP3 Elongator Complex 0 MS 177 yes B 50 
ELP4 Elongator Complex 0 HS 177 yes A 8 
ELP5* Elongator Complex 
      
ELP6 Elongator Complex 0 HS 177 yes B 29 
KTI11* Elongator Complex 
      
KTI12 Elongator Complex 0 MS 177 yes C 41 
KTI13 Elongator Complex 
      
KTI14* Elongator Complex 
      
SAP185** Elongator Complex 
      
SAP190** Elongator Complex 
      
SIT4 Elongator Complex MS HS 488 
   
TRM9 Trm9p/Trm112p 0 MS 177 yes B 43 
TRM112* Trm9p/Trm112p 
      
TUM1 Thiolation Step 
      
UBA4 Thiolation Step 0 MS 177 yes B 33 
URM1 Thiolation Step 0 LS 488 
   
NCS2 Thiolation Step 
      
NCS6 Thiolation Step 0 MS 177 yes D 81 
NFS1* mt/cy Fe/S Cluster 
      
ISU1** mt/cy Fe/S Cluster 
      
ISU2** mt/cy Fe/S Cluster 
      
CFD1* cy Fe/S Cluster 
      
CIA1* cy Fe/S Cluster 
      
NBP35* cy Fe/S Cluster 
      
*deletant not present in the haploid deletants collection used. 
**only double mutants show phenotype (sap185Δsap190Δ and isu1Δisu2Δ) 
underlined genes were found to be not sensitive in tested condition. 
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Out of 26 mentioned genes 11 were identified in the mentioned screening as 
essential for mitochondrial biogenesis at 37˚C.  
Among 15 genes of the pathway not identified, 8 corresponding null mutants were 
not present in the collection used for the screening (ELP5, KTI11, KTI14, TRM112, 
NFS1, CFD1, CIA1, NBP35). For five of those the corresponding null mutant is 
unviable. The three others were not included in the deletion project for reason 
unknown. 
Relatively to ISU1/ISU2 and SAP185/SAP190 was demonstrated a concerted role in 
tRNA modification and impairments in the pathway could be observed only in 
corresponding double deletants (Nakai et al. 2007; Huang et al. 2008). Eventually 
only three null mutants corresponding to genes of the pathway were found to be not 
sensitive in the tested conditions (KTI13, TUM1 and NCS2). 
For 9 out of 11 identified mutants an OXPHOS impairment under stress condition 
was demonstrated for the first time and all displayed a specific severe phenotype 
(MS or HS). For 2 genes, SIT4 and URM1, a role in mitochondrial biogenesis was 
already reported even if related to aspects different from tRNA chemical modification. 
Indeed URM1 is yet involved in urmylation process, an ubiquitin-related protein 
modification, and its deletion was already identified in mitochondria genome-wide 
analysis (Luban et al. 2005). Targets of this non-canonical modifier are also involved 
in oxidative stress and apoptosis in both S. cerevisiae and mammalian cell lines (Van 
der Veen et al. 2011; Wang F. et al. 2011). 
A deletion in SIT4, a 2A type serine-threonine phosphatase, was already shown to 
cause a defective growth in glycerol media at 30˚C (Dimmer 2002), confirmed also in 
the present screening. The defect was subsequently addressed and related to a 
carbohydrate metabolism shift toward a futile glycogenesis with consequent 
deprivation of Krebs cycle intermediates, detrimental for the cell (Jablonka et al. 
2006). Independently, other mitochondrial related phenotypes were also observed in 
sit4 mutants as oxidative stress sensitivity or cytoskeleton abnormalities (SGD). 
As just mentioned the identified pathway targets cytoplasmic tRNAs. Many 
organisms are known to import cytosolic tRNAs in mitochondria with a role in some 
cases totally proven and obvious and in others only hypothetical or totally unknown. 
As pointed out in 2.1.5 some species do not harbor a complete set of mitochondrial 
tRNAs and import from cytosolic pool is obviously essential for mitochondrial protein 
synthesis. However genus like H. sapiens and S. cerevisiae harbor complete sets of 
mitochondrial tRNAs but still import cytosolic ones. In S. cerevisiae tRNALysCUU, 
tRNAGlnCUG and tRNA
Gln
UUG import have been clearly demonstrated and at least for 
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tRNALysCUU the mitochondrial function is clear (Martin et al. 1979; Rinehart 2005; 
Rubio M. A. et al. 2008). Furthermore tRNAGlnCUG and tRNA
Gln
UUG are imported also in 
mammal mitochondria but the functional role of this event remains unclear (Rubio M. 
A. et al. 2008). 
Out of the three cytosolic tRNAs found in mitochondria only tRNAGlnUUG is modified 
through all the three steps of the aforementioned pathway (i.e. contains an 
mcm5s2U34 wobble base). The role of this pathway and importance of the 
modification in fine-tuning the performance of tRNAs suggests that mitochondrial 
protein synthesis (MPS) could be the target from which depends a correct 
mitochondrial biogenesis at 37˚C. To this end different hypotheses can be proposed 
regarding the mechanisms underlying. 
The first hypothesis concern a direct role of the modification pathway in MPS 
mediated uniquely by the imported cytosolic tRNAGlnUUG whose role in mitochondria is 
still unknown. 
The second hypothesis concern the import and a direct role of few other cytosolic 
tRNAs modified by the pathway rather then the unique tRNAGlnUUG. In this case 
import in mitochondria of these tRNAs would be still unproven. 
The third scenario involves an indirect effect of these tRNAs on MPS via cytoplasmic 
defects. It is possible that loss of these modifications could impair cytoplasmic 
translation of proteins functional to the correct MPS. To this concern has to be noted 
that a similar effect was proposed to mediate trm9Δ sensitivity to DNA damage 
agents (Begley et al. 2007). 
In order to shed some light into these hypotheses mitochondrial protein synthesis in 
mutants of the pathway was considered an essential experimental investigation. 
Three representative mutants were chosen resembling each of the essential steps in 
the modification pathway: elp3Δ (first methylation), trm9Δ (second methylation) and 
ncs6Δ (thiolation). Interestingly the three corresponding genes are conserved: NCS6 
is the yeast ortholog of human CTU1, which in combination with CTU2 (NCS2 in 
yeast) performs the same reaction (Dewez et al. 2008; Schlieker et al. 2008). TRM9 
is the yeast ortholog of ALKBH8 and its functional partner TRM112 is conserved too 
(ortholog of TRMT112). Also ELP3, coding the catalytic subunit of Elongator 
complex, is conserved in all phyla. 
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2.2.2 Phenotypical Analysis of ncs6Δ, trm9Δ and elp3Δ Null 
Mutants 
Phenotypes relative to oxidative growth, cytochrome spectra profiles, oxygen 
consumption and mitochondrial DNA stability in ncs6Δ, trm9Δ and elp3Δ strains are 
reported in figure 2.10. 
 
 
NAME YPE 30˚C YPE 37˚C CLASS R. EFF% Gal R. EFF% Glu petites (Gal) 
NCS6 0 MS D 86% 81% 1.4 
TRM9 0 MS B 43% 43% 1.1 
ELP3 0 MS B 55% 50% 1.5 
 
FIG 2.10: Cytochrome spectra profiles and respiratory rates recorded in glucose and 
galactose media after 24hrs of incubation at 37˚C. Frequency % of spontaneous petite 
mutants in the population was assayed after growth of 24hrs at 37˚C in complete galactose 
media. Fold-values of frequency increase compared to wild type are reported for each 
mutant. 
 
Growth phenotypes on oxidative carbon sources were similar for all the mutants at 
37˚C, scored as medium sensitive (MS). Cytochrome spectra profiles recorded after 
growth in non-repressing glucose (0.6%) at 37˚C (as described in 4.2.3) allowed 
classification of trm9Δ and elp3Δ as class B mutants thus showing both qualitative 
and quantitative defects in mitochondrial respiratory chain. On the other hand ncs6Δ 
mutants displayed a cytochrome profile similar to a wild type strain (class D). 
Oxygen consumption was markedly reduced in trm9Δ and elpΔ mutants, with 
efficiency rate of 43% and 50% of the wild type strain respectively. This decrease 
was less pronounced in ncs6Δ mutant, with efficiency as high as 81%. 
Mutants were also assayed for cytochromes profiles and respiratory efficiencies after 
growth in complete galactose media under thermal stress. These analyses were 
performed to rule out any possible influence of this not-repressive fermentable 
carbon source usually implemented in MPS experiments. Cytochrome profiles at 
Galactose 37˚C Glucose 37˚C 
ncs6Δ 
trm9Δ 
elp3Δ 
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37˚C in galactose media are comparable to that in low glucose even if slight 
differences could be observed. After growth in glucose trm9Δ strain displayed a small 
peak at about 603nm resembling residual COX complex that totally disappeared in 
galactose media. Nevertheless phenotypical classes are confirmed and respiratory 
efficiencies totally comparable thus concluding that the carbon source utilized could 
not influence final interpretation of the results. 
Analysis of petite mutants accumulation was instead performed to exclude any 
correlation between observed MRC defects and potential instability of mitochondrial 
DNA in conditions used for cytochrome spectra analysis, oxygen consumption 
recording and MPS. Petite mutants indeed arise from spontaneous events of 
mitochondrial genome alteration as point mutation or recombination (with partial or 
total deletions) giving rise to ρ- and ρ0 genomes. To evaluate petite frequency the 
same cultures used for cytochrome spectra and respiratory efficiency evaluation has 
been used. Therefore 10ml pre-inoculations in YP galactose media are performed 
with strains previously purified of accumulated RD mutants. After over-night (o/n) 
incubation at 30˚C 150ml flasks of YP Gal 2% are inoculated and incubated for 24hrs 
at 37˚C in constant shacking at 120rpm. Petite frequency was estimated on aliquots 
from 150ml flasks. After serial dilutions 300 colonies are plated in fifth replicates on 
complete media containing ethanol 2% and 0.25% glucose. RD mutants grow until 
glucose is totally consumed, conversely wild type can shift to ethanol metabolism and 
continues to divide; petite mutants can therefore be distinguished by colony size. 
As reported in figure 2.10 the petite frequency accumulation is very similar among 
the mutants with 1.1, 1.4 and 1.5 fold-increases for trm9Δ, elp3Δ and ncs6Δ 
respectively. Concerning ncs6Δ mutant appears clear that a petite accumulation 1.4 
times higher then wild type is not index of extensive mtDNA damage as proven by a 
wild type cytochrome spectra profile. On these bases it is reasonable that structural 
defects observed in trm9Δ and elp3Δ mutants, showing petite accumulation 
comparable or even lower to ncs6Δ, should not be due to mtDNA mutations. 
Interesting is the observation that petite frequency is quite different for both mutants 
and wild type in glucose and galactose media with a significantly higher accumulation 
in galactose media (data not shown). 
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2.2.3 Mitochondrial Protein Synthesis Is Impaired in elp3 and trm9 
Null Mutants 
Mitochondrial protein synthesis can be directly evaluated in a pulse experiment with 
35S-methionine in the presence of cycloheximide (inhibitor of cytoplasmatic 
translation). The protocol used (reported in section 4.2.5) requires normally cells 
grown in galactose media. Neo-synthetized products of mitochondrial translation 
were directly labeled with 35S-methionine as described in 4.2.5 from cells grown at 
both 30 and 37˚C. Proteins were precipitated with TCA, resolved in SDS-page and 
transferred to nitrocellulose membrane. 
A first analysis is reported in figure 2.11 and no differences could be observed at 
permissive temperature of 30˚C, results expected as none of the mutants displayed 
an OXPHOS negative phenotype in this condition. At 37˚C no evident reduction was 
observed in ncs6Δ. This leads to the conclusion that the enzymatic step impaired in 
ncs6Δ mutant, i.e. thiolation, does not have effects on MPS per se. This is in good 
agreement with the observed wild type cytochrome spectra profile. 
 
 
FIG 2.11: MPS analysis. Mitochondrial products of translation are labeled with 
35
S-methionine 
in presence of cycloheximide, inhibitor of cytoplasmic translation. An equivalent of 0.6OD of 
cells was labeled for 5 and 10 minutes and total protein extracted, precipitated with TCA and 
resolved in SDS page (as described in 4.2.5). Autoradiography of MPS analysis carried out 
on cells grown at 30˚ and 37˚C for about 15 hrs is shown. 
 
These results point out that OXPHOS negative phenotype observed at 37˚C for 
ncs6Δ mutant is not due to MPS defects. However it is known that NCS6 plays a role 
not only in tRNA thiolation but in other processes like urmylation, a common 
ubiquintin-related post translational modification not involved in promoting proteolysis 
Var1  
Cox1  
Cox2  
Cyt b 
Apt6  
Atp8/9 
Cox
3  
10 5 10 5 10 5 pulse (min)  
BY4742 trm9Δ elp3Δ 
30˚C 
ncs6Δ 
10 5 10 5 10 5 10 5 
BY4742 trm9Δ elp3Δ 
37˚C 
ncs6Δ 
10 5 
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but rather in nutrient sensing, budding and recently in oxidative stress response in S. 
cerevisiae (Goehring et al. 2003; Petroski et al. 2011). Also in the present screening, 
as reported in table 2.1, “protein urmylation” was among biological processes 
specifically enriched at 37˚C. Moreover different evidences indicate that NCS6 gene 
product could be localized also in mitochondria without its functional partner Ncs2p 
(Huh et al. 2003; Nakai et al. 2008). Seems reasonable that Ncs6p in mitochondria 
could play a distinct role from tRNAs thiolation, may related to protein urmylation, 
whose defect is cause of the OXPHOS phenotype observed. This is also in 
agreement with the observation that ncs2Δ did not displayed any OXPHOS defects 
in the present screening. At this point “protein urmylation” pathway could be essential 
for mitochondrial biogenesis at 37˚C for its role in post-translational modification and 
not in modification of cytoplasmic tRNAs, as initially thought. 
On the other hand extensive impairments were observed in trm9Δ and elp3Δ strains. 
Given the running distortions in elp3Δ lanes of the SDS-page (clear in the right panel 
in fig 2.11) to confirm the role of TRM9 and ELP3 in mitochondrial protein synthesis 
and better compare the effects on the single mitochondrial products two additional 
experiments were performed. Also the thermal stress was slightly increased 
performing growth and labeling at 38˚C to stress differences; results are shown in 
figure 2.12. Each protein band was afterwards quantified in both independent 
experiments for trm9Δ and elp3Δ strains and mean values were normalized to the 
synthesis rate of corresponding protein in wild type strain. The band intensities were 
thus converted in synthesis efficiencies (% of wild type) and results are shown in 
figure 2.12 panel b and c. 
Autoradiography shows a decrease in MPS in trm9Δ strain especially in some 
mitochondrial products. Quantification reveals that: i) synthesis of Var1p and Atp6p 
(after 10 minutes of labeling) is comparable with that of wild type; ii) Cox1p and 
Cox2p result the most impaired products with synthesis efficiencies of about 55% 
and 65% respectively: iii) Cytb and Cox3p are synthetized at about 70% and 80% of 
a wild type level respectively. 
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FIG 2.12: (a) Labeling of mitochondrial translation products with 
35
S-methionine in presence of 
cycloheximide. Cells were grown about 15hrs at 38˚C on complete galactose media. An 
equivalent of 0.6OD of cells was labeled for 5 and 10 minutes and total protein extracted, 
precipitated with TCA and resolved in SDS page (as described in 4.2.5). (b)(c) Each band 
was quantified in two independent experiments (QuantityOne software). Mean values were 
calculated for each protein and then normalized to wild type (= 100%). 
  
To rule out which of the proposed hypotheses is compatible with results obtained in 
MPS analysis a codon usage analysis was carried out. Frequency values for each 
codon whose corresponding tRNA is modified by the identified pathway (i.e. 11 
different tRNAs) were calculated for the whole mitochondrial genome. A table (table 
elp3Δ 
trm9Δ 
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b 
c 
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2.3) was then composed reporting for principal products of mitochondrial translation 
the frequency of each codon in the gene normalized to the overall mitochondrial 
genome occurrence. A value >100 means that a particular codon is over-represented 
in a gene, compared to the whole genome. Conversely a value <100 means low-
occurrence of a particular codon in a given gene, always reported to the overall 
genome frequency. A 0.0 value mean that that particular codon in a gene is totally 
absent. If lack of a particular modification affects directly decoding of a particular 
codon it can be expected that proteins enriched in that codon could be specifically 
affected. This was previously demonstrated for tRK3 that being hypomodified at 37˚C 
was not able anymore to decode UUG lysine codons (Kamenski et al. 2007). 
On the basis of codon frequencies the first hypothesis, focused a direct role in MPS 
of the sole cytosolic tRNAGlnUUG, can be discarded. Indeed Gln codons are equally 
distributed among principal products of MPS, and given this distribution an equal 
impairment in all the mitochondrial proteins was expected. For instance Cyt b is 
among the most impaired products while from its Gln codon distribution would 
suggest an opposite effect. The analysis for the other four codons susceptible of 
Trm9p modification revealed that the only tRNA for which codon frequency is 
compatible with experimental results is tRNAGlyUCC. Indeed Cox1p and Cox2p harbor 
significant over representation of Gly GGA codons and in MPS appeared as the most 
affected proteins. Conversely Var1p, that harbors no Gly GGA codons, is synthetized 
efficiently. These results would suggest that the second or the third hypothesis could 
be true: a direct participation of a cytosolic tRNA in MPS (cyt tRNAGlyUCC) or an 
indirect effect mediated through proteins translated in the cytosol. 
More in general, effects of TRM9 deletion are less severe then ones observed in elp3 
null mutation. A more diffused impairment in mitochondrial protein synthesis is 
indeed observed: i) Cox1p and Cox2p are the most affected proteins, synthetized at 
only about 28% and 31% of a wild type level; ii) Cytb, Var1p and Cox3p are 
synthetized at 43, 50 and 56% of a wild type level; iii) a marked decreased in Atp6p 
synthesis was observed after 5 minutes of labeling, but the translation reached 70% 
of wild type at 10 minutes. The observation of a strong impairment in Var1p synthesis 
support the presence of other mechanisms involved rather then import of the unique 
cyt tRNAGlyUCC. However is difficult to imagine a direct role for all the remaining 
Elongator modified tRNAs based on an import mechanism still totally not supported. 
To this end a realistic interpretation could be that the identified pathway could affect 
MPS via a totally indirect effect, or based on a combination of a direct effect 
mediated by one or few imported tRNAs and indirect one. 
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TABLE 2.3: Mitochondrial genome codon usage analysis was performed in concern to 11 
codons whose corresponding tRNA is chemically modified. Boxes are highlighted in light blue 
if a particular modification is present. Identity of chemical group added change in accordance: 
ncm
5
 (first methylation only), mcm
5
 (first and second methylation) and mcm
5
s
2
 (first, second 
methylation and thiolation). For each mitochondrial gene frequency of each codon are 
reported, normalized to mitochondrial genome occurrence. Boxes are highlighted in yellow for 
significant over representations. 
 
tRNA Ala Glu Gly Lys Leu Pro Gln Arg Ser Thr Val 
codon GCA GAA GGA AAA TTA CCA CAA AGA TCA ACA GTA 
I˚methyl. yes yes yes yes yes yes yes yes yes yes yes 
II˚methyl.  yes yes yes   yes yes    
thiolation  yes  yes   yes     
ATP6 60.2 85.6 88.1 104.2 103.1 137.9 87.7 113.3 131.4 102.7 114.6 
ATP8 0.0 0.0 0.0 104.2 103.1 184.8 109.6 113.3 71.1 180.1 92.4 
COB 150.6 114.1 97.9 104.2 101.9 129.6 73.5 113.3 122.8 75.6 105.4 
COX1 144.5 101.6 161.6 104.2 101.9 121.3 97.6 113.3 140.0 135.1 122.0 
COX2 120.4 107.3 122.4 91.7 104.2 126.9 97.6 113.3 116.3 113.5 68.4 
COX3 123.5 114.1 102.8 104.2 103.1 91.0 109.6 113.3 94.8 84.6 110.9 
OLI1 120.4 114.1 97.9 104.2 103.1 137.9 109.6 113.3 215.4 180.1 153.4 
VAR1 0.0 114.1 0.0 99.0 99.7 0.0 109.6 68.0 40.9 23.4 37.0 
  
The more severe effects observed in elp3Δ mutant in comparison to trm9Δ is 
compatible with the higher number of modified tRNAs that in turn can affect an higher 
number of proteins translated in the cytoplasm. Nevertheless it cannot be excluded 
that this worsening could be due to a different importance that ELP3 and TRM9 
modifications might have on tRNAs biology. Is therefore known that tRNA chemical 
remodeling could be used to fine-tune tRNAs translation performances affecting 
directly decoding capacities, thermostability and folding properties. Different kind of 
cellular stresses (as oxidative stress and DNA damage) were shown to cause a 
significant change in tRNA chemical profile, favoring particular modifications (Chan et 
al. 2010). 
Obtained results allowed demonstration that, in S. cerevisiae, Elongator and 
Trm9/Trm112 complex regulate mitochondrial protein synthesis under stress 
condition (37˚C). Remain to be demonstrated which cytoplasmic proteins mediate 
this effect and/or other cytoplasmic tRNAs that could directly take part in 
mitochondrial protein synthesis process at 37˚C. 
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3.1 Introduction 
3.1.1 ARH1 and YAH1 Roles in Fe/S Clusters and Heme A 
Biosynthesis 
The functional pair Arh1p/Yah1p was extensively characterized around the year 2000 
with a substantial timing overlap. ARH1 was identified as first but major contribution to 
the characterization of this functional pair came from YAH1 gene. 
Cytochrome P450 system receives electrons from the pair Adrenodoxin (ADX) and 
Adrenodoxin Reductase (ADR) during conversion of cholesterol into pregnenolone, 
common precursor of all steroid hormones. Existence in yeast of a protein with ADR was 
suggested observing that mitochondrial directed bovine Cytochrome P450 along with 
Adrenodoxin (ADX) alone were able to perform in yeast mitochondria the same reaction 
catalyzed in mammals (Dumas et al. 1996). Looking for a possible homolog a partially 
sequenced gene on chromosome IV was shown to code for a protein with similarity to 
ADR. This gene was found to be neighbor of BCS1, starting from its 5’ with opposite 
direction (Nobrega F. G. et al. 1992). Named systematically YDR376W after genome 
sequencing was confirmed to be the yeast homolog of ADR and therefore called ARH1, 
Adrenodoxin Reductase Homolog 1 (Lacour et al. 1996; Lacour et al. 1998). The protein 
was demonstrated to be mitochondrial, associated to the inner membrane and 
containing a FAD and a NADPH binding domain. Extensive studies of ARH1 were 
presented in 1998 when it was totally sequenced and demonstrated to be an essential 
gene in yeast (Manzella et al. 1998). Although in mammals ARH1 is involved in sterol 
biosynthesis, effects of ARH1 downregulation failed to be complemented with different 
sterols supplementation ruling out this possibility and opening the horizon to the other 
processes involved (Manzella et al. 1998). Being an essential gene almost all 
experimental data were obtained using a conditional allele driven by GAL1 promoter. 
Also under repressing conditions the GAL1-ARH1 expressing strain was viable, allowing 
a deeper study of phenotypes. Initially the most interesting observations were made in 
connection to iron metabolism. Indeed Arh1p depleted cells showed a total lack of iron 
homeostasis control with a cellular and subsequent mitochondrial iron overload (Li 
2000). Moreover upon depletion of Arh1p defects in Fe/S clusters proteins (both 
mitochondrial and cytoplasmic as Aco1p and Leu3p) and heme containing proteins as 
Cyc1p and Cyt1p (Li 2000). These two impairments can be considered as the two first 
hints into the principal Arh1p roles in yeast mitochondria: Fe/S clusters and heme A 
biosynthesis. 
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Both these roles, as mentioned previously, are played with the functional and physical 
interactor Yah1p. Arh1p indeed takes electrons from NADH or NADPH that are then 
shuttled via cofactor FAD to the acceptor Yah1p. Although YAH1 was identified later 
then ARH1, all the hints about function of this pair of proteins in S. cerevisiae come from 
its characterization. YAH1 is coded at YPL252C locus, in chromosome XVI, and was 
demonstrated to be the homolog of human Adrenodoxin and thus called Yeast 
Adrenodoxin Homologue 1 (Barros et al. 1999). YAH1, as ARH1, is an essential gene 
and was studied in a conditional mutant. Yah1p localization was analyzed and confirmed 
to be mitochondrial soluble protein of the matrix and upon its depletion impairments in 
mitochondrial respiratory chain were observed (Barros et al. 1999). Accordingly to the 
phenotypes shown for Arh1p depleted cells, also in this case iron homeostasis defects 
were observed with a 30-fold increase of mitochondrial iron (Lange et al. 2000). 
Moreover Yah1p was the first protein from ferredoxins family (low molecular weight 
proteins with a Fe/S cluster as active site) with a characterized role in Fe/S cluster 
biosynthesis, role later demonstrated also for Yah1p bacterial counterpart Fdx. Yah1p 
depleted cells showed strong decay in activity of proteins containing Fe/S clusters such 
as Aconitase, Complex II and Complex III although protein levels were constant. This 
effect was also exploited in cytoplasmic Fe/S proteins such as Leu1p and resembled the 
same phenotype observed after ARH1 repression. Measurements of 55Fe incorporation 
in Fe/S proteins is used as index for a good synthesis and incorporation of these 
prosthetic groups; the direct role of Yah1p in this process was demonstrated in GAL1-
YAH1 strains, failing to detect any 55Fe in a mitochondrial version of Leu1p upon 
establishment of repressive conditions (Lange et al. 2000). This role was further 
demonstrated studying the role of Isu1/Isu2 scaffold proteins, essential for Fe/S cluster 
biosynthesis. This scaffold is a protein structure where the rising Fe/S is assembled 
starting from sulfur obtained by Nfs1p desulfurase activity and iron from Yfh1p (Frataxin). 
If defects in these enzymatic activities are present, 55Fe incorporated in the scaffold will 
be very low. On the other hand if later steps are defective 55Fe will be accumulated. A 
lack of accumulation of iron in the scaffold was observed upon depletion of Yah1p, like in 
Yfh1p and Nfs1p depleted cells (Muhlenhoff et al. 2003). This not only confirmed the role 
of Yah1p in Fe/S cluster assembly but also shifted the main interest on the first steps of 
the process. 
Arh1p and Yah1p thus generate an electron flow that is clearly used in Fe/S cluster 
biosynthesis. Although the role is clear, the molecular details are still lacking. Indeed the 
real acceptor of electrons from Yah1p is not known. Actually the electron flow is 
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proposed to start from Arh1p passing two electrons to Yah1p that in turn transfers to S0 
formed in the desulfurase activity of Nfs1p from the donor cysteine. In this way the sulfur 
is reduced to S2-, the form found in Fe/S clusters. The preferential electron donor for the 
couple Arh1p/Yah1p is NADH (Muhlenhoff et al. 2002), but probably also the 
phosphorylated form is used. Indeed Arh1p has a NADPH binding domain and levels of 
this cofactor were found to influence clusters synthesis: a pos5Δ strain, lacking the sole 
mitochondrial NADH kinase, cannot accumulate NADPH in the mitochondria with 
consequent failure in assembling clusters (Pain et al. 2010). 
A role for YAH1 and consequently for ARH1 in heme biosynthesis came mostly from the 
study of COX15, already shown to be essential for cytochrome c oxidase assembly 
(Glerum et al. 1997). Heme biosynthesis starts in mitochondria from succinyl-CoA and 
glycine that via multiple enzymatic steps are converted in a porphyrin ring (catalyzed by 
Hem1p to Hem4p). This is in turn converted with three enzymatic steps, catalyzed by 
Hem12p, Hem13p and Hem14p into protoporphyrin IX (SGD, KEGG). The final addition 
of iron2+ is catalyzed by ferrochelatase Hem15p giving rise to heme B (protoheme). 
Defects in early steps cause a complex set of pathologies called “porphyrias” in human. 
Mitochondrial heme B is inserted in complex III or modified in different forms to be 
inserted in other mitochondrial respiratory chain (MRC) complexes. In the IMS two 
different lyases, namely Cyc3p and Cyt2p, covalently attach heme B to cytochrome c 
and cytochrome c1 respectively. Heme A, present only in complex IV, is synthetized in 
the matrix modifying heme B structure in two positions: carbon C-2 is farnesylated and 
carbon C-8 is formylated (Moraes et al. 2004). The first modification occurs in C-2 
producing heme O and is catalyzed by COX10 gene product, already characterized for 
its role in COX biogenesis and subsequently in heme A biosynthesis (Nobrega M. P. et 
al. 1990; Tzagoloff et al. 1993). A mutant in COX15 was also shown to harbor defects in 
mitochondrial heme profile. In particular it showed an accumulation of heme O and 
undetectable heme A (Barros et al. 2001). This suggested a monoxygenase role for 
Cox15p on C-8. In Schizosaccharomyces pombe COX15 coding frame is fused with 
YAH1 giving rise to a fusion product and leading to the conclusion that they could act in 
the same enzymatic pathways. The same fusion product can be obtained starting from 
S. cerevisiae genes and it is able to be localized in mitochondria and complements 
specific defects of both COX15 and YAH1 mutants (Barros et al. 2001). Furthermore 
yah1 temperature sensitive mutants were shown to have decreased level of heme A but 
still detectable heme O and being unable to efficiently incorporate radioactive δ-
aminolevulinic acid (product of glycine and succinyl-CoA condensation) into heme A 
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(Barros 2002). Thus a direct role for Yah1p in heme O to heme A conversion was 
demonstrated. The reaction was proposed to involve a first hydroxylation on C-8, 
catalyzed by the three-component monooxygenase Cox15p, Yah1p and Arh1p. The 
subsequently conversion of the alcohol to aldehyde would be catalyzed by a yet 
unknown protein (Barros et al. 2001; Barros et al. 2002). 
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3.1.2 YIR024C Gene: State of Art 
YIR024C gene is located on chromosome nine with a coding sequence of 651bp 
(Churcher et al. 1997). It codes for a verified polypeptide of 216 amino acids with 
theoretical mass of 24.597Da. The protein was localized to mitochondria in high-
throughput analyses (Huh et al. 2003; Sickmann et al. 2003). As no experimental 
evidences on functional role of Yir024cp exist, no GO functional classes are related and 
up to date is still classified as gene product with molecular function and biological 
process unknown. However among several genome-wide screenings performed on 
deletants collection, YIR024C gene was related to mitochondrial biogenesis. It is indeed 
included in the database created by Hess DC and colleagues, already described in 
section 1.1.3. Briefly a complex iterative algorithm was used to predict genes involved in 
mitochondrial function, with subsequent experimental confirmation. Hess DC 
implemented extensive analyses on petites frequency, respiratory growth rate and 
mitochondrial inheritance. Although YIR024C was among the predicted genes, no 
evident phenotypes could be observed in the null mutant (Hess et al. 2009). YIR024C 
was for the first time associated to a mitochondrial phenotype in genome-wide screening 
described in Chapter 1 of this dissertation. As mentioned previously, total results (488 
genes identified as oxidative growth defective) were compared with existing literature. 
YIR024C was initially filtered as already reported in Hess DC screening, but 
subsequently retained as gene with uncharacterized function. Deletion in YIR024C gene 
caused a low sensitive phenotype in ethanol containing media at 30˚C, exacerbated at 
37˚C. Spectra analysis and oxygen consuming revealed a Class A mutant with 
respiratory efficiency of 13%, thus strongly impaired (figure 3.1).  
One interesting aspect in YIR024C limited literature is found among physical interactors. 
Indeed it was found to be a positive match with Adrenodoxin Reductase Homolog 
(Arh1p) in a double hybrid assay. Using Arh1p as bait (fused with DNA binding domain) 
and Yir024Cp as prey (fused with a transactivator domain) authors were able to detect 
reporter activity (Uetz et al. 2000). Although double-hybrid is considered a “non-
physiological” assay especially for mitochondrial proteins, it is widely used and 
represents a solid research approach. 
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FIG 3.1: (a) Cartoon representation of Yir024Cp features. IS import sequence, N n-terminus, TM 
predicted trans-membrane domain. (b) Original phenotype in high-throughput screening at 37˚C 
in YPE media. (c) Cytochromes spectra profile of yir024cΔ strain. Profile was classified as class A 
and respiratory efficiency was 13% of a wild type. 
 
Arh1p along with its functional partner Yah1p, plays an important role in at least two 
essential cellular processes: heme biosynthesis and Fe/S clusters assembly.  
Heme is a prosthetic group widely used in nature, from bacteria to humans with roles not 
only as cofactor in respiratory complexes. Three different forms of mitochondrial heme 
are embedded in respiratory complexes allowing electron transport through 
mitochondrial inner membrane. Moreover it is a versatile molecule used both in yeast 
and human to regulate cellular responses to oxygen availability: yeast Hap1p and 
mammal Bach1 transcription factors activities are regulated by heme and in turn they 
activate or repress nuclear genes (Mense et al. 2006). Fe/S clusters are essential 
prosthetic groups used for redox processes, catalysis and also for structural purposes. 
Many mitochondrial proteins use different forms of clusters, ranging from simple rhombic 
2Fe/2S to complex combination of three and more clusters chemically linked. Synthesis 
of these essential cofactors is carried out in mitochondria but they are also exported to 
be used in the cytosol. Fe/S cluster biosynthesis is in fact one of the mitochondrial 
functions essential for the cell besides respiratory metabolism. Indeed many of the 
genes required for Fe/S cluster biosynthesis are essential for cell viability (Lill et al. 2006; 
Lill 2008). Very recently also a role in coenzyme Q biosynthesis for Arh1p/Yah1p pair 
was characterized (Pierrel et al. 2010).  
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Despite the extensive study of this essential processes some aspects are still not 
completely characterized, moreover in the steps in which Arh1p and Yah1p take part. A 
hypothetical physical interactor could therefore represent an interesting research focus 
although no homologs exist in upper eukaryotes. Therefore a functional characterization 
of YIR024C gene product was undertaken and will be the focus of this chapter. 
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3.2 Results and Discussion 
3.2.1 Confirmation of yir024cΔ Phenotypes 
Coming from a high-throughput analysis, the first step towards a single gene functional 
characterization consists of confirming the originally reported phenotypes. A suitable 
approach includes the transfer of the deletion cassette to a different genetic context and 
retests these phenotypes. In the aforementioned screening, a BY4742 haploid deletants 
collection was used, each carrying a single gene disruption achieved with PCR created 
KanMX4 cassette, coding a resistance determinant for geneticin (G418). Although this 
collection was widely used in genomic-wide screenings focused on mitochondrial 
biogenesis, the BY4742 genetic bacgkround is not ideal for mitochondrial studies. This 
background carries a mutant allele for the HAP1 gene, coding for a transcription factor 
essential for gene regulation in response to oxygen and heme levels (Mortimer et al. 
1986). For this reason, the YIR024C::KanMX4 cassette was amplified from BY4742 
yir024cΔ and transferred to the W303 genetic context. The cassette was PCR-amplified 
from a genomic DNA preparation by using two external primers (FWYIR024c and 
RVYIR024c, sequences reported in Appendix 6). Identity of amplification product was 
granted with a restriction enzyme digestion control as KanMX4 harbors a unique HindIII 
restriction site. A wild-type W303-1B strain was transformed with 1µg of purified 
YIR024C::KanMx4 and transformants selected on media containing geneticin. Twenty 
independent clones were patched on selective media and on five random additional 
controls were performed. Integration at the correct locus was checked with a PCR 
strategy. Using an additional upstream forward primer specific for YIR024C locus 
(A1YIR024c) and a reverse primer internal to the KanMX4 gene (K3), an amplification 
product could be obtained only if the disruption cassette was at the correct locus. This 
was confirmed in four out of five strains. Eventually, a W3031b YIR024c::KanMX4 strain 
was obtained and used for all the further analysis that will be described below. This 
approach granted the correct profile of the new deletant strain and at the same time the 
identity of original BY4742 deletant strain present in the collection thus confirming that 
yir024cΔ was responsible for the observed phenotypes. 
Respiratory growth in spot assay, cytochrome spectra and oxygen consumption were 
analyzed in W303 yir024cΔ. As showed in figure 3.2 all the original phenotypes were 
confirmed. The analysis was extended to 30˚C for cytochromes spectra and oxygen 
consumption. The same protocols, reported in sections 4.2.3 and 4.2.4 were used 
(Ferrero et al. 1981). Generally, defects were observed on complete media only at 37˚C, 
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as expected. Indeed cytochrome profile was scored as class A, although wild-type W30-
1B in the same condition was altered to a certain extent in comparison with the results 
obtained at 30oC. The absence of cytochromes in the yir024cΔ mutant at 37oC was 
consistent with a reduction in oxygen consumption efficiency that was of 15% of wild-
type. Conversely, on complete media at 30˚C no such defects were observed. 
Cytochromes were indeed classified as D profile with respiratory efficiency of 85% at 
30˚C. To analyze respiratory growth, we performed a serial dilutions growth test in both 
complete and synthetic minimum media at 30 and 37˚C. As expected from original 
phenotypes (low sensitive in complete media at 30˚C and 37˚C) in complete media, only 
a slightly deficient phenotype was observed at 30˚C, which was exacerbated at 37˚C. 
This is a controversial aspect among yir024cΔ phenotypes as cytochrome spectra and 
oxygen consuming in the same condition would suggest more evident defects. If 
respiratory growth is analyzed in a minimum synthetic media, phenotypes are strongly 
exacerbated with almost total impairment at 30˚C too. 
 
 
 
FIG 3.2: (a) Cytochromes spectra profile recorded on whole cells after growth in complete media. 
Analysis was carried out at both 30 and 37˚C. (b) Spot assay of serial dilutions in complete YP or 
synthetic minimal (Wo). Plates were incubated at indicated temperatures for 3 days 
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Trying to explore the controversial aspect of yir024cΔ phenotypes, cytochrome content 
was analyzed directly on isolated mitochondria to allow a more sensitive analysis. 
Mitochondria with intact outer membrane were isolated from yir024cΔ and wild-type 
strains grown in complete media containing galactose at 30 and 37˚C (see section 
4.3.1). Total cytochromes were extracted and analyzed spectrophotometrically as 
described in section 4.3.3 (Ferrero et al. 1981). As shown in figure 3.3, no evident 
defects were observed at 30˚C, as expected. Cytochrome spectra profile at 37˚C on 
purified mitochondria displayed strong defects in cyt b and a shift in absorbance peak for 
cyt aa3 (COX). Absorbance of complex IV depends on the coordinated heme A prosthetic 
group that in COX environment shows a maximum at λ of 603nm. The observed 
absorbance shift is indicative of heme A absorption in a non-native environment, already 
shown in other mutants such as cyc3Δ, lacking the cyt c heme lyase (Barros et al. 2002). 
Interestingly, the profile observed on purified mitochondria is quite different from the one 
recorded on whole cells. This profile is in better agreement with the observed growth 
defect and it is still in accordance with a very low efficiency in oxygen consuming. Indeed 
qualitative and quantitative defects were recorded for cyt b and cyt aa3.  
 
 
 
FIG 3.3: Cytochrome spectra profile recorded on isolated mitochondria. An equivalent of 2.5mg of 
mitochondrial proteins were used.  
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Following the confirmation of the original phenotypes also in W303 genetic context we 
have established that YIR024C gene product plays a role in some uncharacterized 
aspect of mitochondrial biogenesis. A better functional characterization of mitochondrial 
phenotypes and extensive biochemical analyses of the gene product were undertaken 
as described below. 
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3.2.2 Yir024cΔ Harbors Several Mitochondrial Respiratory Chain 
Defects 
In order to obtain a comprehensive characterization of defects in mitochondrial 
respiratory chain (MRC) of a yir024cΔ strain, we performed an extensive biochemical 
analysis of respiratory complexes. Mitochondria with intact outer membrane were 
isolated from yir024cΔ and wild type strains grown at 30 and 37˚C in complete media 
supplemented with galactose. An equivalent of 40µg of mitochondrial proteins were 
resolved in 12% SDS-page and transferred to nitrocellulose membrane, as described in 
section 4.1.8. Membranes were immuno-decorated with primary antibodies against 
following MRC proteins: Cox1p, Cox2p, Cox3p, Cox4p, Cytb, Rip1p, Cytc, Sdh1p and 
βATPase for complex V. Results are shown in figure 3.4. 
Among the tested subunits of complex IV, the steady state levels of Cox1p, Cox2p and 
Cox3p were substantially affected in yir024cΔ at 37˚C. Interestingly these three subunits 
are mitochondrial DNA-encoded and form the catalytic core of the enzyme, which is 
unstable in the absence of holoenzyme assembly. No decrease was observed in Cox4p 
steady state level at 37˚C, although both strains show defects compared to the 
counterparts at 30˚C. The substantial decrease of Cox1p, common to all bona fide COX 
mutants, could also explain the peak shift observed in cytochromes profile. Probably the 
heme A environment is changed thus affecting its coordination and absorbance 
properties (Barros et al. 2002).  
Also complex III was found affected at 37˚C, with a marked decrease in Cytb in yir024Δ 
at 37˚C. Conversely, for rieske-protein Rip1p (ubiquinol-cytochrome-c reductase), Cytc 
and βATPase no changes in steady state levels were detected. Complex II behavior was 
initially unexpected: Sdh1p subunit appeared substantially increased in yir024cΔ strain 
at 37˚C. To further address this phenotype the level of fully assembled complex II was 
assessed. An equivalent of 200µg of mitochondrial proteins were resolved in one 
dimension BN-page as described elsewhere (Cruciat et al. 2000), western blot and 
immune-decoration using antibody against Sdh2p were then performed. As shown in 
figure 3.4 panel b, the level of fully assembled complex was totally comparable in all the 
conditions. Furthermore the steady state level of Sdh2p subunit in SDS-page was 
constant and no changes in SDH specific enzymatic activity could be recorded (data not 
shown). Therefore, it can be concluded that the detected increase in Sdh1p subunit in 
yir024cΔ at 37˚C might be an unpecific event. 
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Enzymatic activities of Complex IV (COX) and ComplexIII+NADH dehydrogenase 
(NCCR) were recorded on isolated mitochondria at 30 and 37˚C (see sections 4.3.4 and 
4.3.6). COX and NCCR specific activities at 37˚C were reduced of about 80% and 50% 
respectively. Conversely, no defects were observed on mitochondria isolated after 
growth at 30˚C. This is in general accordance with observed steady state levels of MRC 
chain subunits. 
. 
 
 
 
FIG 3.4: (a) 40µg of mitochondrial proteins were resolved in 12% SDS-page. Western blot were 
immune-decorated with primary antibodies against indicated proteins. Suitable secondary 
antibodies and ECL based chemistry were used for developing. Porin was used as loading 
control. (b) 200µg of mitochondrial proteins were analyzed is 1D BN-page and fully assembled 
complex II was visualized with antibody against Sdh2p. SDS-page and western blot with antibody 
against Sdh2p was also included. (c) COX and NCCR enzymatic activities recorded on 
mitochondria isolated from cells grown at 37˚C. Three replicates for each sample were assayed 
and mean values considered. Wild type activity is considered as 100% 
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In summary, deletion in YIR024C gene causes several MRC defects. Mitochondrial 
encoded subunits of complex IV (Cox1p, Cox2p and Cox3p) were markedly decreased 
at 37˚C, with a concomitant reduction of enzymatic specific activity to 20% of wild type. 
Complex III was similarly affected with evident diminution in Cytb steady state level and 
NCCR activity reduction to 50% of the wild type. All the performed assays used 
mitochondria isolated from cells grown in complete media supplemented with galactose 
and results are in general accordance with the physiological analyses described 
previouslyThe interesting aspect of Yir024cp physical interaction with Arh1p suggested 
that some defects in heme metabolism could also be present. Therefore, 2mg of total 
mitochondrial proteins isolated at 30˚C and 37˚C were used for HPLC analysis of total 
heme content (see section 4.3.7) and results are shown in figure 3.5. In strain harboring 
YIR024C deletion defects in heme metabolism could be observed at 37˚C, compared to 
a wild type strain. As expected no such changes were detected at 30˚C (data not 
shown).  
Specific enzymatic defects in heme biosynthesis can be postulated from profiles of total 
mitochondrial heme resolved in C18 reverse phase HPLC in acetonitrile gradient (Barros 
et al. 2001). For instance a cox10Δ strain has neither heme A nor heme O, but a normal 
level of heme B (Tzagoloff et al. 1993). Cox15Δ and yah1Δ instead accumulate (to 
different extents) heme O with no detectable levels of heme A. Defects in different steps 
can be postulated observing accumulation in different mitochondrial heme species and 
was the principal observation used to propose the enzymatic roles of Cox10p, Cox15p 
and Yah1p. In yir024cΔ strain no specific changes in A and O ratios were observed at 
37˚C thus no specific enzymatic defects in the steps involving heme B to Heme A 
conversion could be postulated. Nevertheless, in the mutant all the three species of 
heme were about half of the wild-type counterpart. In particular, a lower content of heme 
B could cause the corresponding decrease in heme A and heme O. Thus if a direct role 
of Yir024cp in heme biosynthesis exists it is likely played in a different step then 
biosynthesis of heme A starting from heme B or heme O. For instance it could be 
involved in the conversion of porphyrin ring to heme B in mitochondria. 
The role of YIR024C gene in heme metabolism remains still unclear and requires further 
investigations. 
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FIG 3.5: HPLC analysis of total heme content on 2mg of mitochondrial proteins as described 
previously (Barros et al. 2001). Mitochondria were isolated at 37˚C. Heme A and O are shown in 
the upper panel with retention time of about 26-27 min and 30-31 min respectively. Heme B 
profile is shown in the lower panel with retention time of about 11 minutes  
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3.2.3 Yir024cp-3HA Localizes to Mitochondrial Inner Membrane and 
Faces the IMS 
To better understand the functional role of Yir024cp in mitochondria, we created a strain 
expressing an epitope tagged version of the protein. From wild type W303 genomic DNA 
YIR024C gene was amplified using the primers Y024CFWBam and Y024CHA3RVPst 
(sequences reported in Appendix 6). The former was designed to create a BamHI 
restriction site and the latter to introduce a triple Hemagglutinin tag (3HA) in frame with 
the coding sequence along with a PstI restriction site. The expected product of 1350bp 
was purified and cloned as BamHI-PstI in YIplac211 integrative vector. The construct 
YIplac211-YIR024C3HA was then sequenced to confirm the correct in frame tagging. 
The shuttle vector YIplac211 harbors TRP1 gene as selectable marker that can be used 
to direct a locus specific integration in S. cerevisiae (Rothstein 1983). Using the unique 
AarI restriction site in TRP1 gene the construct was linearized and used to transform 
yir024cΔ strain. Selection of YIR024C::KanMX4 trp1-1::YIplac211-YIR024C3HA strain 
was performed on minimum media without Trp. Complementation of YIR024C deletion 
phenotype by tagged version of the protein was confirmed by a serial dilutions growth 
test on minimum media with Gly (data not shown). Additionally, the presence of HA-tag 
was confirmed in SDS-page on total cellular extracts followed by western blot and 
immuno-detection using an antibody against HA. HA signal was detected at expected 
size of about 30 kDa (data not shown). Total cellular extracts were obtained as 
described in 4.2.6. 
All existing Yir024cp localization data published so far were obtained with high-
throughput approaches and therefore the subcellular localization was experimentally 
tested using the strain expressing the HA-tagged Yir024c protein. Equivalent of 40µg of 
purified mitochondrial proteins and post mitochondrial supernatant (PMS, cytoplasmic 
fraction) of Yir024cp3HA expressing strain were resolved in 12% SDS-page followed by 
western blot. The membranes were probed with an antibody against HA and as 
cytoplasmic and mitochondrial controls Pgk1p and Cox2p. Cox2p was localized in 
mitochondrial fraction and Pgk1p mostly in PMS. Also mitochondrial fraction was positive 
to Pgk1p detection indicating some cytoplasmic contamination. Nevertheless being the 
HA signal exclusively mitochondrial the subcellular localization of Yir024cp3HA was 
confirmed (fig 3.6 panel a). 
Although mitochondrial localization was expected from previous results and phenotypes 
observed, no data existed on sub-mitochondrial localization and topology of the protein. 
 102 
Sub-localization of a protein in mitochondrial compartments can be determined from its 
solubility after sonication and extraction under alkaline conditions as described in 4.3.9. 
Mitochondria for a total of 200µg proteins were sonicated to allow separation of 
mitochondrial soluble proteins (S) from membrane fraction proteins. Carbonate 
extraction of membrane fraction is used to achieve further separation of integral in 
membrane (CP) and membrane-associated proteins (CS). Equivalents of 40µg for each 
fraction were resolved in SDS-page followed by western blot and immune detection (fig 
3.6 panel b). Soluble proteins such as Cytb2 were predominant in S fraction and 
conversely Cox2p, which has several transmembrane domains, exclusively in the CP 
fraction. Mss51p is known to be a peripheral protein of the mitochondrial inner 
membrane (Siep et al. 2000) and it is usually enriched in CS fraction compared to S. 
Same fractions were probed with antibody against HA and signal was exclusively 
revealed in CP fraction. Yir024Cp3HA is indeed a mitochondrial integral membrane 
protein. Its presence in the membrane fraction is in accordance with the predicted N-
terminal trans-membrane domain of 20 amino acids. Treatment of mitochondria and 
mitoplasts obtained by hypotonic swelling with proteinase K can give hints in proteins 
topology. Indeed a matrix protein is protected from proteinase digestion in both 
mitochondria and mitoplasts. A protein residing or facing the IMS is instead digested 
when outer membrane is disrupted by hypotonic swelling, but protected in intact 
mitochondria. Yir024cp3HA behavior was comparable to that of Cmc2p, an IMS protein, 
and Cox2p a protein facing the matrix. As shown in figure 3.6 panel c, like Cmc2p HA 
was detected only when outer membrane was intact. Taken together, these results 
indicate that Yir024cp is a mitochondrial integral membrane protein that faces the IMS. 
Moreover, it can be postulated that Yir024cp is inserted in the mitochondrial inner 
membrane and not in the outer membrane. Indeed the position of the unique predicted 
hydrophobic trans-membrane leaves only a short N-terminal portion on one side, and the 
major C-terminal with HA tag on the other. With this topology if Yir024cp had been in the 
outer membrane it would not have been protected in intact mitochondria. 
Given that only twenty amino acids would be residing in the mitochondrial matrix, 
justifying a physical interaction between Yir024cp and Arh1p, a soluble protein of the 
mitochondrial matrix, become challenging. However this cannot be excluded and 
therefore native size determination and co-immunoprecipitation studies were undertaken 
to determine whether Yir024cp resides in a complex and if it contains or not the 
predicted interactor Arh1p.  
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FIG 3.6: Localization and topology analysis of Yir024cp3HA protein. (a) Mitochondrial proteins 
(MT) and post mitochondrial supernatant (PMS) were isolated as described in 4.3.1. (b) 200µg of 
mitochondrial protein were subjected to sonic irradiation as described in 4.3.9 to separate soluble 
proteins (S) from membrane fraction. Alkaline treatment of membrane fraction allowed separation 
of membrane bound proteins (CS) and integral membrane proteins (CP). (c) Mitochondria and 
mitoplasts obtained by hypotonic swelling were treated with proteinase K as described in 4.3.8. 
(d) Cartoon representing topology of Yir024cp. A small N-terminus of 20aa is the mitochondrial 
matrix and the remaining globular part faces intermembrane space (IMS). 
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3.2.4 Yir024cp-3HA Resides in a 250Kda Complex without Arh1p 
Determination of native size is a very indicative analysis of physiological protein state. 
Indeed in denaturing conditions of SDS-page destroy all the physical interactions and is 
not possible to determine if a protein is physiologically in mono or oligomeric forms and if 
it normally forms a complex. Sedimentation properties of a protein in a density gradient 
are indicators of its native size. To perform this kind of analysis it is necessary to extract 
the protein in native conditions from isolated mitochondria. Extraction conditions are a 
crucial parameter: strong detergents efficiently solubilize proteins but also disrupt 
physical interactions among partners. Thus, it is necessary to start by finding the mildest 
extraction conditions that are able to solubilize most of the protein. Key components of 
the extraction buffer are type and concentration of detergent and salt concentration. 
Different detergents have different properties and each protein needs a unique condition 
for efficient solubilization. Salt increases in a dose-dependent fashion the efficiency but 
also impairs ionic interactions among proteins, being then able to disrupt complexes. To 
test the extraction conditions, 50µg of mitochondrial proteins from Yir024cp3HA 
expressing strain were treated with different detergents and KCl concentration as 
described in section 4.3.10. After a clarification step with high-speed centrifugation, 
solubilized proteins are found in the supernatant fraction (S) and retained proteins in 
pellet (P). Equivalent amounts of S and P fraction were loaded and resolved in SDS-
page followed by western blot and immune-detection with antibody against HA epitope 
and results are shown in figure 3.7. At least 90% of Yir024cp3HA was efficiently 
solubilized with lauryl-maltoside at 0.5%. KCl addition showed no efficiency increase. 
These conditions were used in all subsequent analyses. 
 
 
FIG 3.7: Selection of extraction conditions tested. 50µg of protein were treated with indicated 
conditions. Digitonin, lauryl-maltoside and triton X100 were tested with or without KCl 150mM. 
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Sedimentation properties of Yir024cp3HA were assessed in a linear 7-20% sucrose 
gradient and compared with those of known markers used to calibrate the gradient 
(LDH=130Kda and Hemoglobin=67Kda). Mitochondrial extracts were solubilized with 
0.5% digitonin and gradient was performed as described in 4.3.11 with 12hrs 
centrifugation at 28000rpm, 4˚C. Fractions were recovered and Yir024cp3HA distribution 
assayed by western blot with antibodies against HA epitope. Estimated native molecular 
weight was calculated as 250Kda suggesting that it relies in a complex across the inner 
mitochondrial membrane. To address whether Arh1p is a physical interactor residing in 
this complex, the same fractions were assayed with Arh1p antibody provided by Dr. 
Alexander Tzagoloff (Manzella et al. 1998). As shown in figure 3.8, no evident co-
localization of the two signals was observed suggesting that in these conditions Arh1p is 
not part of the complex. However, weak signals showed co-localization is heavy weight 
fractions, indicating that a possible not predominant, labile or transient interaction could 
exist. Being most of the phenotypes observed at high temperature it was reasoned that 
interaction of the two proteins could exist only under thermal stress. Mitochondria from 
Yir024cp3HA expressing strain were isolated after growth at 37˚C and sedimentation 
properties tested in the same conditions, however no co-localization was observed and 
the native size of Yir024cp3HA was still of 250Kda. This led to the conclusion that Arh1p 
is not residing in the same complex than Yir024cp3HA. The Y2H assay results reported 
by Huh and colleagues could thus be a false positive; alternative, the interaction could 
just be transient. To be sure of this conclusion a final confirmation was obtained with co-
immunoprecipitation analysis (CoIP) performed as described in 4.3.12. Equivalent of 
4mg of mitochondrial proteins were solubilized with 0.5% digitonin and incubated with 
agarose-HA affinity matrix to retain Yir024cp3HA and physical interactors. Unbound 
material was recovered and matrix washed prior final elution with SDS-page loading 
buffer. Retained proteins and unbound material were resolved in SDS-page and assayed 
with western blot using antibodies against HA, Arh1p and also Yah1p, provided by Dr. 
Mario Barros (Barros et al. 1999). As shown in figure 3.8, Yir024cp3HA was absorbed in 
the matrix with efficiency of at least 90% but Arh1p and Yah1p signals were exclusively 
in the unbound fraction. At this point a simple model of physical interaction between the 
short N terminal matrix domain of Yir024cp and Arh1p has to be excluded. Still a 
transient and very unstable interaction not detectable in the conditions used might exist. 
For instance the 250Kda complex were Yir024cp resides, working like a scaffold, could 
bridge this interaction. However is unlikely that the same complex could have mediated 
the interaction also in the nuclear environment in which the Y2H assay is performed. 
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Although Yir024cp is not a physical interactor of Arh1p, its role remains unclear and 
interesting. Indeed it has an uncommon topology in the mitochondrial compartments, 
with a small N terminal of 20 amino acids exposed to the mitochondrial matrix and a big 
globular domain of 152 amino acids in the IMS. Not many proteins are known to share 
this kind of topology. Some of those are involved in different steps of complex IV 
maturation like Sco1p, Cox11p, Pet100p and Pet191p or complex III like Bca1p (Glerum 
et al. 1996; Forsha et al. 2001; Carr et al. 2005; Khalimonchuk et al. 2008; Mathieu et al. 
2011). A defect in such processes could explain the observed phenotypes of yir024cΔ 
FIG 3.8: (a,b) Sedimentation properties of Yir024cp3HA 
and Arh1p. Linear density gradients ranging from 20 to 
7% were performed and calibrated with Hemoglobin 
(67Kda) and LDH (130Kda). Fractions were assayed with 
western blot using indicated antibodies. (c) Co-
immunoprecipitation performed on 4mg of mitochondrial 
proteins extracted from Yir024cp3HA expressing strain. 
Bound fraction and supernatant were assayed with 
antibodies against HA, Arh1p and Yah1p. Cytb2, Sco1p 
and Cox4p antibodies were used as control for eventual  
non specific immunoprecipitation. 
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that could therefore represent an ancillary assembly factor for respiratory complexes. 
Some others proteins with same topology are involved in mitochondrial morphology, as 
Fmp30p (Kuroda et al. 2011), or inner membrane organization. Strikingly three 
independent studies, published within few days in October 2011, completely 
characterized the same six protein complex of mitochondrial inner membrane needed for 
cristae organization (named MICOS, MINOS and MitOS). The complex contained 
Mitofillin/Fcj1 plus Aim5p, Aim37p, Aim13p, Mos1p and Mos2p. All these proteins except 
Aim13p and Mos2p were demonstrated to share the same topology of Yir024cp3HA 
(Harner et al. 2011; Hoppins et al. 2011; von der Malsburg et al. 2011). None of these 
approaches identified Yir024cp as a component of this complex but would be interesting 
to analyze mitochondrial morphology in yir024cΔ looking for cristae defects or other 
morphological phenotypes. It is indeed known that defects in cristae formation can cause 
respiratory deficiency like in mutants of the aforementioned complex. Also, it would be 
interesting to understand if Yir024cp function resides in its localization anchored to the 
inner membrane. To address this point a strain expressing only the globular domain 
along with an import sequence should be created and phenotypes compared with those 
of the mutant strain. 
Certainly, one of the most direct ways to shed light into functional role of this protein in 
the inner membrane is to characterize the complex in which it resides. In order to do that 
the 250Kda complex was purified. Six linear 7-20% sucrose gradients were prepared for 
a total of 24mg of mitochondrial proteins treated and all the corresponding fractions were 
pooled together and assayed with western blot. The three fractions with most intense HA 
signal were used as starting material for a co-immunoprecipitation with agarose-HA 
affinity matrix. The final elution was successfully achieved with SDS loading buffer. Elute 
was loaded in 12% SDS-page and protein bands were stained with Coomassie blue. 
Different bands with a molecular weight of about 60-70Kda were identified. Some bands 
were cut from the gel and submitted to mass-spectrometry analysis. Identification of 
250Kda complex partners should give precise hints in the function of this 
uncharacterized protein. Unfortunately no proteins were identified in the bands we sent 
for sequencing, but only background interference. This analysis should be repeated with 
large amounts of starting material. 
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4.1 Miscellanea 
4.1.1 Strains used 
NAME GENOTYPE REF 
BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 (Brachmann et al. 1998) 
BY4739 MATα leu2Δ0 lys2Δ0 ura3Δ0 (Brachmann et al. 1998) 
W303-1a MATa leu2-3112 trp1-1 can1-100 ura3-1 ade2-1 his3-
11,15 
(Brachmann et al. 1998) 
W303-1b MATα leu2-3112 trp1-1 can1-100 ura3-1 ade2-1 his3-
11,15 
(Brachmann et al. 1998) 
elp3Δ BY4742 elp3::KANMX4 (Giaever et al. 2002) 
trm9Δ BY4742 trm9::KANMX4 (Giaever et al. 2002) 
ncs6Δ BY4742 ncs6::KANMX4 (Giaever et al. 2002) 
yir024cΔ BY4742 yir024c::KANMX4 (Giaever et al. 2002) 
yir024cΔ W303-1b yir024c::KANMX4 this study 
yir024c3HA W303-1b yir024c::KANMX4 ura3-1::YIR024C3HA this study 
 
To perform the genome-wide screening the S. cerevisiae Genome Deletion Project 
collection was used (Giaever et al. 2002). It was purchased from Open Biosystems 
(Huntsville, AL) and rearranged in 13 24x16 plates, each with eight empty fixed positions 
as contaminations control. One copy of each 384 plate is maintained in liquid medium 
YPD 15% glycerol (see above for composition) at -80˚C as stab culture. 
As bacterial system the strain DH10B (Brachmann et al. 1998) was used. 
4.1.2 Media and growth conditions 
For yeast the following media were used: YP (1% peptone, 0.5% yeast extract), YPA 
(2% peptone, 1% yeast extract, 7.5mg/ml adenine), YNB (YNB ForMedium™ w/o 
aminoacids w/o NH4SO4 1,9 g/L, NH4SO4 5 g/L). Minimum media was enriched with 
drop-out powder (Kaiser et al. 1994). If necessary singles aminoacids could be excluded 
from complete drop-out to maintain selective pressure. As solidifying agent agar 
ForMedium™ 2% was added. 
Carbon sources were added at final concentration of 2% if not specified differently. The 
following sources were used: Glucose (D), Ethanol (E), Glycerol (G), Potassium Acetate 
(KAc), Lactate (L).  
S. cerevisiae was cultured at 30˚C, in constant shacking 120 rpm if liquid media was 
used. To induce heat stress, cultures were incubated at 37˚C in thermostat or water 
bath. 
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For E. coli LB media was used (1% bacto tryptone Difco™, 0.5% yeast extract Difco™, 
0.5% NaCl, pH 7.2-7.5). Agar 2% and ampicillin (Sigma-Aldrich®) 100mg/ml were added 
if needed. For α-complementation selection 80µl of 5-bromo-4-chloro-3-indolyl-b-D-
galactopyranoside (Xgal) 2% (dissolved in dimethilformamide) and 40µl isopropyl-beta-
D-thiogalactopyranoside (IPTG) 23,8 mg/ml were added. Cultures were incubated at 
37˚C in constant shacking if necessary. 
4.1.3 Nucleic Acids manipulation 
All the manipulations were carried out with standard techniques (Maniatis et al. 1982). 
Plasmid DNA was extracted from E. coli with Wizard® Plus SV Minipreps, Wizard® Plus 
Minipreps (©Promega) or following standard procedures (Maniatis et al. 1982). DNA 
recovery from agarose gel and purification of PCR products were carried out with 
Wizard® SV Gel and PCR Clean-up System (©Promega) commercial kit. 
Genomic DNA from S. cerevisiae was extracted as previously described (Hoffman et al. 
1987; Looke et al. 2011).  
Enzymatic manipulations (restriction, ligation, dephosphorylation) were carried out 
following manufacturer indications (New England Biolabs® Inc. NEB, Invitrogen™). 
Sequencing was performed with external services (©Eurofins-MWG for Europe, 
Genewiz® Inc. for United States). 
4.1.4 E. coli transformation 
E. coli transformation was achieved with electroporation. Competent cells were prepared 
as previously described (Dower et al. 1988). Transformation was carried out with 1-3µl of 
plasmid DNA or ligation product. One mm or 2 mm cuvettes were used, applying 
respectively a current of 1.75KV, 25 F 200  or 2KV, 25 F 200 . 
Alternatively, CaCl2 competent cells were prepared and transformed with standard 
techniques (Maniatis et al. 1982). 
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4.1.5 S. cerevisiae transformation 
Yeast transformation was carried out with Lithium Acetate (LiAc) as described by Gietz 
et al. If a greater efficiency was desired, the long protocol was applied (Gietz et al. 
2002). 
For the one-step gene disruption and episomic plasmids integration (Rothstein 1983) the 
protocol used was modified from Schiestl et al. method (Schiestl et al. 1989) and 
performed as follows: 
1. Inoculate strain to be transformed in 10ml YPD and grow o/n at 30˚C 
2. Inoculate from overnight batch into fresh 10ml YPD to OD600 of about 0.1 
3. Grow cells at 30˚C until OD600 reaches 0.6 to 1 
4. Harvest 1ml of culture centrifuging 2000-3000rpm for 1-2 minutes. Resuspend in 1ml 
of TEL solution and centrifuge 2000-3000rpm for 5 minutes. 
 TEL solution:  10mM TrisHCl pH 7.5 
    1mM EDTA pH 8 
    0.1M LiAc 
5. Resuspend pellet in 0.1ml TEL and transfer to a clean sterile eppendorf tube. Add 
transforming DNA (1-10µg) and 5µl of 10mg/ml salmon sperm DNA solution 
(previously denatured for 5 minutes at 95˚C and cooled 2 minutes on ice). Mix and 
incubate 30 minutes at room temperature without shacking 
6. Add 0.7ml of 40% PEG4000 in TEL buffer and mix by pipetting. Incubate 45-60 
minutes at room temperature without shacking 
7. Heat shock at 42˚C for 10 minutes and incubate on ice 2-5 minutes 
8. Pellet for 1 minute and wash once in 0.2ml of TE (10mM TrisHCl pH 7.5, 1mM EDTA 
pH 8). Pellet again for 1 minute ad resuspend in 100µl of sterile water. Plate on 
selective medium. 
4.1.6 Polymerase Chain Reaction 
All the reactions were performed following manufacturer indications. For analytical 
purpose Taq DNA polymerase 2X master mix (NEB) or GoTaq® DNA polymerase 
(©Promega) were used. Preparative reactions (for gene cloning, cassette transfer, 
sequencing) were performed with a high fidelity polymerase. KOD HiFi DNA polymerase 
was used (Novagen®). 
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4.1.7 Protein separation with SDS-page  
Protein separation with SDS-page was performed with classical Laemmli system 
(Laemmli 1970). Separating gels were prepared at 12% polyacrylamide (30:0.8 
acrylamide-bis), stacking gel at 6%. Running was performed for 1hr 30’ at 100-120volts. 
4.1.8 Western Blotting and Ig-detection 
Separated proteins were transferred to nitrocellulose membrane by electroblot for 1hr 15’ 
at 200mA. Semi-dry blotting system was used. Quality of the blot was assessed with 
Ponceau S staining. 
 Transfer Buffer:  200mM glycine 
     25 mM Tris 
     20% methanol 
Membranes were blocked 1hr with 5% non-fat dry milk prepared in washing buffer and 
incubated o/n with appropriate primary antibody (mono or polyclonal). 
 Washing Buffer:   TBS 1%  
     tween 0.1% 
Blocked membranes were washed 2 times 15 min with washing buffer prior incubation 
with suitable secondary antibodies, conjugated with horseradish peroxidase (1:10000 in 
5% milk if anti rabbit Ig, 1.5% milk if anti mouse). After 1hr incubation membranes were 
washed as above and developed with ECL based immune revelation. If greater 
sensitivity was necessary SuperSignal West Femto or Pico commercial kits were 
implemented (© Thermo Scientific).  
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4.2 Whole Cell Analysis 
4.2.1 Growth Analysis of BY4742 Knock Out Collection (primary 
screening) 
To perform genome-wide growth analysis a pin-replica strategy was used. A multi-blot 
replicator VP384S2A (V&P Scientific, Inc.) and a semiautomatic device (designed and 
built in c/o Department of Genetics, University of Parma) were used (Fig 4.1). All 
replication steps were carried out under sterile hood flux. 
 
 
Each 384-well format plate of the knock out collection (See Strains section) is 
maintained at -80˚C as stab culture. To work on fresh cells a first replica from stab 
culture to solid media was performed as follows: 
 The multi-blot replicator is sterilized washing sequentially in bleach 10% (no more 
than 30’’), twice in sterile water and finally in propan-2-ol (Sigma-Aldrich®) for 1 
minute. The replicator is left hanging for five minutes to let the propanol dry. 
Between each wash replicator pins are dried on a piece of blotting paper. Using 
the up/down mechanism of semiautomatic device the replicator pins are dipped 
in the thawed stab and subsequently printed on a fresh YPD medium plus 
200µg/ml G418 plate. The new 384-well plate is incubated at 30˚C for 48hrs. 
For growth analysis each collection plate was used to create new plates for conditions of 
interest (different media or growth temperature): 
 Sterile replicator is used to pick up cells from a fresh plate prepared from stab 
culture as described. Before printing a new agar plate is necessary to dilute and 
normalize the number of cells on every pin. To this purpose the replicator is 
FIG. 4.1: instrumentation used in 
the primary screening. (a) 
semiautomatic device. (b) 384 
pins multi-blot replicator 
VP384S2A. (c) replicator inserted 
in the device with up/down 
mechanism. 
a c b 
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dipped up/down 20 times in a 384-well plate, each well filled with 70µl of sterile 
water. Afterward a new plate is printed and incubated in condition of interest (for 
instance 37˚C). After 48hrs a picture is taken of every plate and semi-quantitative 
growth scores are attributed to each clone, comparing to opportune controls. 
4.2.2 Serial Dilution Growth Test (Spot Assay) 
Spot assay is a classical phenotypic analysis used to test growth of single strains in 
different condition. The principle is a 10-fold serial dilution from a starting culture at 
1*10e7 cells/ml, performed then three or four times. From these suspensions a fixed 
volume is spotted in ordered rows on agar plates then incubated for at least 48hrs. 
Spot assay was used as secondary screening during high-throughput analysis. A total 
number of 16 strains (14 null mutants plus WT and ρ0) were managed in a single 
experiment. The first column and the seventh of a 96-well plate were filled with 150µl of 
YPD and strains inoculated with sterile toothpick. After incubation at 30˚C o/n the OD600 
was measured for each strain. The second column was used to dilute each strain to a 
concentration of 1 OD (1*10e7). Other 4 columns were used for four 10-fold serial 
dilutions, using a multichannel pipette. From each column 4µl were spotted in YPD and 
YPE plates, in conditions resembling the primary screening. 
Comparing to WT and ρ0 ones strains were classified as low sensitive (LS), medium 
sensitive (MS) or high sensitive (HS), as shown in Fig. 4.2.  
 
  
Spot assay was performed using the same principles for single strains. Dilutions were 
carried out in eppendorf tubes and 10 or 5µl of suspensions were spotted in ordered 
rows on agar plates in conditions of interest. After 48 or 72hrs images of the plates were 
taken. 
 
HS 
LS 
MS 
10E4 10E3 10E2 10E1 10E0 
wt 
ρ
0
 
cells 4x Fig. 4.2. Examples of spot assay of serial dilutions ranging 
from 4*10e4 to 4*10
 
cells.  
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4.2.3 Cytochromes Spectra Absorption 
Mitochondrial respiratory chain intactness can be assessed recording the cytochromes 
absorption profile on whole cells. All the experiments were carried out with a Cary 
300Scan UV-vis spectrophotometer (Varian Inc.), recording continuously from 630 to 
540nm. The following general protocol was used: 
1. Strains are pre inoculated in 10ml YPD plus G418 200µg/ml and incubated o/n 30˚C 
2. Inoculate 2.5ml in 150ml of YPD 0.6% and incubate 24hrs at 37˚C 
3. After checking that glucose is finished (to be sure that any repression is affecting the 
cells) harvest cells centrifuging 5000rpm 10 minutes, 4˚C 
4. Resuspend in water proportionally to the cells humid wet (to normalize concentration 
among different strains) 
5. Register the spectra oxidized versus reduced. 
Raw data were processed using Excel functions (Microsoft® Office). WT strain was 
included in each analysis. 
4.2.4 Oxygen Consumption 
Oxygen consumption was recorded using Oxygraph system from Hansatech, composed 
of a S1 Clark electrode core controlled with Oxygraph Plus software (Hansatech 
Instruments Ltd.). 
Cells were obtained as described for cytochromes spectra recording. One hundred µl 
were added to 900µl of K-ftalate 0.1M pH5 in the chamber. Oxygen decrease was 
recorded for at least 1 minute. 
Five hundred µl of cell suspension were exsiccated at 37˚C for 48hrs and dry wet 
estimated. Absolute oxygen consumption rate was expressed as nmol O2 for minute for 
mg of cells (nmol/min mg). 
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4.2.5 In Vivo Labeling of Mitochondrial Products with 35S-met 
1. Grow strains on YP Gal plates and inoculate at very low concentration in 10ml of 
synthetic minimum media with galactose and auxotrophic requirements. This step 
can also be performed in YP Gal media. Grow until OD600 is 0.6 – 2 maximum. 
2. Harvest equivalent of 0.6 OD in eppendorf tube. Centrifuge 1 minute 6000-8000rpm 
3. Wash the pellet with 500µl of 40mM phosphate pH 6, galactose 2% (Important: 
repeat twice this step if cells were grown in complete media to eliminate any residual 
methionine). Resuspend cells in 500µl of the same buffer 
4. Add 10µl of freshly prepared cycloheximide (10mg/ml in water), mix and incubate 2.5 
minutes at 30˚C (or the temperature at which the cells were grown) 
5. Add 2.5-4µl of 35S-methionine (10Ci/ml). Mix and incubate for a definite time 
depending on the experiment (usually 5 to 15 minutes) 
6. Centrifuge 1 minute at maximum speed and resuspend cells in 75µl of Rodel Mix 
(protect stock solution from light). Immediately add 500µl of bidistilled H2O. Add 
575µl of 50% tri-chloroacetic acid (TCA). Incubate at least 15 minutes on ice. 
Centrifuge 15000rpm, 10 minutes 
 Rodel Mix:  5.56ml 5M NaOH 
    1.11ml ß-mercaptoethanol 
    6.84ml H2O 
    1.5ml 0.1M PMSF 
7. Wash pellet once without resuspending with 0.5M Tris-Base (no pH adjusted) to 
neutralize TCA. Wash once without resuspending with bi-distilled H2O. 
8. Resuspend in 25µl of 1X Loading Buffer without heating. Load on 17.5% SDS-PAGE 
(10X15cm separating gel at least)  
 Loading Buffer 1X: 2% SDS 
    10% Glycerol  
    60mM Tris-HCl, pH 6.8 
    2.5% ß-mercaptoethanol 
    bromophenol blue 
9. Run until blue reaches the bottom, without exiting the gel. Maximum 40mA. 
10. Semidry transfer to nitrocellulose membrane for 1hr 30minutes at 200mA. Let the 
membrane dry for few minutes at 37˚C and perform a first exposition of about 24 hrs. 
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Buffers and Gel composition 
Solution Separating Gel 17.5% Stacking Gel 5% 
30% acrylamide 0.2 bis-acrylamide 12.61ml 1.079ml 
1.825M TrisHCl pH 8.8 4.55ml - 
0.6M TrisHCl pH 6.8 - 0.650ml 
water 4.55ml 4.620ml 
SDS 10% 217µl 65µl 
APS 10% 109µl 32.5µl 
TEMED 7.8µl 6.5µl 
final volume 22.1ml 6.5ml 
 
 Running Buffer: 50mM Tris-HCl, pH 8.3 
    384mM glycine 
    0.1% SDS 
Prepare a 5X stock solution (30gr Tris-Base, 144gr glycine, 5gr SDS for 1 liter). Dilute to 
1X and adjust the pH precisely to pH 8.3. The pH is crucial for optimal proteins 
resolution. Check frequently the pH of 1X running buffer. 
4.2.6 Crude Total Protein Extraction 
1. Grow cells overnight to 0.7-1.2 OD 
2. Harvest the equivalent of 1.2OD of cells by centrifugation 1min 6000-8000rpm 
3. Wash once with water and resuspend the pellet in 75µl of Rodel mix (see above) 
4. Add 500µl of water 
5. Add 575µl of TCA50% 
6. Incubate on ice at least 15 minutes. Centrifuge 15000rpm 10min 
7. Wash pellet once with 0.5M Tris-base without resuspending (about 1ml) 
8. Wash pellet once with water without resuspending (about 1ml) 
9. Resuspend in 25µl of 1X LB and add few µl of Tris-base if the color is yellowish  
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4.3 Mitochondrial Analysis 
4.3.1 Preparation of Yeast Mitochondria with Intact Outer Membrane 
(Glick et al. 1995) 
1. Cells are harvested at 2000-3500 rpm for 7 minutes and washed once with sorbitol 
1.2M 
2. Washed cells are suspended in digestion buffer at concentration of 1gr of cells in 3ml 
 Digestion Buffer:  30ml 2M sorbitol 
    3ml 1M phosphate buffer, pH 7.5 
    0.1ml 0.5M EDTA pH 8 
    0.5ml ß-mercaptoethanol 
    50mg of zymolyase 20000 
    16ml of water (Vf=50ml) 
Incubate at 30˚C or 37˚C depending on the used growth conditions until most of the cells 
have been converted to spheroplasts. 
3. Add cold Buffer A and immediately centrifuge 6000rpm for 10 minutes. Wash two 
additional times with Buffer A 
 Buffer A:   1.2M deionized sorbitol (use BioRad® AG501-X8 resin) 
    20mM KPO4 pH 7.5 
4. Washed spheroplasts are suspended in 0.6M sorbitol, 20mM KMES pH 6, 0.5mM 
PMSF at concentration of 1gr/3ml. Homogenize with and glass/Teflon pestle and 
overhead stirrer (Wheaton Science Products) 
5. Centrifuge 3500rpm for 5 minutes to pellet debries. Collect the supernatant and 
centrifuge 10000rpm for 10 minutes to sediment mitochondria. The supernatant is 
the post mitochondrial fraction (PMS) and represent the cytosolic component 
6. Mitochondria are briefly suspended with plastic sticks in 8ml of 0.6M sorbitol, 20mM 
KMES pH 6. Mitochondria are now suspended by gently homogenization in 
glass/Teflon pestle. Centrifuge at 3500rpm for 5 minutes to pellet broken 
mitochondria 
7. Collect supernatant and centrifuge at 10000rpm for 10 minutes. Mitochondrial pellet 
is suspended in 2ml of 0.6M sorbitol, 20mM KMES and diluted with 20ml of 0.6M 
sorbitol, 20mM HEPES pH 7.4. Centrifuge 10000rpm for 10 minutes. 
8. Suspend mitochondrial pellet in 0.6M sorbitol, 20mM HEPES accordingly to the 
pellet dimension. Mitochondria can be stored at -80˚C 
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4.3.2 Quantification of Total Mitochondrial Proteins 
Quantification of protein concentration in mitochondrial extracts was performed with folin 
assay as follows: 
1. Add 5 µl of proteins to 0.6ml of H2O (two independent replicates for sample) 
2. Add 3ml of Copper Reagent 
 Copper Reagent: 0.5 ml 1% CuSO4 
    0.5 ml 2% K-Na tartrate 
    49 ml 2% Na2CO3 in 0.1M NaOH 
3. Incubate 10 min room temperature 
4. Add 0.3ml of Folin&Ciocalteau’s reagent (Sigma-Aldrich®) diluted 1:1 in water. Mix 
immediately vortexing briefly 
5. Incubate at 90˚C for 2 min 
6. Cool down on ice for 2 min 
7. Measure absorbance at 750nm. 
Absorbance values were converted in mg/ml concentrations fitting to a standard curve 
built with BSA standard solutions. 
4.3.3 Extraction of Total Mitochondrial Cytochromes 
(Tzagoloff et al. 1975) 
Mitochondria were prepared with intact outer membrane. Following protocol was used: 
1. Use 2.5 – 5mg of total mitochondrial proteins 
2. Add 50mg of KCl and mix with plastic stick 
3. Add water (to final volume of 1ml) 
4. Add 50µl of 1M Tris-HCl pH 7.5 
5. Add 100µl of 10% K deoxycholate 
Centrifuge 40000rpm for 15 min 4˚C, transfer clear supernatant to a new tube and add 
100µl of 20% K deoxycholate. Divide equally the solution in two cuvettes. The reference 
cuvette will be oxidized with few µl of a concentrate KFeCN3 solution, the sample cuvette 
will be reduced adding few grains of Na-dithionite (add very small amount each time to 
avoid over reduction). Register the spectra continuously from 650 to 450nm. 
Cytochromes can be quantified using following extinction coefficients (ε): 
 cytochrome c+c1   ε=18.7 (552 – 540 nm) 
 cytochrome b    ε=23.4 (560 – 575 nm) 
 cytochrome a+a3   ε=24.0 (605 – 630 nm) 
and following formula:   [(ΔOD/ε)*(1/mg)*1000] = nmol cyt / mg 
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4.3.4 NADH Cytochrome c Reductase (NCCR) Enzymatic Activity 
This assay measures the combined activity of NADH dehydrogenase and complex III in 
yeast. Electron flux is from NADH-DH to complex III via ubiquinol to the final acceptor 
cytochrome c. Mitochondria were prepared as described and following protocol: 
Solutions needed:   10mM K-phosphate pH 7.5 
     80mM KCN 
     1% cytochrome c (bovine or horse heart,   
     Sigma-Aldrich®) 
     0.1M NADH in K-phosphate pH 7.5 
     0.5% Na-deoxycholate 
Protocol: Prepare two cuvettes with 0.920ml of 10mM K-phosphate, 80µl of 1% 
cytochrome c, 5µl of KCN and 10µl of NADH. Use one of the two as reference and 
record the baseline for about 30’’ at 550nm. Add solubilized mitochondria to the reaction 
and record for additional 1 minute (volume variable in accordance with concentration, 
usually 10-50µg). 
To solubilize mitochondrial protein treat with 1 volume of Na-deoxycholate 0.5% (Na-
DOC) just before the assay, pipetting up/down few times. For good statistical analyses 
repeat each sample three times solubilizing mitochondria once in a bigger volume (for 
instance 15µl of mitochondria plus 15µl of Na-DOC and neutralizing Na-DOC with 50µl 
of sorbitol HEPES EDTA solution. 
Specific Activity: NCCR activity is calculated with cytochrome c ε of 18.5 and the 
following formula (ΔOD*ε/min mg). 
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4.3.5 Succinate Dehydrogenase (SQDR) enzymatic activity 
This assay measures the rate of reduction of an artificial electron acceptor as 
dichlorophenolindophenol (DCPIP) by complex II. Mitochondria were prepared as 
described and following protocol: 
Solutions needed:   10mM K-phosphate pH 7.4 
     0.4M succinate pH 7.4 
     80mM KCN 
     20mM phenazyne methosulfate (PMS) 
     20mM DCPIP 
     0.5% Na-DOC 
Protocol: Add to a cuvette 900µl of K-phosphate, 40µl of succinate, 5µl of KCN and 
mitochondrial protein (about 25µg) previously solubilized. Incubate 3 minutes (this step 
is needed to release SDH from tight binding with oxaloacetate). 
Add 50µl of PMS and finally start reaction with 5µl DCPIP. Record activity at 600nm. 
Solubilization of mitochondrial protein is carried out 1 volume treatment of 0.5% Na-
DOC. 
Specific Activity: SQDR activity is calculated with ε of 22 and the following formula 
(ΔOD*ε/min mg). 
4.3.6 Cytochrome c Oxidase (COX) Enzymatic Activity 
This assay measures the rate of cytochrome c oxidation by complex IV in yeast. 
Mitochondria were prepared as described and following protocol: 
Solutions needed:   20mM K-phosphate pH 7.5 
     1% cytochrome c in 20mM K-phosphate 
     0.5% Na-DOC 
Protocol: Prepare two cuvettes with 920µl of K-phosphate and 80µl of cytochrome c 
reduced (with few grains of Na-dithionite). The reference cuvette will be oxidized with 
few drops of a concentrate KFeCN3 solution. The difference in absorption between the 
two cuvettes should be 1OD. Add about 10µg of mitochondrial proteins previously 
solubilized to start reaction and record activity at 550nm. For computation of enzymatic 
rate it will be necessary also the zero value of absorbance (A0). 
Solubilization of mitochondrial proteins is achieved with 1 vol 0.5% Na-DOC treatment. 
Specific activity: COX activity is calculated with cytochrome c ε of 18.5 and the following 
formula [2.3log(A1/A2)/(ε*mg*min)]*A0 
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4.3.7 Heme Analysis using High Pressure Chromatography (HPLC) 
HPLC analysis of total heme was performed in reverse phase C18 column as described 
previously (Barros et al. 2001). Total mitochondria were extracted as described 
previously. Total heme was extracted in the following conditions: 
1. Pellet 2mg of total mitochondria centrifuging 10000rpm 10 minutes, 4˚C 
2. Resuspend pellet in 250µl of Acetone HCl 3% vortexing vigorously 
3. Centrifuge 5 minutes, 14000rpm 4˚C 
4. Prepare in a clean eppendorf 250µl of a 50% Acetonitrile 0.02% trifluoroacetic acid 
(TFA) solution 
5. Transfer the supernatant of the centrifugation to the 50% Acetonitrile 0.02% TFA 
solution. Mix well 
6. Centrifuge 7-10 minutes 14000rpm 4˚C 
7. Collect supernatant and transfer to a clean tube 
8. Add 25µl of 1.65M ammonium hydrochloride to adjust pH to 3.5 
9. Mix well and centrifuge 5 minutes 14000rpm 4˚C 
10. Load 400µl of the extract to an HPLC tube for analysis 
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4.3.8 Mitochondrial Protein Localization 
Based on Glick BS procedure (Glick et al. 1995) 
Mitochondria were prepared as describe. Following protocol was used: 
1. Centrifuge 10000rpm, 10 minutes 4˚C to pellet mitochondria. Set up four different 
tubes with 200µg of total proteins 
2. Wash sample 1 and 2 with 0.6M sorbitol, 20mM HEPES pH 7.4. Sample 3 and 4 with 
20mM HEPES pH 7.4 
3. Set up the following conditions: 
 1 2 3 4 
Mitochondria 200µg 200µg 200µg 200µg 
0.6M sorbitol, HEPES 20 mM pH 7.4 250µl 250µl - - 
HEPES 20 mM pH 7.4 - - 250µl 250µl 
Proteinase K (1:20 of a 0.63 mg/ml) solution) - 5µl - 5µl 
 
4. Incubate samples on ice for 60 minutes 
5. Add 5µl of 0.1M PMSF to stop reaction of Proteinase K 
6. Centrifuge 20000rpm, 15 minutes 4˚C. Remove and keep supernatants 
7. Pellet is resuspended in 0.1ml of 0.6M sorbitol, 20mM HEPES pH 7.4 
8. Centrifuge 14000rpm, 5 minutes 4˚C 
9. Dissolve pellets in 100µl of 1X SDS-page loading buffer (LB) and add 2µl of 0.1M 
PMSF 
10. Load 20-30µl in 12% SDS-page and perform western against different mitochondrial 
proteins. Ideally use a control for each mitochondrial compartment  
4.3.9 Solubility Assay (Alkaline Carbonate Extraction) 
(Fujiki et al. 1982) 
Mitochondria were prepared as previously described. Following protocol was used: 
1. Pellet 200µg of total mitochondrial protein by centrifugation 10000rpm, 10minutes 
4˚C 
2. Suspend mitochondria in 100µl of 0.6M sorbitol 20mM HEPES and add 4µl of 0.1M 
PMSF 
3. This mitochondrial suspension is sonicated 2 timed for 3 seconds, intensity 2 
(conditions has to be optimized each time) 
4. Sonicated mitochondria are centrifuged at 35000rpm, 15 minutes 4˚C 
5. Supernatant is collected and centrifuged again to remove any additional insoluble 
portins that might have remained. Pellet is washed gently twice with 0.6M sorbitol 
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20mM HEPES without resuspending. This allow removal of any supernatant 
remained 
6. The centrifuged again supernatant (S fraction) is mixed with SDS page loading buffer 
(75µl of S + 25µl of LB4X) 
7. The pellet (not soluble fraction) is resuspended in 100µl of Na2CO3 100mM pH 11 
(dissolved in water, the pH is critical) and incubated on ice 30 minutes 
8. Centrifuge 35000rpm, 15 minutes 4˚C 
9. The supernatant (CS fraction) is centrifuged again to remove any additional insoluble 
fraction and eventually mixed with LB4X to a final volume of 100µl 
10. The pellet (CP fraction) is washed gently twice with carbonate without resuspending 
to remove any CS fraction that might have remained 
11. CP fraction is resuspended in 100µl of LB1X 
12. Load proportionally the three fractions on SDS page and perform western using 
controls for soluble proteins, integral membrane proteins and loosely bound 
membrane proteins 
4.3.10 Solubilization of Mitochondrial Proteins 
To solubilize mitochondrial tagged proteins (for following biochemical characterization) 
different extracting conditions were tested to find the mildest one. The following test 
protocol was used: 
1. Pellet 0.5mg of total mitochondrial proteins centrifuging 10000rpm 4˚C 
2. Discard supernatant and resuspend n 50µl of Extraction buffer 
 Extraction buffer: 20mM HEPES 
    0.5mM PMSF 
    + detergent (digitonin, laurylmaltoside) 
    + salt (KCl, NaCl) 
    water to 100µl 
3. Incubate 10 min on ince 
4. Centrifuge 21000 rpm, 15 minutes 4˚C 
5. Transfer 37.5µl of supernatant in a new tube and add 12.5µl of LB4X 
6. Wash the pellet twice with 10mM HEPES without resuspending 
7. Resuspend pellet in 50µl of LB1X 
Equivalent µg from pellet and supernatant are loaded in SDS page to evaluate the 
extraction efficiency for protein of interest.  
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4.3.11 Sucrose Density Gradients 
Linear sucrose density gradients were used to estimate native molecular size of tagged 
proteins and for co-sedimentation analysis. This general protocol was used: 
Sample preparation: 4mg of total mitochondrial proteins are solubilized with previously 
tested conditions in a total volume of 400µl. Forty µl of supernatant are kept and used as 
positive control of extraction. Two mg of hemoglobin (Sigma-Aldrich®) and 60µg of 
lactate dehydrogenase resuspended in 40µl of extraction buffer are added to the clarified 
supernatant. 
Gradient preparation: for a 5ml linear 7-20% sucrose gradient the following solutions 
were prepared 
 7% sucrose 20% sucrose 
sucrose powder 210 mg 600 mg 
HEPES 1M 60 µl 60 µl 
PMSF 0.1M 15 µl 15 µl 
Detergent 1/10 of tested 1/10 of tested 
water to final volume 3 ml 3 ml 
 
Use 2.5ml of each solution to prepare a 5ml linear gradient with a gradient maker. Load 
the entire sample on the top of the gradient. 
Spinning and fractioning: loaded gradients are spinned in a swinging-bucket rotor. Speed 
and time depend on the ranges of molecular weights (MW) and have to be optimized 
each time. Two standard conditions can be: 
 CLASSICAL: 28000 rpm for 12hrs, 4˚C (high-medium MW) 
 EXPANDED: 45000 rpm for 16hrs, 4˚C (low MW) 
Gradients are recovered and fractioned in a variable number of fractions. For instance 5 
ml gradients can give about 15 fractions of 350µl approx. Loading samples are prepared 
with 73µl of each fraction, 2µl of PMSF 0.1M and 25µl of LB4X. Separation is performed 
on 12% SDS-page loading 20-30µl of each sample. 
Gradient calibration: To calibrate the gradient each fraction is tested for hemoglobin and 
LDH concentrations as follows: 
 Hemoglobin: read at 409nm a 1:20 dilution in water of each fraction 
 LDH: estimate the activity of LDH for 40’’ at 340nm as follows 
o 865µl of 20mM K-phosphate pH 7.4 
o 100µl of 2mM NADH 
o 30µl of 10mM pyruvate 
o 5µl of fraction 
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Is possible to estimate roughly the molecular size of a protein/complex comparing with 
sedimentation behavior of known loading controls as hemoglobin (67Kda) and LDH 
(130Kda) (Martin et al. 1961; Barrientos et al. 2002). 
4.3.12 Co-immunoprecipitation (CoIP) Analysis with HA Affinity Matrix 
For CoIP studies an HA affinity matrix was used, consisting of purified HA.11 antibody 
immobilized on Sepharose™ beads (AFC-101P, Covance Inc.). 
General protocol can be briefly summarized as follows: 
Pre-cleaning: step required if starting from total mitochondria. If sucrose gradient 
fractions are used this can be avoided. 
1. Pellet naked agarose beads (1/10 vol of the sample to process) 1000 rpm 1min 4˚C 
2. Wash twice with 6 volumes of PBS pH 7.4 
3. Add supernatant from mitochondrial protein solubilization (2-4mg) 
4. Incubate 1hr, 4˚C in gently rotation 
Binding:  
1. Pellet appropriate volume of HA-beads and wash twice with PBS pH 7.4 
2. Recover the supernatant from naked beads and transfer to HA-beads 
3. Incubate 4hrs (up to o/n) at 4˚C, in gently rotation 
4. Pellet beads at 1000 rpm 1 min 4˚C 
5. Recover the supernatant (UNBOUND fraction) 
6. Wash 4 times with PBS pH 7.4 (or with extraction buffer to lower stringency) 
Elution: elution can be achieved in two ways. 
1. Elution with SDS loading buffer 1X: this will remove all the proteins bound to the 
matrix but will also destroy physical interactions. 
2. Competitive elution with HA peptide: a solution of HA peptide 400µg/ml in 50mM 
Tris-HCl (pH 7.5) 50mM NaCl, 1mM EDTA (pH 8) can be applied to the beads to 
release the HA-tagged proteins. This is a native elution that will not destroy 
interactions. 
Volumes and timing have to be optimized. A standard condition can be 20-30 minutes in 
gently rotation at room temperature. Load equivalent quantities of UNBOUND and 
ELUTE fractions on SDS-page along with extraction control. 
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Appendices 
 
APPENDIX 1: Total list of 488 identified. Phenotypes in primary screening and filter parameter are 
reported. 
ORF GENE ORF TYPE Ethanol, 30°C Ethanol, 37°C FILTER 
YAL002W VPS8 VER 0 HS NEW 
YAL013W DEP1 VER MS HS genome 
YAL021C CCR4 VER LS LS NEW 
YAL039C CYC3 VER HS HS genome 
YAL044C GCV3 VER MS HS genome 
YAL046C AIM1 VER 0 HS genome 
YAL047C SPC72 VER HS HS genome 
YBL019W APN2 VER HS HS genome 
YBL021C HAP3 VER HS HS genome 
YBL031W SHE1 VER HS HS genome 
YBL032W HEK2 VER HS HS genome 
YBL036C   VER HS HS genome 
YBL038W MRPL16 VER HS HS genome 
YBL045C COR1 VER HS HS genome 
YBL046W PSY4 VER HS HS genome 
YBL057C PTH2 VER HS HS genome 
YBL079W NUP170 VER 0 LS genome 
YBL080C PET112 VER HS HS genome 
YBL082C ALG3 VER HS HS genome 
YBL090W MRP21 VER HS HS genome 
YBL099W ATP1 VER HS HS genome 
YBR003W COQ1 VER HS HS genome 
YBR021W FUR4 VER LS HS NEW 
YBR026C ETR1 VER 0 HS genome 
YBR044C TCM62 VER LS MS pet only 
YBR081C SPT7 VER MS MS NEW 
YBR084W MIS1 VER 0 MS pet only 
YBR095C RXT2 VER LS LS NEW 
YBR126C TPS1 VER 0 MS NEW 
YBR127C VMA2 VER HS HS genome 
YBR128C ATG14 VER HS HS genome 
YBR146W MRPS9 VER HS HS genome 
YBR179C FZO1 VER HS HS genome 
YBR185C MBA1 VER LS MS pet only 
YBR221C PDB1 VER LS HS pet only 
YBR251W MRPS5 VER HS HS genome 
YBR267W REI1 VER LS 0 NEW 
YBR268W MRPL37 VER HS HS genome 
YBR282W MRPL27 VER HS HS genome 
YBR289W SNF5 VER MS HS genome 
YBR298C MAL31 VER 0 MS NEW 
YCL001W-A   UNC 0 LS genome 
YCL005W LDB16 VER 0 MS NEW 
YCL008C STP22 VER 0 HS NEW 
YCL010C SGF29 VER HS HS genome 
YCR003W MRPL32 VER HS HS genome 
YCR009C RVS161 VER 0 HS genome 
YCR020C-A MAK31 VER LS LS NEW 
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ORF GENE ORF TYPE Ethanol, 30°C Ethanol, 37°C FILTER 
YCR024C SLM5 VER HS HS genome 
YCR028C-A RIM1 VER HS HS genome 
YCR046C IMG1 VER HS HS genome 
YCR051W   UNC 0 LS NEW 
YCR077C PAT1 VER 0 LS NEW 
YCR079W PTC6 VER 0 LS pet only 
YDL005C MED2 VER MS MS NEW 
YDL006W PTC1 VER 0 HS genome 
YDL012C   VER HS HS genome 
YDL033C SLM3 VER HS HS genome 
YDL039C PRM7 VER HS HS genome 
YDL044C MTF2 VER HS HS genome 
YDL045W-A MRP10 VER HS HS genome 
YDL047W SIT4 VER MS HS genome 
YDL056W MBP1 VER HS HS genome 
YDL067C COX9 VER HS HS genome 
YDL077C VAM6 VER HS HS genome 
YDL088C ASM4 VER 0 HS NEW 
YDL091C UBX3 VER HS HS genome 
YDL104C QRI7 VER 0 MS genome 
YDL119C   UNC HS HS genome 
YDL129W   UNC HS HS genome 
YDL157C   UNC HS HS genome 
YDL160C DHH1 VER LS 0 genome 
YDL192W ARF1 VER HS HS genome 
YDL198C GGC1 VER LS HS genome 
YDL202W MRPL11 VER HS LS genome 
YDL203C ACK1 VER 0 LS NEW 
YDL204W RTN2 VER LS LS NEW 
YDL232W OST4 VER 0 MS NEW 
YDR005C MAF1 VER 0 HS NEW 
YDR017C KCS1 VER LS MS genome 
YDR065W RRG1 VER HS HS genome 
YDR069C DOA4 VER 0 HS genome 
YDR074W TPS2 VER LS 0 NEW 
YDR079W PET100 VER HS HS genome 
YDR114C   UNC HS HS genome 
YDR115W   UNC HS HS genome 
YDR116C MRPL1 VER HS HS genome 
YDR129C SAC6 VER 0 HS genome 
YDR140W MTQ2 VER 0 LS NEW 
YDR162C NBP2 VER HS HS NEW 
YDR175C RSM24 VER HS HS genome 
YDR176W NGG1 VER MS MS genome 
YDR178W SDH4 VER MS 0 genome 
YDR194C MSS116 VER HS HS genome 
YDR195W REF2 VER MS HS genome 
YDR197W CBS2 VER HS HS genome 
YDR202C RAV2 VER 0 HS genome 
YDR204W COQ4 VER HS HS genome 
YDR207C UME6 VER MS HS NEW 
YDR226W ADK1 VER MS MS genome 
YDR231C COX20 VER HS HS genome 
YDR237W MRPL7 VER HS HS genome 
YDR244W PEX5 VER HS HS NEW 
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ORF GENE ORF TYPE Ethanol, 30°C Ethanol, 37°C FILTER 
YDR264C AKR1 VER 0 HS genome 
YDR270W CCC2 VER MS MS genome 
YDR276C PMP3 VER 0 HS NEW 
YDR293C SSD1 VER 0 HS NEW 
YDR296W MHR1 VER HS HS genome 
YDR298C ATP5 VER HS HS genome 
YDR316W OMS1 VER 0 LS genome 
YDR322W MRPL35 VER HS HS genome 
YDR323C PEP7 VER MS HS genome 
YDR332W IRC3 VER HS HS genome 
YDR337W MRPS28 VER HS HS genome 
YDR347W MRP1 VER HS HS genome 
YDR349C YPS7 VER LS MS NEW 
YDR350C ATP22 VER HS HS genome 
YDR363W-A SEM1 VER 0 MS NEW 
YDR368W YPR1 VER 0 MS NEW 
YDR375C BCS1 VER HS HS genome 
YDR388W RVS167 VER 0 HS genome 
YDR403W DIT1 VER 0 MS NEW 
YDR430C CYM1 VER 0 MS genome 
YDR435C PPM1 VER 0 HS NEW 
YDR443C SSN2 VER LS LS NEW 
YDR458C HEH2 VER HS HS genome 
YDR493W MZM1 VER HS HS genome 
YDR495C VPS3 VER MS HS genome 
YDR512C EMI1 VER MS MS genome 
YDR523C SPS1 VER HS HS genome 
YDR529C QCR7 VER HS HS genome 
YEL007W   UNC LS MS NEW 
YEL024W RIP1 VER HS HS genome 
YEL027W VMA3 VER HS HS genome 
YEL038W UTR4 VER 0 MS NEW 
YEL050C RML2 VER HS HS genome 
YER050C RSM18 VER HS HS genome 
YER058W PET117 VER HS HS genome 
YER087W AIM10 VER MS HS genome 
YER117W RPL23B VER MS HS NEW 
YER122C GLO3 VER HS HS genome 
YER131W RPS26B VER HS HS genome 
YER145C FTR1 VER HS HS genome 
YER154W OXA1 VER HS HS genome 
YER155C BEM2 VER HS HS genome 
YER178W PDA1 VER LS HS pet only 
YFL025C BST1 VER LS LS NEW 
YFL036W RPO41 VER HS HS genome 
YFR019W FAB1 VER MS HS genome 
YFR033C QCR6 VER 0 MS pet only 
YGL012W ERG4 VER 0 HS NEW 
YGL017W ATE1 VER HS HS genome 
YGL045W RIM8 VER 0 MS NEW 
YGL058W RAD6 VER LS MS genome 
YGL062W PYC1 VER 0 HS NEW 
YGL070C RPB9 VER HS HS genome 
YGL071W AFT1 VER HS HS genome 
YGL084C GUP1 VER 0 LS genome 
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ORF GENE ORF TYPE Ethanol, 30°C Ethanol, 37°C FILTER 
YGL095C VPS45 VER 0 HS genome 
YGL129C RSM23 VER HS HS genome 
YGL135W RPL1B VER HS HS genome 
YGL136C MRM2 VER LS HS pet only 
YGL143C MRF1 VER HS HS genome 
YGL167C PMR1 VER MS HS genome 
YGL168W HUR1 VER HS HS genome 
YGL173C KEM1 VER 0 HS NEW 
YGL211W NCS6 VER 0 MS NEW 
YGL212W VAM7 VER 0 MS NEW 
YGL213C SKI8 VER 0 LS NEW 
YGL226W MTC3 VER LS LS genome 
YGL237C HAP2 VER HS HS genome 
YGL244W RTF1 VER HS HS genome 
YGL251C HFM1 VER LS MS genome 
YGR036C CAX4 VER LS 0 genome 
YGR062C COX18 VER HS HS genome 
YGR076C MRPL25 VER HS HS genome 
YGR084C MRP13 VER LS MS pet only 
YGR092W DBF2 VER 0 HS NEW 
YGR102C   VER HS HS genome 
YGR104C SRB5 VER LS MS NEW 
YGR112W SHY1 VER HS HS genome 
YGR127W   UNC 0 MS NEW 
YGR150C CCM1 VER HS HS genome 
YGR155W CYS4 VER MS HS genome 
YGR165W MRPS35 VER HS HS genome 
YGR171C MSM1 VER HS HS genome 
YGR174C CBP4 VER MS HS genome 
YGR180C RNR4 VER HS HS genome 
YGR183C QCR9 VER MS HS genome 
YGR188C BUB1 VER MS MS genome 
YGR200C ELP2 VER 0 HS NEW 
YGR215W RSM27 VER HS HS genome 
YGR220C MRPL9 VER HS HS genome 
YGR222W PET54 VER HS HS genome 
YGR229C SMI1 VER 0 HS NEW 
YGR243W FMP43 UNC HS HS genome 
YGR252W GCN5 VER 0 MS genome 
YGR260W TNA1 VER 0 HS NEW 
YHL012W   UNC 0 LS NEW 
YHL027W RIM101 VER 0 HS NEW 
YHL038C CBP2 VER HS HS genome 
YHR001W-A QCR10 VER 0 MS pet only 
YHR006W STP2 VER HS HS genome 
YHR008C SOD2 VER 0 HS genome 
YHR009C   UNC HS HS genome 
YHR011W DIA4 VER HS HS genome 
YHR013C ARD1 VER 0 LS NEW 
YHR021C RPS27B VER LS LS NEW 
YHR026W VMA16 VER HS HS genome 
YHR029C YHI9 VER MS MS NEW 
YHR030C SLT2 VER 0 MS NEW 
YHR038W RRF1 VER HS HS genome 
YHR039C-A VMA10 VER MS HS NEW 
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YHR041C SRB2 VER 0 MS genome 
YHR049W FSH1 VER LS LS NEW 
YHR051W COX6 VER HS HS genome 
YHR067W HTD2 VER 0 HS genome 
YHR091C MSR1 VER HS HS genome 
YHR100C GEP4 VER LS MS pet only 
YHR111W UBA4 VER 0 MS NEW 
YHR116W COX23 VER HS HS genome 
YHR120W MSH1 VER HS HS genome 
YHR129C ARP1 VER 0 MS NEW 
YHR147C MRPL6 VER HS HS genome 
YHR168W MTG2 VER HS HS genome 
YHR194W MDM31 VER 0 MS genome 
YIL008W URM1 VER 0 LS genome 
YIL039W TED1 UNC LS MS NEW 
YIL093C RSM25 VER 0 LS genome 
YIL157C COA1 VER HS HS genome 
YIR021W MRS1 VER HS HS genome 
YIR024C   VER LS LS genome 
YIR026C YVH1 VER LS LS NEW 
YJL003W COX16 VER 0 MS genome 
YJL063C MRPL8 VER HS HS genome 
YJL095W BCK1 VER 0 HS NEW 
YJL101C GSH1 VER 0 MS genome 
YJL117W PHO86 VER MS HS NEW 
YJL126W NIT2 VER 0 HS NEW 
YJL131C AIM23 VER MS MS genome 
YJL176C SWI3 VER LS MS genome 
YJL183W MNN11 VER LS MS NEW 
YJL189W RPL39 VER LS LS NEW 
YJL209W CBP1 VER HS HS genome 
YJR033C RAV1 VER 0 HS NEW 
YJR040W GEF1 VER MS HS genome 
YJR048W CYC1 VER LS MS pet only 
YJR049C UTR1 VER 0 LS NEW 
YJR074W MOG1 VER 0 HS NEW 
YJR077C MIR1 VER HS HS genome 
YJR079W   UNC LS MS NEW 
YJR102C VPS25 VER LS HS genome 
YJR113C RSM7 VER HS HS genome 
YJR120W   VER HS HS genome 
YJR121W ATP2 VER HS HS genome 
YJR122W IBA57 VER HS HS genome 
YJR144W MGM101 VER HS HS genome 
YKL002W DID4 VER MS HS genome 
YKL003C MRP17 VER HS HS genome 
YKL006W RPL14A VER LS MS NEW 
YKL011C CCE1 VER 0 MS NEW 
YKL016C ATP7 VER HS HS genome 
YKL037W AIM26 VER MS HS genome 
YKL054C DEF1 VER LS HS genome 
YKL055C OAR1 VER HS HS genome 
YKL067W YNK1 VER 0 LS NEW 
YKL080W VMA5 VER HS HS genome 
YKL087C CYT2 VER MS HS genome 
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YKL109W HAP4 VER HS HS genome 
YKL110C KTI12 VER 0 MS NEW 
YKL134C 41183 VER HS HS genome 
YKL137W CMC1 VER MS 0 genome 
YKL138C MRPL31 VER HS HS genome 
YKL148C SDH1 VER 0 MS genome 
YKL155C RSM22 VER HS HS genome 
YKL167C MRP49 VER LS MS genome 
YKL170W MRPL38 VER HS HS genome 
YKL185W ASH1 VER LS LS NEW 
YKL194C MST1 VER HS HS genome 
YKL204W EAP1 VER 0 MS NEW 
YKL208W CBT1 VER MS HS genome 
YKL212W SAC1 VER LS HS genome 
YKL213C DOA1 VER 0 MS NEW 
YKR006C MRPL13 VER HS HS genome 
YKR016W FCJ1 VER 0 HS genome 
YKR035W-A DID2 VER 0 MS NEW 
YKR052C MRS4 VER 0 MS NEW 
YKR085C MRPL20 VER HS HS genome 
YKR097W PCK1 VER LS LS NEW 
YLL002W RTT109 VER LS MS NEW 
YLL009C COX17 VER HS HS genome 
YLL018C-A COX19 VER HS HS genome 
YLL027W ISA1 VER HS HS genome 
YLL033W IRC19 VER HS HS genome 
YLL039C UBI4 VER 0 HS NEW 
YLL041C SDH2 VER MS MS genome 
YLL042C ATG10 VER HS HS genome 
YLR015W BRE2 VER 0 MS NEW 
YLR021W IRC25 VER 0 LS NEW 
YLR025W SNF7 VER LS HS genome 
YLR038C COX12 VER MS HS genome 
YLR042C   UNC 0 MS NEW 
YLR055C SPT8 VER LS LS NEW 
YLR056W ERG3 VER MS HS genome 
YLR059C REX2 VER 0 HS genome 
YLR067C PET309 VER HS HS genome 
YLR069C MEF1 VER HS HS genome 
YLR070C XYL2 VER HS HS genome 
YLR079W SIC1 VER 0 HS NEW 
YLR087C CSF1 VER LS LS NEW 
YLR091W GEP5 VER HS HS genome 
YLR114C AVL9 VER LS HS genome 
YLR119W SRN2 VER LS HS NEW 
YLR125W   UNC HS HS genome 
YLR139C SLS1 VER HS HS genome 
YLR144C ACF2 VER HS HS genome 
YLR148W PEP3 VER HS HS genome 
YLR182W SWI6 VER LS MS NEW 
YLR200W YKE2 VER 0 HS NEW 
YLR201C COQ9 VER HS HS genome 
YLR203C MSS51 VER HS HS genome 
YLR218C COA4 VER MS MS genome 
YLR260W LCB5 VER HS HS genome 
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YLR270W DCS1 VER HS HS genome 
YLR304C ACO1 VER LS LS pet only 
YLR312W-A MRPL15 VER HS HS genome 
YLR315W NKP2 VER 0 HS NEW 
YLR320W MMS22 VER LS MS NEW 
YLR357W RSC2 VER MS HS NEW 
YLR362W STE11 VER 0 HS NEW 
YLR377C FBP1 VER MS MS genome 
YLR382C NAM2 VER HS HS genome 
YLR384C IKI3 VER 0 HS NEW 
YLR393W ATP10 VER HS HS genome 
YLR417W VPS36 VER LS HS NEW 
YLR439W MRPL4 VER HS HS genome 
YML008C ERG6 VER 0 MS genome 
YML009C MRPL39 VER 0 HS pet only 
YML013W UBX2 VER 0 MS NEW 
YML014W TRM9 VER 0 MS NEW 
YML030W AIM31 VER 0 MS genome 
YML061C PIF1 VER HS HS genome 
YML081C-A ATP18 VER LS LS genome 
YML087C AIM33 VER HS HS genome 
YML112W CTK3 VER LS HS genome 
YMR015C ERG5 VER HS HS genome 
YMR021C MAC1 VER HS HS genome 
YMR035W IMP2 VER HS HS genome 
YMR054W STV1 VER 0 MS genome 
YMR058W FET3 VER LS MS genome 
YMR063W RIM9 VER MS HS genome 
YMR064W AEP1 VER HS HS genome 
YMR070W MOT3 VER HS HS genome 
YMR072W ABF2 VER HS HS genome 
YMR077C VPS20 VER HS HS genome 
YMR097C MTG1 VER HS HS genome 
YMR098C ATP25 VER HS HS genome 
YMR116C ASC1 VER 0 HS NEW 
YMR123W PKR1 VER MS HS genome 
YMR125W STO1 VER 0 HS NEW 
YMR142C RPL13B VER LS LS NEW 
YMR150C IMP1 VER HS HS genome 
YMR154C RIM13 VER 0 LS NEW 
YMR158W MRPS8 VER HS HS genome 
YMR164C MSS11 VER 0 HS NEW 
YMR179W SPT21 VER MS LS NEW 
YMR188C MRPS17 VER HS HS genome 
YMR193W MRPL24 VER HS HS genome 
YMR198W CIK1 VER 0 MS NEW 
YMR202W ERG2 VER LS HS NEW 
YMR207C HFA1 VER 0 HS genome 
YMR216C SKY1 VER LS LS NEW 
YMR228W MTF1 VER HS HS genome 
YMR231W PEP5 VER MS HS genome 
YMR238W DFG5 VER LS LS NEW 
YMR244C-A   UNC MS HS genome 
YMR256C COX7 VER HS HS genome 
YMR257C PET111 VER HS HS genome 
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YMR263W SAP30 VER 0 LS genome 
YMR275C BUL1 VER 0 HS NEW 
YMR282C AEP2 VER HS HS genome 
YMR286W MRPL33 VER HS HS genome 
YMR287C DSS1 VER HS HS genome 
YMR293C HER2 VER HS HS genome 
YMR312W ELP6 VER 0 HS NEW 
YNL005C MRP7 VER HS HS genome 
YNL052W COX5A VER HS HS genome 
YNL071W LAT1 VER LS HS pet only 
YNL073W MSK1 VER HS HS genome 
YNL079C TPM1 VER 0 MS genome 
YNL081C SWS2 VER HS HS genome 
YNL136W EAF7 VER 0 HS NEW 
YNL159C ASI2 VER HS HS genome 
YNL177C MRPL22 VER HS HS genome 
YNL185C MRPL19 VER HS HS genome 
YNL199C GCR2 VER LS MS NEW 
YNL215W IES2 VER 0 MS NEW 
YNL252C MRPL17 VER HS HS genome 
YNL280C ERG24 VER HS HS genome 
YNL298W CLA4 VER LS HS NEW 
YNL320W   UNC 0 LS NEW 
YNR020C ATP23 VER HS HS genome 
YNR037C RSM19 VER HS HS genome 
YNR041C COQ2 VER HS HS genome 
YNR045W PET494 VER HS HS genome 
YNR052C POP2 VER MS HS NEW 
YOL004W SIN3 VER LS HS genome 
YOL008W COQ10 VER HS HS genome 
YOL009C MDM12 VER HS HS genome 
YOL012C HTZ1 VER 0 LS NEW 
YOL023W IFM1 VER LS MS genome 
YOL027C MDM38 VER MS HS genome 
YOL033W MSE1 VER HS HS genome 
YOL051W GAL11 VER HS HS genome 
YOL071W EMI5 VER LS MS genome 
YOL076W MDM20 VER 0 HS genome 
YOL083W ATG34 VER HS HS genome 
YOL087C   UNC LS MS NEW 
YOL091W SPO21 VER 0 HS NEW 
YOL095C HMI1 VER HS HS genome 
YOL096C COQ3 VER HS HS genome 
YOL126C MDH2 VER 0 LS NEW 
YOR014W RTS1 VER 0 MS NEW 
YOR017W PET127 VER 0 MS pet only 
YOR030W DFG16 VER 0 MS NEW 
YOR036W PEP12 VER MS HS genome 
YOR037W CYC2 VER LS MS genome 
YOR065W CYT1 VER HS HS genome 
YOR068C VAM10 VER 0 MS NEW 
YOR106W VAM3 VER 0 MS NEW 
YOR125C CAT5 VER HS HS genome 
YOR127W RGA1 VER HS HS genome 
YOR141C ARP8 VER 0 HS genome 
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YOR150W MRPL23 VER HS HS genome 
YOR155C ISN1 VER HS HS genome 
YOR158W PET123 VER HS HS genome 
YOR184W SER1 VER LS MS NEW 
YOR187W TUF1 VER HS HS genome 
YOR211C MGM1 VER HS HS genome 
YOR221C MCT1 VER MS HS genome 
YOR275C RIM20 VER 0 HS NEW 
YOR286W RDL2 VER LS 0 genome 
YOR322C LDB19 VER LS MS NEW 
YOR323C PRO2 VER 0 MS NEW 
YOR330C MIP1 VER HS HS genome 
YOR334W MRS2 VER LS MS genome 
YOR350C MNE1 VER MS HS genome 
YOR358W HAP5 VER HS HS genome 
YOR375C GDH1 VER HS HS genome 
YPL002C SNF8 VER 0 HS NEW 
YPL013C MRPS16 VER HS HS genome 
YPL040C ISM1 VER HS HS genome 
YPL051W ARL3 VER 0 MS NEW 
YPL060W MFM1 VER MS MS genome 
YPL065W VPS28 VER 0 HS NEW 
YPL066W   UNC LS HS NEW 
YPL084W BRO1 VER 0 HS NEW 
YPL086C ELP3 VER 0 MS NEW 
YPL097W MSY1 VER HS HS genome 
YPL101W ELP4 VER 0 HS NEW 
YPL104W MSD1 VER HS HS genome 
YPL118W MRP51 VER HS HS genome 
YPL120W VPS30 VER 0 MS NEW 
YPL132W COX11 VER HS HS genome 
YPL148C PPT2 VER HS HS genome 
YPL172C COX10 VER HS HS genome 
YPL173W MRPL40 VER HS HS genome 
YPL174C NIP100 VER MS MS genome 
YPL178W CBC2 VER 0 HS NEW 
YPL188W POS5 VER MS HS genome 
YPL215W CBP3 VER HS HS genome 
YPL259C APM1 VER 0 LS NEW 
YPL262W FUM1 VER MS MS genome 
YPL271W ATP15 VER HS HS genome 
YPR020W ATP20 VER LS HS pet only 
YPR024W YME1 VER LS MS genome 
YPR029C APL4 VER LS LS NEW 
YPR043W RPL43A VER 0 MS NEW 
YPR047W MSF1 VER HS HS genome 
YPR051W MAK3 VER LS MS NEW 
YPR066W UBA3 VER HS HS genome 
YPR100W MRPL51 VER HS HS genome 
YPR116W RRG8 VER HS HS genome 
YPR131C NAT3 VER LS LS NEW 
YPR133W-A TOM5 VER 0 HS genome 
YPR134W MSS18 VER MS HS genome 
YPR135W CTF4 VER LS LS NEW 
YPR173C VPS4 VER 0 HS NEW 
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APPENDIX 2: List of 177 candidates with mitochondrial localization, presence of ortholog, original 
phenotypes, phenotypical classes and respiratory efficiency. 
ORF GENE MITOC ORTHOLOG FILTER CLASS RESP EFF% 
YPR116W RRG8 ?   genome A 0 
YDL157C   mitoc   genome A 0 
YDL088C ASM4     NEW A 0 
YBL031W SHE1     genome A 1 
YDL012C       genome A 1 
YDL091C UBX3     genome A 1 
YHR009C       genome A 1 
YLR125W       genome A 1 
YML087C AIM33 ?   genome A 1 
YLR091W GEP5 mitoc   genome A 2 
YCL010C SGF29     genome A 2 
YDR114C       genome A 2 
YBL036C       genome A 2 
YDR458C HEH2     genome A 2 
YDL129W       genome A 2 
YGR243W FMP43 mitoc YES genome A 2 
YHR168W MTG2 mitoc YES genome A 2 
YDR244W PEX5   YES NEW A 2 
YNL081C SWS2 mitoc   genome A 2 
YDR115W   mitoc YES genome A 3 
YOL091W SPO21     NEW A 3 
YLL033W IRC19     genome A 3 
YER087W AIM10 mitoc YES genome A 3 
YDL039C PRM7     genome A 3 
YDR512C EMI1     genome A 4 
YOL012C HTZ1   YES NEW A 4 
YHR013C ARD1   YES NEW A 4 
YLR362W STE11     NEW A 6 
YJR120W       genome A 8 
YPL101W ELP4   YES NEW A 8 
YDL005C MED2     NEW A 8 
YJR074W MOG1   YES NEW A 9 
YPR131C NAT3   YES NEW A 11 
YOL087C       NEW A 12 
YJL131C AIM23 mitoc   genome A 12 
YIR024C   mitoc   genome A 13 
YDR074W TPS2     NEW A 14 
YOR275C RIM20   YES NEW A 14 
YKL006W RPL14A   YES NEW A 15 
YDR332W IRC3 mitoc   genome A 15 
YJL183W MNN11     NEW A 16 
YGR092W DBF2   YES NEW A 17 
YLR087C CSF1 mitoc   NEW A 18 
YIL039W TED1     NEW A 21 
YDR065W RRG1 mitoc   genome A 25 
YHR021C RPS27B   YES NEW A 26 
YLR055C SPT8     NEW A 27 
YCR051W     YES NEW A 28 
YHR030C SLT2     NEW A 37 
YNL199C GCR2     NEW A 41 
YDR202C RAV2     genome A 76 
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YDR493W MZM1 mitoc   genome A 87 
YNL136W EAF7   YES NEW B 8 
YPL178W CBC2   YES NEW B 11 
YGR104C SRB5     NEW B 13 
YJL189W RPL39   YES NEW B 16 
YMR116C ASC1   YES NEW B 18 
YHL027W RIM101     NEW B 19 
YDR207C UME6     NEW B 21 
YPL084W BRO1   YES NEW B 23 
YML030W AIM31 mitoc YES genome B 23 
YDR435C PPM1   YES NEW B 23 
YLR200W YKE2   YES NEW B 24 
YPR051W MAK3   YES NEW B 24 
YPR043W RPL43A   YES NEW B 24 
YJL095W BCK1   YES NEW B 25 
YNL215W IES2     NEW B 25 
YKL011C CCE1 mitoc   NEW B 25 
YNR052C POP2   YES NEW B 25 
YCR077C PAT1   YES NEW B 26 
YMR063W RIM9     genome B 27 
YLR079W SIC1     NEW B 29 
YMR312W ELP6     NEW B 29 
YGR200C ELP2   YES NEW B 30 
YKL204W EAP1     NEW B 31 
YOR014W RTS1   YES NEW B 31 
YLL002W RTT109     NEW B 31 
YGL173C KEM1   YES NEW B 32 
YKR052C MRS4 mitoc YES NEW B 32 
YHR111W UBA4   YES NEW B 33 
YIR026C YVH1   YES NEW B 33 
YLR021W IRC25     NEW B 36 
YOR106W VAM3     NEW B 37 
YLR182W SWI6     NEW B 38 
YOR030W DFG16     NEW B 41 
YEL038W UTR4     NEW B 41 
YPL065W VPS28   YES NEW B 41 
YML014W TRM9     NEW B 43 
YHR029C YHI9     NEW B 45 
YLL039C UBI4   YES NEW B 46 
YDR005C MAF1   YES NEW B 46 
YPL086C ELP3   YES NEW B 50 
YGL168W HUR1     genome B 51 
YDR162C NBP2     NEW B 51 
YBR021W FUR4     NEW B 51 
YMR164C MSS11     NEW B 56 
YKL213C DOA1   YES NEW B 57 
YCL005W LDB16 mitoc   NEW B 57 
YDR363W-A SEM1     NEW B 61 
YOR323C PRO2   YES NEW B 62 
YLR315W NKP2     NEW B 65 
YCL008C STP22   YES NEW B 67 
YML013W UBX2     NEW B 67 
YMR142C RPL13B   YES NEW B 70 
YKL002W DID4   YES genome B 74 
YDR316W OMS1 mitoc   genome C 17 
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YBR095C RXT2     NEW C 31 
YHR129C ARP1   YES NEW C 32 
YLR384C IKI3   YES NEW C 36 
YMR216C SKY1   YES NEW C 37 
YCR020C-A MAK31     NEW C 38 
YMR179W SPT21     NEW C 38 
YDR140W MTQ2   YES NEW C 40 
YKL110C KTI12   YES NEW C 41 
YMR125W STO1     NEW C 43 
YHR039C-A VMA10   YES NEW C 44 
YMR202W ERG2   YES NEW C 46 
YLR417W VPS36     NEW C 46 
YPL002C SNF8   YES NEW C 49 
YJR079W   mitoc   NEW C 49 
YDR495C VPS3     genome C 50 
YDL232W OST4     NEW C 50 
YGL045W RIM8     NEW C 51 
YBR267W REI1   YES NEW C 52 
YEL007W       NEW C 53 
YGR260W TNA1     NEW C 55 
YMR275C BUL1     NEW C 56 
YBR081C SPT7     NEW C 57 
YKL037W AIM26 ?   genome C 57 
YLR357W RSC2     NEW C 57 
YDL204W RTN2     NEW C 57 
YMR244C-A     YES genome C 58 
YJL126W NIT2   YES NEW C 58 
YHL012W     YES NEW C 59 
YGR229C SMI1     NEW C 59 
YLR042C       NEW C 61 
YGL226W MTC3 mitoc   genome C 63 
YMR238W DFG5     NEW C 66 
YGL212W VAM7   YES NEW C 66 
YNL320W   mitoc YES NEW C 68 
YPR135W CTF4     NEW C 68 
YMR154C RIM13     NEW C 68 
YDR403W DIT1     NEW C 70 
YOR322C LDB19     NEW C 72 
YPR029C APL4   YES NEW C 75 
YPL051W ARL3   YES NEW C 76 
YDR276C PMP3     NEW C 78 
YKL067W YNK1   YES NEW C 78 
YGL213C SKI8     NEW C 79 
YPR173C VPS4   YES NEW C 79 
YLR320W MMS22     NEW C 79 
YAL021C CCR4   YES NEW C 79 
YPL120W VPS30   YES NEW C 83 
YNL298W CLA4   YES NEW C 85 
YFL025C BST1   YES NEW C 87 
YOR286W RDL2 mitoc   genome D 57 
YLR015W BRE2     NEW D 65 
YBR126C TPS1     NEW D 67 
YJR033C RAV1     NEW D 73 
YAL002W VPS8     NEW D 76 
YGL012W ERG4   YES NEW D 80 
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YGL211W NCS6 mitoc YES NEW D 81 
YDR368W YPR1   YES NEW D 82 
YKR097W PCK1     NEW D 82 
YOL126C MDH2   YES NEW D 83 
YDR443C SSN2     NEW D 84 
YHR049W FSH1   YES NEW D 86 
YJL117W PHO86     NEW D 87 
YLR119W SRN2     NEW D 87 
YDR349C YPS7     NEW D 87 
YKR035W-A DID2   YES NEW D 91 
YDL119C   mitoc YES genome D 106 
YER117W RPL23B   YES NEW D 111 
YPL259C APM1   YES NEW D 117 
YAL046C AIM1 ? YES genome D 121 
YCL001W-A       genome D 129 
YOR068C VAM10     NEW D 263 
 
 
APPENDIX 3: List of 10 gene whose deletion caused EtOH specific phenotype. 
ORF GENE MITOC ORTHOLOG FILTER OXPHOS 
YBR298C MAL31     NEW EtOH SPECIFIC 
YDL203C ACK1 mitoc   NEW EtOH SPECIFIC 
YDR293C SSD1   YES NEW EtOH SPECIFIC 
YGL062W PYC1   YES NEW EtOH SPECIFIC 
YGR127W     YES NEW EtOH SPECIFIC 
YJR049C UTR1   YES NEW EtOH SPECIFIC 
YKL185W ASH1     NEW EtOH SPECIFIC 
YMR198W CIK1     NEW EtOH SPECIFIC 
YOR184W SER1   YES NEW EtOH SPECIFIC 
YPL066W       NEW EtOH SPECIFIC 
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APPENDIX 4: Total results of GO Term Finder analysis applied total list of 488 genes. 
GO TERM BIOLOGICAL PROCESS p-value genes
s GO:0007005 mitochondrion organization 6.45E-75 146 
GO:0032543 mitochondrial translation 1.84E-56 83 
GO:0006996 organelle organization 4.38E-33 220 
GO:0071842 cellular component organization at cellular level 7.16E-30 242 
GO:0016043 cellular component organization 7.13E-25 256 
GO:0097034 mitochondrial respiratory chain complex IV biogenesis 1.71E-16 18 
GO:0070271 protein complex biogenesis 2.14E-15 59 
GO:0071841 cellular component organization or biogenesis at cellular level 5.10E-15 250 
GO:0045333 cellular respiration 7.58E-15 38 
GO:0033108 mitochondrial respiratory chain complex assembly 8.80E-15 19 
GO:0071840 cellular component organization or biogenesis 1.33E-14 260 
GO:0000959 mitochondrial RNA metabolic process 2.27E-13 17 
GO:0000002 mitochondrial genome maintenance 1.10E-11 19 
GO:0006461 protein complex assembly 1.16E-11 51 
GO:0071822 protein complex subunit organization 2.12E-10 53 
GO:0006412 translation 3.33E-10 109 
GO:0043623 cellular protein complex assembly 3.63E-10 41 
GO:0033617 mitochondrial respiratory chain complex IV assembly 3.82E-10 11 
GO:0015980 energy derivation by oxidation of organic compounds 6.04E-10 39 
GO:0042773 ATP synthesis coupled electron transport 7.98E-10 15 
GO:0042775 mitochondrial ATP synthesis coupled electron transport 7.98E-10 15 
GO:0006119 oxidative phosphorylation 1.53E-09 15 
GO:0019538 protein metabolic process 1.89E-09 204 
GO:0044267 cellular protein metabolic process 2.02E-09 194 
GO:0070127 tRNA aminoacylation for mitochondrial protein translation 3.65E-09 10 
GO:0008535 respiratory chain complex IV assembly 3.92E-09 11 
GO:0022904 respiratory electron transport chain 5.05E-09 15 
GO:0009060 aerobic respiration 5.81E-09 26 
GO:0010821 regulation of mitochondrion organization 5.36E-08 11 
GO:0070129 regulation of mitochondrial translation 8.09E-08 10 
GO:0044249 cellular biosynthetic process 9.09E-08 241 
GO:0017004 cytochrome complex assembly 9.11E-08 8 
GO:0010822 positive regulation of mitochondrion organization 1.02E-07 9 
GO:0070131 positive regulation of mitochondrial translation 1.02E-07 9 
GO:0043038 amino acid activation 1.03E-07 16 
GO:0043039 tRNA aminoacylation 1.03E-07 16 
GO:0009058 biosynthetic process 1.42E-07 243 
GO:0006091 generation of precursor metabolites and energy 3.03E-07 42 
GO:0007035 vacuolar acidification 3.51E-07 12 
GO:0045851 pH reduction 3.51E-07 12 
GO:0051452 intracellular pH reduction 3.51E-07 12 
GO:0043162 ubiquitin-dependent protein catabolic process via the MVB pathway 3.96E-07 11 
GO:0030641 regulation of cellular pH 5.84E-07 12 
GO:0051453 regulation of intracellular pH 5.84E-07 12 
GO:0065003 macromolecular complex assembly 2.19E-06 64 
GO:0034220 ion transmembrane transport 2.31E-06 18 
GO:0000372 Group I intron splicing 2.72E-06 7 
GO:0000376 RNA splicing, via transesterification reactions 2.72E-06 7 
GO:0097033 mitochondrial respiratory chain complex III biogenesis 2.72E-06 7 
GO:0015992 proton transport 3.05E-06 14 
GO:0002097 tRNA wobble base modification 3.18E-06 11 
GO:0002098 tRNA wobble uridine modification 3.18E-06 11 
GO:0006885 regulation of pH 3.46E-06 12 
GO:0006818 hydrogen transport 4.23E-06 14 
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GO:0030004 cellular monovalent inorganic cation homeostasis 4.81E-06 13 
GO:0006122 mitochondrial electron transport, ubiquinol to cytochrome c 6.95E-06 7 
GO:0006418 tRNA aminoacylation for protein translation 9.37E-06 13 
GO:0010557 positive regulation of macromolecule biosynthetic process 1.11E-05 41 
 
GO TERM CELLULAR COMPONENT p-value genes 
GO:0044429 mitochondrial part 4.21E-78 191 
GO:0005739 mitochondrion 2.78E-58 242 
GO:0005759 mitochondrial matrix 2.64E-57 102 
GO:0000313 organellar ribosome 3.35E-44 58 
GO:0005761 mitochondrial ribosome 3.35E-44 58 
GO:0005743 mitochondrial inner membrane 4.43E-32 80 
GO:0019866 organelle inner membrane 5.95E-32 82 
GO:0005740 mitochondrial envelope 1.61E-28 102 
GO:0044444 cytoplasmic part 1.04E-27 349 
GO:0000315 organellar large ribosomal subunit 4.27E-26 32 
GO:0005762 mitochondrial large ribosomal subunit 4.27E-26 32 
GO:0031966 mitochondrial membrane 1.73E-24 92 
GO:0043226 organelle 6.04E-21 427 
GO:0043229 intracellular organelle 6.04E-21 427 
GO:0031967 organelle envelope 9.02E-21 108 
GO:0031975 envelope 9.02E-21 108 
GO:0043227 membrane-bounded organelle 7.10E-19 406 
GO:0043231 intracellular membrane-bounded organelle 7.10E-19 406 
GO:0005840 ribosome 8.69E-18 68 
GO:0000314 organellar small ribosomal subunit 1.75E-17 23 
GO:0005763 mitochondrial small ribosomal subunit 1.75E-17 23 
GO:0005737 cytoplasm 8.29E-17 408 
GO:0044422 organelle part 1.14E-16 317 
GO:0044446 intracellular organelle part 1.14E-16 317 
GO:0044455 mitochondrial membrane part 4.84E-16 46 
GO:0031974 membrane-enclosed lumen 1.62E-13 155 
GO:0015934 large ribosomal subunit 2.39E-12 38 
GO:0005746 mitochondrial respiratory chain 1.63E-11 16 
GO:0070469 respiratory chain 4.10E-11 17 
GO:0043233 organelle lumen 1.05E-10 142 
GO:0070013 intracellular organelle lumen 1.05E-10 142 
GO:0031090 organelle membrane 1.17E-10 144 
GO:0032991 macromolecular complex 1.87E-09 221 
GO:0015935 small ribosomal subunit 1.02E-08 27 
GO:0005622 intracellular 4.76E-08 457 
GO:0044424 intracellular part 1.21E-07 455 
GO:0016469 proton-transporting two-sector ATPase complex 1.10E-06 13 
GO:0044440 endosomal part 1.25E-06 22 
GO:0005758 mitochondrial intermembrane space 1.28E-06 15 
GO:0005750 mitochondrial respiratory chain complex III 2.19E-06 7 
GO:0045275 respiratory chain complex III 2.19E-06 7 
GO:0031970 organelle envelope lumen 5.69E-06 15 
GO:0033588 Elongator holoenzyme complex 1.96E-05 5 
GO:0005768 endosome 3.69E-05 26 
GO:0016602 CCAAT-binding factor complex 4.34E-05 4 
GO:0009295 nucleoid 6.26E-05 9 
GO:0042645 mitochondrial nucleoid 6.26E-05 9 
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APPENDIX 5: Total results of GO Slim Mapper analysis applied total list of 488 genes 
GOID GO term 
 
Gene(s) 
8150  biological process unknown 34 
AIM1, YBL036C, YCL001W-A, LDB16, YCR051W, 
YDL012C, UBX3, YDL129W, YDL157C, RTN2, 
YDR114C, OMS1, IRC3, HEH2, MIT1, AIM10, MTC3, 
FMP43, YHL012W, FSH1, YIR024C, NIT2, AIM23, 
YJR079W, YLR042C, YLR125W, NKP2, AIM31, AIM33, 
YMR244C-A, IES2, YNL320W, YOL087C, RDL2 
6366 
 transcription from RNA 
polymerase II promoter 
27 
CCR4, RXT2, SGF29, MED2, UME6, SSN2, EMI1, 
SRB5, ELP2, RIM101, KTI12, RTT109, SPT8, SWI6, 
RSC2, IKI3, VPS36, MSS11, SPT21, ELP6, EAF7, 
GCR2, POP2, HTZ1, SNF8, ELP3, ELP4 
42221  response to chemical stimulus 16 
UME6, YPR1, SSN2, RIM101, YHI9, SLT2, UBA4, BCK1, 
SWI6, STE11, VPS36, ASC1, SKY1, CLA4, SNF8, BRO1 
6605  protein targeting 15 
VPS8, STP22, PEX5, VPS3, SLT2, MOG1, DID2, SRN2, 
VPS36, SKY1, MDH2, SNF8, VPS28, BRO1, VPS30 
70271  protein complex biogenesis 12 
SPT7, RAV2, PEX5, SEM1, PPM1, MZM1, EMI1, SKI8, 
RAV1, IRC25, YKE2, VPS4 
51603 
 proteolysis involved in cellular 
protein catabolic process 
12 
STP22, SEM1, BST1, DID4, DOA1, SRN2, VPS36, 
UBX2, SNF8, VPS28, BRO1, VPS30 
7005  mitochondrion organization 11 
RRG1, YDR115W, MZM1, EMI1, YJR120W, CCE1, 
GEP5, BUL1, SWS2, RRG8, NAT3 
278  mitotic cell cycle 11 
CCR4, SHE1, REI1, XRN1, SMI1, ARP1, SIC1, SWI6, 
CLA4, RTS1, CTF4 
43934  sporulation 10 
DIT1, EMI1, RIM101, YVH1, IRC19, UBI4, RIM9, SWS2, 
SPO21, RIM20 
5975  carbohydrate metabolic process 9 
TPS1, OST4, TPS2, YPR1, MNN11, PCK1, MSS11, 
GCR2, MDH2 
9451  RNA modification 9 
NCS6, ELP2, UBA4, KTI12, IKI3, TRM9, ELP6, ELP3, 
ELP4 
16197  endosome transport 9 
VPS8, STP22, TDA3, RAV1, DID4, DID2, BRO1, VPS30, 
VPS4 
51321  meiotic cell cycle 9 
UME6, RIM8, SKI8, RIM101, YVH1, SWI6, MMS22, 
SPO21, RTS1 
71554 
 cell wall organization or 
biogenesis 
9 
YPS7, DIT1, SMI1, RIM101, SLT2, YVH1, STE11, DFG5, 
SPO21 
8033  tRNA processing 9 
NCS6, ELP2, UBA4, KTI12, IKI3, TRM9, ELP6, ELP3, 
ELP4 
43543  protein acylation 9 
SPT7, SGF29, MAK31, ARD1, RTT109, SPT8, EAF7, 
MAK3, NAT3 
51726  regulation of cell cycle 8 CCR4, UME6, SEM1, XRN1, SMI1, SIC1, CLA4, RTS1 
6325  chromatin organization 8 
SPT7, SGF29, ARD1, RTT109, BRE2, SPT8, RSC2, 
EAF7 
6468  protein phosphorylation 8 NBP2, DBF2, SLT2, BCK1, SIC1, STE11, SKY1, CLA4 
6401  RNA catabolic process 8 CCR4, PAT1, XRN1, SKI8, IRC25, STO1, POP2, HTZ1 
18193  peptidyl-amino acid modification 8 
SPT7, SGF29, ARD1, RTT109, BRE2, SPT8, EAF7, 
NAT3 
6873  cellular ion homeostasis 8 
RRG1, RAV2, PMP3, VPS3, DBF2, VMA10, RAV1, 
SKY1 
23052  signaling 8 YHI9, SLT2, YVH1, BCK1, SWI6, STE11, ASC1, CLA4 
6397  mRNA processing 7 CCR4, SLT2, SWI6, STO1, SKY1, POP2, CBC2 
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6974 
 response to DNA damage 
stimulus 
7 YNK1, DOA1, RTT109, MMS22, RSC2, EAF7, CTF4 
16570  histone modification 7 SPT7, SGF29, ARD1, RTT109, BRE2, SPT8, EAF7 
2181  cytoplasmic translation 7 
RPL23B, RPS27B, MTG2, RPL39, RPL14A, RPL13B, 
RPL43A 
1403 
 invasive growth in response to 
glucose limitation 
7 RXT2, RIM8, UBA4, STE11, ASC1, MSS11, RIM20 
70647 
 protein modification by small 
protein conjugation or removal 
7 NCS6, ELP2, UBA4, UBI4, BUL1, ELP6, BRO1 
6281  DNA repair 6 DOA1, RTT109, MMS22, RSC2, EAF7, CTF4 
6629  lipid metabolic process 6 UME6, BST1, ERG4, ERG2, VPS30, VPS4 
51169  nuclear transport 6 REI1, ASM4, SEM1, SLT2, MOG1, SKY1 
7124  pseudohyphal growth 6 UME6, UBA4, STE11, MSS11, DFG5, DFG16 
48193  Golgi vesicle transport 6 BST1, TED1, PHO86, ARL3, APM1, APL4 
10324  membrane invagination 5 RIM8, VAM7, VAM3, LDB19, VPS30 
7033  vacuole organization 5 VPS3, VAM7, CLA4, VAM10, VAM3 
7059  chromosome segregation 5 PAT1, MMS22, RSC2, RTS1, CTF4 
16050  vesicle organization 5 BST1, VAM7, DID4, VAM3, VPS4 
7031  peroxisome organization 5 PEX5, SLT2, BCK1, MDH2, VPS30 
8380  RNA splicing 4 MRS4, STO1, SKY1, CBC2 
55085  transmembrane transport 4 FUR4, SLT2, SKY1, CLA4 
746  conjugation 4 SPT7, RXT2, PRM7, STE11 
6310  DNA recombination 4 SKI8, IRC19, MMS22, CTF4 
6260  DNA replication 4 CCR4, HUR1, MMS22, CTF4 
7114  cell budding 4 REI1, UBA4, DFG5, CLA4 
48308  organelle inheritance 4 VPS3, BUL1, CLA4, NAT3 
15931 
 nucleobase-containing 
compound transport 
4 FUR4, ASM4, SEM1, TNA1 
51604  protein maturation 4 RIM8, RIM13, DFG16, RIM20 
6417  regulation of translation 4 PAT1, MTQ2, EAP1, ASC1 
7010  cytoskeleton organization 3 SHE1, ARP1, NAT3 
31399 
 regulation of protein modification 
process 
3 NBP2, SIC1, STE11 
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6970  response to osmotic stress 3 NBP2, STE11, STO1 
42594  response to starvation 3 SIC1, VAM3, VPS30 
910  cytokinesis 3 RIM101, SLT2, CLA4 
8213  protein alkylation 3 MTQ2, PPM1, BRE2 
6091 
 generation of precursor 
metabolites and energy 
3 YJR120W, CSF1, GCR2 
6811  ion transport 3 PMP3, PHO86, MRS4 
6354 
 transcription elongation,  DNA-
dependent 
3 CCR4, RSC2, POP2 
51049  regulation of transport 3 SLT2, PHO86, SKY1 
9408  response to heat 3 ASM4, NBP2, STE11 
61025  membrane fusion 3 VAM7, VAM10, VAM3 
6352 
 transcription initiation,  DNA-
dependent 
2 MED2, SRB5 
6869  lipid transport 2 YJR120W, CLA4 
6486  protein glycosylation 2 OST4, MNN11 
6520 
 cellular amino acid metabolic 
process 
2 UTR4, PRO2 
70925  organelle assembly 2 RPS27B, YVH1 
6979  response to oxidative stress 2 YPR1, UBA4 
32196  transposition 2 RTT109, STE11 
6457  protein folding 2 PHO86, YKE2 
42255  ribosome assembly 2 RPS27B, YVH1 
32543  mitochondrial translation 2 YDR115W, SWS2 
9311 
 oligosaccharide metabolic 
process 
2 TPS1, TPS2 
6470  protein dephosphorylation 2 YVH1, RTS1 
6364  rRNA processing 2 XRN1, RPS27B 
6897  endocytosis 2 RIM8, LDB19 
48285  organelle fission 2 DBF2, CTF4 
42273 
 ribosomal large subunit 
biogenesis 
2 REI1, YVH1 
48284  organelle fusion 2 VAM7, VAM3 
6413  translational initiation 1 PAT1 
42274 
 ribosomal small subunit 
biogenesis 
1 RPS27B 
6997  nucleus organization 1 ASM4 
6887  exocytosis 1 SEM1 
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45333  cellular respiration 1 YJR120W 
6383 
 transcription from RNA 
polymerase III promoter 
1 MAF1 
51052 
 regulation of DNA metabolic 
process 
1 CCR4 
55086 
 nucleobase-containing small 
molecule metabolic process 
1 YNK1 
32200  telomere organization 1 BRE2 
 
 
APPENDIX 6: Primer used in YIR024C characterization 
Primer Sequence 5’-3’ Used For 
FWYIR024c GGGCGAATTCGCCGTCTAGTAACTGACTGGCTG cassette transf. 
RVYIR024c GGGCGGATCCCCCTCTAATACATCTTCACCAAG cassette transf. 
A1YIR024c CCTTCCGCGTTTTGAGCTCGTG cassette transf. 
K3 GGAGAAAACTCACCGAGGC cassette transf. 
Y024CFWBam CGCGGGATCCCGTGCTGCCTGAAGTCTTCCTC tagging 
Y024CHA3RVPst 
GCGCCTGCAGTCAAGCGTAATCTGGAACATCGTATGGGTAAGC
GTAATCTGGAACATCGTATGGGTAAGCGTAATCTGGAACATCGT
ATGGGTATAGAAATTTTGGGATTTTATCATGTTCTTTGGC 
tagging 
 
